UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 1, 2013
ACTAVIS PLC
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
|
Ireland
|
|
001-13305
|
|
98-1114402
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
70 Sir John Rogerson’s Quay
Dublin 2, Ireland
(Address of Principal Executive Offices)
(862) 261-7000
(Registrant’s telephone number, including area code)
N/A
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01. Entry into a Material Definitive Agreement.
Amended and Restated Actavis Credit and Guaranty Agreements
On October 1, 2013 (the “Closing Date”) and pursuant to that certain Term Loan Amendment Agreement (the “Term Amendment
Agreement”), by and among Actavis, Inc. (“Actavis”), Bank of America, N.A. (“BofA”), as administrative agent thereunder, and the lenders party thereto, dated as of August 1, 2013, Actavis plc (“New Actavis”
and formerly known as Actavis Limited), as parent guarantor, Actavis WC Holding S.à r.l. (the “ACT Borrower”), as borrower, Actavis, as a subsidiary guarantor, and BofA, as administrative agent, entered into that certain Amended and
Restated Actavis Term Loan Credit and Guaranty Agreement (the “ACT Term Loan Agreement”), dated as of October 1, 2013. The ACT Term Loan Agreement amends and restates Actavis’ existing $1.8 billion senior unsecured term loan
credit agreement dated as of June 22, 2012.
On the Closing Date and pursuant to that certain Revolver Loan Amendment Agreement (the
“Revolver Amendment Agreement” and, together with the Term Amendment Agreement, the “Amendment Agreements”), by and among Actavis, BofA, as administrative agent thereunder, and the lenders party thereto, dated as of
August 1, 2013, New Actavis, as parent guarantor, the ACT Borrower, as borrower, Actavis, as a subsidiary guarantor, and BofA, as administrative agent, entered into that certain Amended and Restated Actavis Revolving Credit and Guaranty
Agreement (the “ACT Revolving Credit Agreement” and, together with the ACT Term Loan Agreement, the “Amended and Restated Credit Agreements”), dated as of October 1, 2013. The ACT Revolving Credit Agreement amends and
restates Actavis’ existing $750 million senior unsecured revolving credit agreement dated as of September 16, 2011, as amended by that certain Amendment No. 1 to Credit Agreement and Joinder Agreement dated as of May 21, 2012.
WC Term Loan Credit and Guaranty Agreement
On the Closing Date, Warner Chilcott Corporation, a Delaware corporation (“WC Corporation”), WC Luxco S.à r.l., a private
limited liability company (société à responsabilité limitée), incorporated under the laws of the Grand-Duchy of Luxembourg (“WC Luxco”), Warner Chilcott Company, LLC, a limited liability company organized
under the laws of the Commonwealth of Puerto Rico (“WC Company” and, together with WC Corporation and WC Luxco, the “WC Borrowers”) and Warner Chilcott Finance LLC, as a subsidiary guarantor, became parties to that certain WC
Term Loan Credit and Guaranty Agreement (the “WC Term Loan Agreement”) dated as of August 1, 2013, by and among New Actavis, as parent guarantor, BofA, as administrative agent thereunder and a syndicate of banks participating as
lenders. Pursuant to the WC Term Loan Agreement, on the Closing Date, the lenders party thereto provided loans to the WC Borrowers in a total aggregate principal amount of $2.0 billion, comprised of (i) a tranche pursuant to which loans were
made in US Dollars to each of the WC Borrowers in a total aggregate principal amount of $1.0 billion, which loans will mature on the third anniversary of the Closing Date and (ii) a tranche pursuant to which loans were made in US Dollars to
each of the WC Borrowers in a total aggregate principal amount of $1.0 billion, which loans will mature on the fifth anniversary of the Closing Date. The proceeds of borrowings under the WC Term Loan Agreement were used to finance, in part, the
repayment in full of all amounts owing under that certain Credit Agreement, dated as of March 17, 2011, as amended by Amendment No. 1 on August 20, 2012, among the WC Borrowers, BofA. as administrative agent thereunder and a syndicate
of banks participating as lenders.
The foregoing description of the Amendment Agreements, the Amended and Restated Credit Agreements and
the WC Term Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the full texts thereof filed as Exhibits 10.1 through 10.5 to Actavis’ current report filed on Form 8-K dated as of August 2, 2013,
and incorporated herein by reference
.
Actavis Supplemental Indenture
On October 1, 2013, New Actavis, Actavis and Wells Fargo Bank, National Association, as trustee, entered into a fourth supplemental
indenture (the “Fourth Supplemental Indenture”) to the indenture, dated as of August 24, 2009 (the “Base Indenture” and, together with the First Supplemental Indenture, the Second Supplemental Indenture and the Third
Supplemental Indenture (each as defined below), the “Indenture”), as supplemented by the first supplemental indenture, dated as of August 24, 2009 (the “First Supplemental Indenture”), the second supplemental indenture,
dated as of May 7, 2010 (the “Second Supplemental Indenture”), and the third supplemental indenture, dated as of October 2, 2012 (the “Third Supplemental Indenture”). Pursuant to the Fourth Supplemental Indenture, New
Actavis has provided a full and unconditional guarantee of Actavis’ obligations under its 5.000% Senior Notes due August 15, 2014, (the “2014 Notes”), 6.125% Senior Notes due August 15, 2019 (the “2019 Notes”),
1.875% Senior Notes due 2017 (the “2017 Notes”), 3.250% Senior Notes due 2022 (the “2022 Notes”) and 4.625% Senior Notes due 2042 (the “2042 Notes,” and together with the 2014 Notes, the 2019 Notes, the 2017 Notes and
the 2022 Notes, the “Notes”). The Fourth Supplemental Indenture is filed as Exhibit 4.1 to this Current Report and is incorporated by reference as if set forth in full.
WC Supplemental Indenture
On October 1, 2013, New Actavis, WC Company, Warner Chilcott Finance LLC (the “Co-Issuer” and together with WC Company, the
“Issuers”) and Wells Fargo Bank, National Association, as trustee (the “WC Trustee”), entered into a third supplemental indenture (the “Supplemental Indenture”) to the indenture, dated as of August 20, 2010 (the
“WC Indenture”), among the Issuers, the guarantors party thereto and the WC Trustee, with respect to the Issuers’ 7
3
⁄
4
% senior notes due 2018
(the “WC Notes”). Pursuant to the Supplemental Indenture, New Actavis has provided a full and unconditional guarantee of the Issuers’ obligations under the WC Notes and the WC Indenture. The Supplemental Indenture is filed as Exhibit
4.2 to this Current Report and is incorporated by reference as if set forth in full.
On October 1, 2013, the Issuers and the Trustee entered into a Release of Guarantees of
Certain Guarantors (the “Release of Guarantees”), pursuant to which Warner Chilcott’s guarantee of the Notes was released in accordance with Section 11.05(f) of the Indenture and the guarantees of certain other guarantors were
released in accordance with Section 11.05(c) or 11.05(e) of the Indenture.
Indemnification Agreements
Effective October 1, 2013, New Actavis entered into deeds of indemnification (the “Deeds of Indemnification”) with certain
directors and officers of New Actavis. The Deeds of Indemnification provide indemnification to such directors and officers to the fullest extent permitted by the laws of Ireland, and in accordance with New Actavis’ Memorandum and Articles of
Association, for all expenses actually and reasonably incurred in any action or proceeding in which the officer or director is or may be involved in by reason of the fact that he or she is or was a New Actavis officer or director, on the terms and
conditions set forth in the Deeds of Indemnification. Further, New Actavis agrees to advance expenses incurred in defense of these proceedings, on the terms and conditions set forth in the Deeds of Indemnification. The Deeds of Indemnification also
provide procedures for requesting and obtaining indemnification and advancement of expenses.
Effective October 1, 2013, Actavis W.C.
Holding Inc. (“U.S. Holdco”), an indirectly wholly-owned subsidiary of Actavis plc, entered into indemnification agreements (the “Holdco Indemnification Agreements”) with certain directors and executive officers of New Actavis.
The Holdco Indemnification Agreements provide indemnification to such directors and officers to the fullest extent permitted by the General Corporation Law of Delaware, and in accordance with U.S. Holdco’s Bylaws, for all expenses actually and
reasonably incurred in any action or proceeding in which the director or officer is or may be involved by reason of the fact that he or she is or was a U.S. Holdco director or officer, on the terms and conditions set forth in the Holdco
Indemnification Agreements. Further, U.S. Holdco agrees to advance expenses incurred in defense of these proceedings, on the terms and conditions set forth in the Holdco Indemnification Agreements. The Holdco Indemnification Agreements also provide
procedures for requesting and obtaining indemnification and advancement of expenses.
The foregoing descriptions of the Deeds of
Indemnification and the Holdco Indemnification Agreements are general descriptions only and are qualified in their entirety by reference to the forms of the Deed of Indemnification and Indemnification Agreement, respectively, which are filed as
Exhibits 10.6 and 10.7 hereto, respectively, and incorporated herein by reference.
Item 1.02. Termination of a Material Definitive Agreement.
In connection with the completion of the Transactions (as defined below), on October 1, 2013, the WC Borrowers paid in full all
amounts owing under that certain Credit Agreement, dated as of March 17, 2011, as amended by Amendment No. 1 on August 20, 2012 (the “Existing WC Credit Agreement”), among the WC Borrowers, Bank of America, N.A. as
administrative agent thereunder and a syndicate of banks participating as lenders. At the time of such payment, the Existing WC Credit Agreement and all commitments to extend further credit under the Existing WC Credit Agreement were terminated and
all liens securing obligations thereunder were released.
Item 2.01. Completion of Acquisition or Disposition of Assets.
On October 1, 2013, pursuant to the transaction agreement, dated May 19, 2013, among Actavis, Warner Chilcott Public Limited Company
(“Warner Chilcott”), New Actavis, Actavis Ireland Holding Limited, Actavis W.C. Holding LLC (now known as Actavis W.C. Holding Inc.) and Actavis W.C. Holding 2 LLC (now known as Actavis W.C. Holding 2 Inc.) (“MergerSub”) (the
“Transaction Agreement”), (a) New Actavis acquired Warner Chilcott (the “Acquisition”) pursuant to a scheme of arrangement under Section 201, and a capital reduction under Sections 72 and 74, of the Irish Companies Act
of 1963 (the “Scheme”) and (b) MergerSub merged with and into Actavis, with Actavis as the surviving corporation in the merger (the “Merger” and, together with the Acquisition, the “Transactions”). Following the
consummation of the Transactions, each of Actavis and Warner Chilcott became wholly owned subsidiaries of New Actavis.
Pursuant to the
terms of the Transaction Agreement, each Warner Chilcott ordinary share (the “Warner Chilcott Ordinary Shares”) was converted into the right to receive 0.160 of a New Actavis ordinary share (the “New Actavis Ordinary Shares”),
and each of Actavis’ common shares (the “Actavis Common Shares”) was converted into the right to receive one New Actavis Ordinary Share.
The issuance of New Actavis Ordinary Shares in connection with the Transactions was registered
under the Securities Act of 1933, as amended, pursuant to New Actavis’ registration statement on Form S-4 (File No. 333-189402) (the “Registration Statement”) filed with the SEC and declared effective on July 31, 2013. The
definitive joint proxy statement/prospectus of Actavis and Warner Chilcott, dated July 31, 2013, that forms a part of the Registration Statement contains additional information about the Transactions and the other transactions contemplated by
the Transaction Agreement, including a description of the treatment of equity awards and information concerning the interests of directors, executive officers and affiliates of Actavis and Warner Chilcott in the Transactions.
Pursuant to Rule 12g-3(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), New Actavis is the successor
issuer to Actavis and to Warner Chilcott. New Actavis’ Ordinary Shares are deemed to be registered under Section 12(b) of the Exchange Act, and New Actavis is subject to the informational requirements of the Exchange Act, and the rules and
regulations promulgated thereunder. New Actavis hereby reports this succession in accordance with Rule 12g-3(f) under the Exchange Act. New Actavis’ Ordinary Shares were approved for listing on the New York Stock Exchange (“NYSE”) and
trade under the symbol “ACT.”
Prior to the Transactions, Actavis’ Common Shares were registered pursuant to
Section 12(b) of the Exchange Act and listed on the NYSE. Warner Chilcott’s Ordinary Shares were registered pursuant to Section 12(b) of the Exchange Act and listed on the NASDAQ. Both the Actavis Common Shares and the Warner Chilcott
Ordinary Shares were suspended from trading on the NYSE and the NASDAQ, respectively, prior to the open of trading on October 1, 2013. Warner Chilcott expects to file a Form 15 with the SEC to terminate the registration under the Exchange
Act of the Warner Chilcott Ordinary Shares. Actavis currently intends to file a Form 15 with the SEC to terminate the registration of the Actavis Common Shares under the Exchange Act and suspend its reporting obligations under Section 15(d) of
the Exchange Act in January 2014.
The foregoing description of the Transaction Agreement and the Transactions does not purport to be
complete and is qualified in its entirety by reference to the full text of the Transaction Agreement filed as Exhibit 2.1 to Actavis’ current report filed on Form 8-K dated as of May 23, 2013, and incorporated herein by reference.
Item 2.03. Creation of a Direct Financial Obligation.
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.
Item 3.03. Material Modification to Rights of Security Holders.
In connection with the Transactions, on October 1, 2013, each Actavis Common Share was cancelled and automatically converted into the
right to receive one New Actavis Ordinary Share. The information set forth in Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.
The issuance of New Actavis ordinary shares in connection with the Transactions was registered under the Securities Act of 1933, as amended,
pursuant to New Actavis’ registration statement on Form S-4 (File No. 333-189402) (the “Registration Statement”) filed with the Securities and Exchange Commission (the “SEC”) and declared effective on July 31,
2013. The definitive joint proxy statement/prospectus of Actavis and Warner Chilcott, dated July 31, 2013, that forms a part of the Registration Statement (the “Joint Proxy Statement/Prospectus”) contains additional information about
the Transactions and the other transactions contemplated by the Transaction Agreement, including information concerning the interests of directors, executive officers and affiliates of Actavis and Warner Chilcott in the Transactions.
Actavis’ common shares (the “Actavis Common Shares”) were registered pursuant to Section 12(b) of the Exchange Act and
listed on the NYSE. Warner Chilcott’s ordinary shares (the “Warner Chilcott Ordinary Shares”) were registered pursuant to Section 12(b) of the Exchange Act and listed on the NASDAQ Global Select Market (the “NASDAQ”).
The Actavis Common Shares and the Warner Chilcott Ordinary Shares were delisted from the NYSE and the NASDAQ, respectively, prior to the open of trading on October 1, 2013. Warner Chilcott expects to file a Form 15 with the SEC to terminate the
registration under the Exchange Act of the Actavis Common Shares and the Warner Chilcott Ordinary Shares, respectively. Actavis currently intends to file a Form 15 with the SEC to terminate the registration of the Actavis Common Shares under the
Exchange Act and suspend its reporting obligations under Section 15(d) of the Exchange Act in January 2014.
Item 5.01. Changes in Control of
Registrant.
The information set forth in Item 2.01 is incorporated by reference into this Item 5.01.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On October 1, 2013, in connection with the consummation of the Transactions, New Actavis amended and restated its memorandum and articles
of association. The New Amended and Restated Memorandum and articles of association of New Actavis are attached hereto as Exhibits 3.2 and are incorporated herein by reference.
Item 7.01. Regulation FD Disclosure.
New Actavis’ news release announcing the completion of the Acquisition is furnished as Exhibit 99.1 to this Form 8-K.
The information in the news release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
|
(a)
|
Financial Statements of Business Acquired
|
The combined/consolidated financial statements of
Actavis Pharma Holding 4 ehf. and Actavis S.à r.l. as of December 31, 2011, 2010, and 2009, and for each of the years in the three-year period ended December 31, 2011, and the combined condensed interim financial statements of
Actavis and Warner Chilcott as of June 30, 2012, and 2011, and for each of the six month interim periods in the two-year period ended June 30, 2012 are substantially the same as those that were incorporated by reference into the Form S-4
that was declared effective on July 31, 2013. Accordingly, no additional financial statements are required to be included herein.
|
(b)
|
Pro Forma Financial Information
|
The pro forma financial information of New Actavis that is
required by this Item is substantially the same as the pro forma information that was included in the Form S-4 that was declared effective on July 31, 2013. Accordingly, no additional pro forma information of New Actavis is required to be
included herein.
|
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
2.1
|
|
Transaction Agreement, dated May 19, 2013, by and among Actavis, Inc., Warner Chilcott Public Limited Company, Actavis Limited (now known as Actavis plc), Actavis Ireland Holding Limited, Actavis W.C. Holding LLC (now known as
Actavis W.C. Holding Inc.) and Actavis W.C. Holding 2 LLC (now known as Actavis W.C. Holding 2 Inc.) (incorporated by reference to Exhibit 2.1 of Actavis, Inc.’s May 23, 2013 Current Report on Form 8-K).
|
|
|
|
|
3.1
|
|
Certificate of Incorporation of Actavis plc (formerly known as Actavis Limited).
|
|
|
|
|
3.2
|
|
Amended and Restated Memorandum and Articles of Association of Actavis plc (formerly known as Actavis Limited).
|
|
|
|
|
4.1
|
|
Fourth Supplemental Indenture, dated as of October 1, 2013, by and among Actavis, Inc., Actavis plc (formerly known as Actavis Limited) and Wells Fargo Bank, National Association, as trustee.
|
|
|
|
|
4.2
|
|
Third Supplemental Indenture, dated as of October 1, 2013, by and among Warner Chilcott Company, LLC, Warner Chilcott Finance LLC, Actavis plc (formerly known as Actavis Limited) and Wells Fargo Bank, National Association, as
trustee.
|
|
|
|
|
|
|
|
|
10.1
|
|
Term Loan Amendment Agreement, by and among Actavis, Inc., Bank of America, N.A., as Administrative Agent, and the lenders party thereto, dated as of August 1, 2013 (incorporated by reference to Exhibit 10.1 of Actavis, Inc.’s
August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.2
|
|
Revolver Loan Amendment Agreement, by and among Actavis, Inc., Bank of America, N.A., as Administrative Agent, and the lenders party thereto, dated as of August 1, 2013 (incorporated by reference to Exhibit 10.2 of Actavis,
Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.3
|
|
Amended and Restated Actavis Term Loan Credit Facility, by and among Actavis WC Holding S.à r.l., Actavis, Inc., Actavis plc (formerly known as Actavis Limited), the lenders from time to time party thereto and Bank of
America, N.A., as Administrative Agent, to be dated as of the Closing Date (incorporated by reference to Exhibit 10.3 of Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.4
|
|
Amended and Restated Actavis Revolving Credit Facility, by and among Actavis WC Holding S.à r.l., Actavis, Inc., Actavis plc (formerly known as Actavis Limited), the lenders from time to time party thereto and Bank of
America, N.A., as Administrative Agent, to be dated as of the Closing Date (incorporated by reference to Exhibit 10.4 of Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.5
|
|
WC Term Loan Credit and Guaranty Facility, dated as of August 1, 2013, by and among Actavis Limited, Warner Chilcott Corporation, WC Luxco S.à r.l, Warner Chilcott Company, LLC, Warner Chilcott Finance LLC, the lenders from
time to time party thereto and Bank of America, N.A., as administrative agent thereunder (incorporated by reference to Exhibit 10.5 to Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.6
|
|
Form of Deed of Indemnification, Actavis plc.
|
|
|
|
|
10.7
|
|
Form of Indemnification Agreement, Actavis W.C. Holding Inc.
|
|
|
|
|
99.1
|
|
Press Release issued by Actavis plc on October 1, 2013.
|
FORWARD-LOOKING STATEMENTS
This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning Actavis,
Actavis plc, Warner Chilcott, the acquisition and other transactions contemplated by the Transaction Agreement, acquisition financing, Actavis’, Actavis plc’s or Warner Chilcott’s long-term credit rating and revenues and operating
earnings. These statements or disclosures may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to Actavis, Actavis plc or Warner
Chilcott, based on current beliefs of management as well as assumptions made by, and information currently available to, management. It is important to note that Actavis’, Actavis plc’s and Warner Chilcott’s goals and expectations are
not predictions of actual performance. Actavis’, Actavis plc’s or Warner Chilcott’s performance, at times, will differ from its goals and expectations. Forward-looking statements generally will be accompanied by words such as
“anticipate,” “believe,” “plan,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “possible,” “potential,”
“predict,” “project” or other similar words, phrases or expressions. These forward-looking statements are subject to various risks and uncertainties, many of which are outside of our control. Therefore, you should not place undue
reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among others, the inherent uncertainty associated with financial projections; successful integration of
the Warner Chilcott acquisition and the ability to recognize the anticipated synergies and benefits of the Warner Chilcott acquisition; the difficulty of predicting the timing and outcome of pending or future litigation and government investigations
and risks that an adverse outcome in such litigation or investigations could render Actavis, Actavis plc or Warner Chilcott liable for substantial damages or penalties; risks that resolution of patent infringement litigation through settlement could
result in investigations or actions by private parties or government authorities or agencies; the impact of competitive products and pricing; risks related to fluctuations in foreign currency exchange rates; periodic dependence on a small number of
products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and
circumstances; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and regulatory agency approvals or actions, if any; risks and uncertainties normally incident to the
pharmaceutical industry, including product liability claims and the availability of product liability insurance on reasonable terms; market acceptance of and continued demand for Actavis’, Actavis plc’s or Warner Chilcott’s products;
difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with governmental regulations applicable to Actavis’, Actavis plc’s or Warner Chilcott’s
facilities, products and/or businesses; and changes in the laws and regulations, including Medicare, Medicaid, and similar laws in foreign countries affecting, among other things, pricing and reimbursement of pharmaceutical products and the
settlement of patent litigation. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and such other risks and uncertainties detailed in Actavis, Inc.’s periodic public filings with the Securities
and Exchange Commission, including but not limited to Actavis, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2012 (as revised pursuant to Actavis, Inc.’s Current Report on Form 8-K dated as of June 17, 2013, which was
filed with the SEC on June 18, 2013) and Quarterly Reports on Form 10-Q for the periods ended March 31, 2013 and June 30, 2013, and Warner Chilcott’s periodic public filings with the Securities and Exchange Commission, including but not limited
to Warner Chilcott’s Annual Report on Form 10-K for the year ended December 31, 2012 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2013 and June 30, 2013. Except as expressly required by law, Actavis disclaims any
intent or obligation to update these forward-looking statements.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
Date: October 2, 2013
|
|
|
|
ACTAVIS PLC
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ David A. Buchen
|
|
|
|
|
|
Name:
|
|
David A. Buchen
|
|
|
|
|
|
Title:
|
|
Chief Legal Officer – Global and Secretary
|
EXHIBIT INDEX
|
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
2.1
|
|
Transaction Agreement, dated May 19, 2013, by and among Actavis, Inc., Warner Chilcott Public Limited Company, Actavis Limited (now known as Actavis plc), Actavis Ireland Holding Limited, Actavis W.C. Holding LLC (now known as
Actavis W.C. Holding Inc.) and Actavis W.C. Holding 2 LLC (now known as Actavis W.C. Holding 2 Inc.) (incorporated by reference to Exhibit 2.1 of Actavis, Inc.’s May 23, 2013 Current Report on Form 8-K).
|
|
|
|
|
3.1
|
|
Certificate of Incorporation of Actavis plc (formerly known as Actavis Limited) (incorporated by reference to Exhibit 3.1 of Actavis plc’s October 1, 2013 Registration Statement on Form S-8).
|
|
|
|
|
3.2
|
|
Amended and Restated Memorandum and Articles of Association of Actavis plc (formerly known as Actavis Limited) (incorporated by reference to Exhibit 3.2 of Actavis plc’s October 1, 2013 Registration Statement on Form
S-8).
|
|
|
|
|
4.1
|
|
Fourth Supplemental Indenture, dated as of October 1, 2013, by and among Actavis, Inc., Actavis plc (formerly known as Actavis Limited) and Wells Fargo Bank, National Association, as trustee.
|
|
|
|
|
4.2
|
|
Third Supplemental Indenture, dated as of October 1, 2013, by and among Warner Chilcott Company, LLC, Warner Chilcott Finance LLC, Actavis plc (formerly known as Actavis Limited) and Wells Fargo Bank, National Association, as
trustee.
|
|
|
|
|
10.1
|
|
Term Loan Amendment Agreement, by and among Actavis, Inc., Bank of America, N.A., as Administrative Agent, and the lenders party thereto, dated as of August 1, 2013 (incorporated by reference to Exhibit 10.1 of Actavis, Inc.’s
August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.2
|
|
Revolver Loan Amendment Agreement, by and among Actavis, Inc., Bank of America, N.A., as Administrative Agent, and the lenders party thereto, dated as of August 1, 2013 ((incorporated by reference to Exhibit 10.2 of Actavis,
Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.3
|
|
Amended and Restated Actavis Term Loan Credit Facility, by and among Actavis WC Holding S.à r.l., Actavis, Inc., Actavis plc (formerly known as Actavis Limited), the lenders from time to time party thereto and Bank of
America, N.A., as Administrative Agent, to be dated as of the Closing Date (incorporated by reference to Exhibit 10.3 of Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.4
|
|
Amended and Restated Actavis Revolving Credit Facility, by and among Actavis WC Holding S.à r.l., Actavis, Inc., Actavis plc (formerly known as Actavis Limited), the lenders from time to time party thereto and Bank of
America, N.A., as Administrative Agent, to be dated as of the Closing Date (incorporated by reference to Exhibit 10.4 of Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.5
|
|
WC Term Loan Credit and Guaranty Facility, dated as of August 1, 2013, by and among Actavis Limited, Warner Chilcott Corporation, WC Luxco S.à r.l, Warner Chilcott Company, LLC, Warner Chilcott Finance LLC, the lenders from
time to time party thereto and Bank of America, N.A., as administrative agent thereunder (incorporated by reference to Exhibit 10.5 to Actavis, Inc.’s August 2, 2013 Current Report on Form 8-K).
|
|
|
|
|
10.6
|
|
Deed of Indemnification
|
|
|
|
|
10.7
|
|
Indemnification Agreement
|
|
|
|
|
99.1
|
|
Press Release issued by Actavis plc on October 1, 2013.
|
Exhibit 3.1
|
|
|
|
|
|
|
Number 527629
|
|
|
|
|
|
|
|
|
|
1524975
|
Certificate of Incorporation
on re-registration as a public limited company
I hereby certify that
ACTAVIS PUBLIC LIMITED COMPANY
has this day been re-registered under the
Companies Acts 1963 to 2009 and
that the
company is a public limited company.
Given under my hand at Dublin, this
Friday, the 20th day of September, 2013
|
|
|
|
|
|
|
|
for Registrar of Companies
|
|
|
|
|
|
Certificate handed to/posted to*:
|
|
Matheson
|
|
|
|
70 Sir John Rogerson’S Quay
|
|
|
|
Dublin 2
|
Signed
:
Date: 20-9-13
Exhibit 3.2
Companies Acts 1963 to 2012
A PUBLIC
COMPANY LIMITED BY SHARES
MEMORANDUM OF ASSOCIATION
-of-
ACTAVIS PUBLIC LIMITED COMPANY
(Amended and restated by special resolution dated 18 September 2013)
|
1
|
The name of the Company is Actavis public limited company.
|
|
2
|
The Company is to be a public limited company.
|
|
3
|
The objects for which the Company is established are
|
|
|
(a)
|
To carry on the business of a pharmaceuticals company, and to research, develop, design, manufacture, produce, supply, buy, sell, distribute, import, export, provide,
promote and otherwise deal in pharmaceuticals, active pharmaceutical ingredients and dosage pharmaceuticals and other devices or products of a pharmaceutical or healthcare character and to hold intellectual property rights and to do all things
usually dealt in by persons carrying on the above mentioned businesses or any of them or likely to be required in connection with any of the said businesses.
|
|
|
(b)
|
To carry on the business of a holding company and to co-ordinate the administration, finances and all other activities of any subsidiary companies or associated
companies, to do all lawful acts and things whatever that are necessary or convenient in carrying on the business of such a holding company including the incorporation of any one or more subsidiaries and in particular to carry on the business of a
management services company, to act as managers and to direct or coordinate the management of other companies or of the business, property and estates of any company or person and to undertake and carry out all such services in connection therewith
as may be deemed expedient by the Company’s board of directors and to exercise its powers as a shareholder of other companies.
|
|
|
(c)
|
To acquire the whole of the issued share capital of Warner Chilcott public limited company, a company incorporated under the laws of Ireland (registered number 471506).
|
|
3.2
|
To acquire shares, stocks, debentures, debenture stock, bonds, obligations and securities by original subscription, tender, purchase, exchange or otherwise and to
subscribe for the same either conditionally or otherwise, and to guarantee the subscription thereof and to exercise and enforce all rights and powers conferred by or incidental to the ownership thereof.
|
|
3.3
|
To facilitate and encourage the creation, issue or conversion of and to offer for public subscription debentures, debenture stocks, bonds, obligations, shares, stocks,
and securities and to act as trustees in connection with any such securities and to take part in the conversion of business concerns and undertakings into companies.
|
|
3.4
|
To purchase or by any other means acquire any freehold, leasehold or other property and in particular lands, tenements and hereditaments of any tenure, whether subject
or not to any charges or incumbrances, for any estate or interest whatever, and any rights, privileges or easements over or in respect of any property, and any buildings, factories, mills, works, wharves, roads, machinery, engines, plant, live and
dead stock, barges, vessels or things, and any real or personal property or rights whatsoever which may be necessary for, or may conveniently be used with, or may enhance the value or property of the Company, and to hold or to sell, let, alienate,
mortgage, charge or otherwise deal with all or any such freehold, leasehold, or other property, lands, tenements or hereditaments, rights, privileges or easements.
|
|
3.5
|
To establish and contribute to any scheme for the purchase of shares in the Company to be held for the benefit of the Company’s employees and to lend or otherwise
provide money to such schemes or the Company’s employees or the employees of any of its subsidiary or associated companies to enable them to purchase shares of the Company.
|
|
3.6
|
To sell, lease, exchange, grant, convey, transfer or otherwise dispose of any or all of the property, investment or assets of the Company of whatever nature or tenure
for such price, consideration, sum or other return whether equal to or less than the market value thereof and whether by way of gift or otherwise as the Directors shall deem fit and to grant any fee, farm grant or lease or to enter into any
agreement for letting or hire of any such property or asset for a rent or return equal to or less than the market or rack rent therefor or at no rent and subject to or free from covenants and restrictions as the Directors shall deem appropriate.
|
|
3.7
|
To acquire and undertake the whole or any part of the business, good-will and assets of any person, firm or company carrying on or proposing to carry on any of the
businesses which this Company is authorised to carry on, and as part of the consideration for such acquisition to undertake all or any of the liabilities of such person, firm or company, or to acquire an interest in, amalgamate with, or enter into
any arrangement for sharing profits, or for co-operation, or for limiting competition or for mutual assistance with any such person, firm or company and to give or accept by way of consideration for any of the acts or things aforesaid or property
acquired, any shares, debentures, debenture stock or securities that may be agreed upon, and to hold and retain or sell, mortgage or deal with any shares, debentures, debenture stock or securities so received.
|
|
3.8
|
To apply for, register, purchase, lease, hold, use, control, license or otherwise acquire any patents, brevets d’invention, copyrights, trademarks, licences,
concessions and the like conferring any exclusive or non-exclusive or limited rights to use or any secret or other inventing information as to any invention which may seem capable of being used for any of the purposes of the Company or the
acquisition of which may seem calculated directly or indirectly to benefit the Company, and to use, exercise, develop or grant licences in respect of or otherwise turn to account the property, rights or information so acquired.
|
2
|
3.9
|
To enter into partnership or into any arrangement for sharing profits, union of interests, co-operation, joint venture, reciprocal concession or otherwise with any
person or company carrying on or engaged in or about to carry on or engage in any business or transaction which the Company is authorised to carry on or engage in or any business or transaction capable of being conducted so as directly to benefit
this Company.
|
|
3.10
|
To invest and deal with the moneys of the Company not immediately required upon such securities and in such manner as may from time to time be determined.
|
|
3.11
|
To lend money to and guarantee the performance of the contracts or obligations of any company, firm or person, and the repayment of the capital and principal of, and
dividends, interest or premiums payable on, any stock, shares and securities of any company, whether having objects similar to those of this Company or not, and to give all kinds of indemnities.
|
|
3.12
|
To engage in currency exchange and interest rate transactions including, but not limited to, dealings in foreign currency, spot and forward rate exchange contracts,
futures, options, forward rate agreements, swaps, caps, floors, collars and any other foreign exchange or interest rate hedging arrangements and such other instruments as are similar to, or derived from, any of the foregoing whether for the purpose
of making a profit or avoiding a loss or managing a currency or interest rate exposure or any other exposure or for any other purpose.
|
|
3.13
|
To guarantee, support or secure, whether by personal covenant or by mortgaging or charging all or any part of the undertaking, property and assets (both present and
future) and uncalled capital of the Company, or by both such methods, the performance of the obligations of, and the repayment or payment of the principal amounts of and premiums, interest and dividends on any securities of, any person, firm or
company including (without prejudice to the generality of the foregoing) any company which is for the time being the Company’s holding company as defined by section 155 of the Act or a subsidiary as therein defined of any such holding company
or otherwise associated with the Company in business.
|
|
3.14
|
To borrow or secure the payment of money in such manner as the Company shall think fit, and in particular by the provision of a guarantee or by the issue of debentures,
debenture stocks, bonds, obligations and securities of all kinds, either perpetual or terminable and either redeemable or otherwise and to secure the repayment of any money borrowed, raised or owing by trust deed, mortgage, charge, or lien upon the
whole or any part of the Company’s property or assets (whether present or future) including its uncalled capital, and also by a similar trust deed, mortgage, charge or lien to secure and guarantee the performance by the Company of any
obligation or liability it may undertake.
|
|
3.15
|
To draw, make, accept, endorse, discount, execute, negotiate and issue promissory notes, bills of exchange, bills of lading, warrants, debentures and other negotiable
or transferable instruments.
|
|
3.16
|
To subscribe for, take, purchase or otherwise acquire and hold shares or other interests in, or securities of any other company having objects altogether or in part
similar to those of this Company, or carrying on any business capable of being conducted so as directly or indirectly to benefit this Company.
|
3
|
3.17
|
To hold in trust as trustees or as nominees and to deal with, manage and turn to account, any real or personal property of any kind, and in particular shares, stocks,
debentures, securities, policies, book debts, claims and choses in actions, lands, buildings, hereditaments, business concerns and undertakings, mortgages, charges, annuities, patents, licences, and any interest in real or personal property, and any
claims against such property or against any person or company.
|
|
3.18
|
To constitute any trusts with a view to the issue of preferred and, deferred or other special stocks or securities based on or representing any shares, stocks and other
assets specifically appropriated for the purpose of any such trust and to settle and regulate and if thought fit to undertake and execute any such trusts and to issue dispose of or hold any such preferred, deferred or other special stocks or
securities.
|
|
3.19
|
To give any guarantee in relation to the payment of any debentures, debenture stock, bonds, obligations or securities and to guarantee the payment of interest thereon
or of dividends on any stocks or shares of any company.
|
|
3.20
|
To construct, erect and maintain buildings, houses, flats, shops and all other works, erections, and things of any description whatsoever either upon the lands acquired
by the Company or upon other lands and to hold, retain as investments or to sell, let, alienate, mortgage, charge or deal with all or any of the same and generally to alter, develop and improve the lands and other property of the Company.
|
|
3.21
|
To provide for the welfare of persons in the employment of or holding office under or formerly in the employment of or holding office under the Company including
Directors and ex-Directors of the Company or any of its subsidiary or associated companies and the wives, widows and families, dependants or connections of such persons by grants of money, pensions or other payments and by forming and contributing
to pension, provident or benefit funds or profit sharing or co-partnership schemes for the benefit of such persons and to form, subscribe to or otherwise aid charitable, benevolent, religious, scientific, national or other institutions, exhibitions
or objects which shall have any moral or other claims to support or aid by the Company by reason of the locality of its operation or otherwise.
|
|
3.22
|
To remunerate by cash payments or allotment of shares or securities of the Company credited as fully paid up or otherwise any person or company for services rendered or
to be rendered to the Company whether in the conduct or management of its business, or in placing or assisting to place or guaranteeing the placing of any of the shares of the Company’s capital, or any debentures or other securities of the
Company or in or about the formation or promotion of the Company.
|
|
3.23
|
To enter into and carry into effect any arrangement for joint working in business or for sharing of profits or for amalgamation with any other company or association or
any partnership or person carrying on any business within the objects of the Company.
|
|
3.24
|
To distribute in specie or otherwise as may be resolved, any assets of the Company among its members and in particular the shares, debentures or other securities of any
other company belonging to this Company or of which this Company may have the power of disposing.
|
4
|
3.25
|
To vest any real or personal property, rights or interest acquired or belonging to the Company in any person or company on behalf of or for the benefit of the Company,
and with or without any declared trust in favour of the Company.
|
|
3.26
|
To transact or carry on any business which may seem to be capable of being conveniently carried on in connection with any of these objects or calculated directly or
indirectly to enhance the value of or facilitate the realisation of or render profitable any of the Company’s property or rights.
|
|
3.27
|
To accept stock or shares in or debentures, mortgages or securities of any other company in payment or part payment for any services rendered or for any sale made to or
debt owing from any such company, whether such shares shall be wholly or partly paid up.
|
|
3.28
|
To pay all costs, charges and expenses incurred or sustained in or about the promotion and establishment of the Company or which the Company shall consider to be
preliminary thereto and to issue shares as fully or in part paid up, and to pay out of the funds of the Company all brokerage and charges incidental thereto.
|
|
3.29
|
To procure the Company to be registered or recognised in any foreign country or in any colony or dependency of any such foreign country or that the central management
and control of the Company be located in any country.
|
|
3.30
|
To do all or any of the matters hereby authorised in any part of the world or in conjunction with or as trustee or agent for any other company or person or by or
through any factors, trustees or agents.
|
|
3.31
|
To make gifts or grant bonuses to the Directors or any other persons who are or have been in the employment of the Company including substitute and alternate directors.
|
|
3.32
|
To do all such other things that the Company may consider incidental or conducive to the attainment of the above objects or as are capable of being conveniently carried
on in connection therewith.
|
|
3.33
|
To carry on any business which the Company may lawfully engage in and to do all such things incidental or conducive to the business of the Company.
|
|
3.34
|
To make or receive gifts by way of capital contribution or otherwise.
|
|
3.35
|
To the extent permitted by law, to give whether directly or indirectly, any kind of financial assistance for the purchase of shares in or debentures of the Company or
any corporation which is at any given time the Company’s holding company.
|
The objects set forth in any
sub-clause of this clause shall be regarded as independent objects and shall not, except, where the context expressly so requires, be in any way limited or restricted by reference to or inference from the terms of any other sub-clause, or by the
name of the Company. None of such sub-clauses or the objects therein specified or the powers thereby conferred shall be deemed subsidiary or auxiliary merely to the objects mentioned in the first sub-clause of this clause, but the Company shall have
full power to exercise all or any of the powers conferred by any part of this clause in any part of the world notwithstanding that the business, property or acts proposed to be transacted, acquired or performed do not fall within the objects of the
first sub-clause of this clause.
5
|
|
NOTE:
|
It is hereby declared that the word “company” in this clause, except where used in reference to this Company shall be deemed to include any partnership or
other body of persons whether incorporated or not incorporated and whether domiciled in Ireland or elsewhere and the intention is that the objects specified in each paragraph of this clause shall except where otherwise expressed in such paragraph be
in no way limited or restricted by reference to or inference from the terms of any other paragraph.
|
|
4
|
The liability of the members is limited.
|
|
5
|
The share capital of the Company is €40,000 and US$101,000 divided into 40,000 deferred ordinary shares of €1.00 each, 1,000,000,000 ordinary shares of
US$0.0001 each and 10,000,000 serial preferred shares of US$0.0001 each.
|
|
6
|
The shares forming the capital, increased or reduced, may be increased or reduced and be divided into such classes and issued with any special rights, privileges and
conditions or with such qualifications as regards preference, dividend, capital, voting or other special incidents, and be held upon such terms as may be attached thereto or as may from time to time be provided by the original or any substituted or
amended articles of association and regulations of the Company for the time being, but so that where shares are issued with any preferential or special rights attached thereto such rights shall not be alterable otherwise than pursuant to the
provisions of the Company’s articles of association for the time being.
|
6
We, the several persons whose names, addresses and descriptions are subscribed, wish to be formed into a
company in pursuance of this memorandum of association, and we agree to take the number of shares in the capital of the company set opposite our respective names.
|
|
|
|
|
Name, address and description of subscriber
|
|
Number of shares taken by the subscriber
|
|
|
|
|
Signed:
Patrick Spicer
For and on behalf of
Matsack Nominees Limited
70 Sir John Rogerson’s Quay
Dublin 2
Ireland
Body Corporate
|
|
1
(One)
|
|
|
|
|
Total shares taken
|
|
1 (One)
|
|
|
|
|
Dated 16 day of May 2013
|
|
|
|
|
|
|
Witness to the above signature:
Name: Amelia Drumm
Address: 70 Sir John
Rogerson’s Quay, Dublin 2
Occupation: Company Secretary
|
|
|
7
COMPANIES ACTS 1963 TO 2012
A PUBLIC COMPANY LIMITED BY SHARES
ARTICLES OF
ASSOCIATION
-of-
ACTAVIS PUBLIC LIMITED COMPANY
(Adopted by special resolution passed on
30 September 2013 with an effective date of 1 October 2013)
Preliminary
|
1
|
The regulations contained in Table A in the First Schedule to the Companies Act 1963 shall not apply to the Company.
|
|
|
|
|
|
“
1983 Act
”
|
|
the Companies (Amendment) Act 1983.
|
|
|
|
|
“
1990 Act
”
|
|
means the Companies Act 1990.
|
|
|
|
|
“
Act
”
|
|
means the Companies Act 1963.
|
|
|
|
|
“
Actavis Certificates
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Actavis Exchange Fund
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Actavis Share(s)
”
|
|
means the common share(s) of Actavis, Inc., par value US$0.0033.
|
|
|
|
|
“
Acts
”
|
|
means the Companies Acts 1963 to 2012, and all statutory instruments which are to be read as one with, or construed, or to be read together with such Acts.
|
|
|
|
|
“
address
”
|
|
includes any number or address used for the purposes of communication, including by way of electronic mail or other electronic communication.
|
8
|
|
|
|
|
“Adoption Date”
|
|
has the meaning set out in article 3.3.
|
|
|
|
|
“Applicable Escheatment Laws”
|
|
has the meaning set out in article 169.2.
|
|
|
|
|
“
Approved Nominee
”
|
|
means a person holding shares or rights or interests in shares in the Company on a nominee basis who has been determined by the Company to be an “Approved
Nominee”.
|
|
|
|
|
“
Assistant Secretary
”
|
|
means any person appointed by the Secretary or the Board from time to time to assist the Secretary.
|
|
|
|
|
“
Auditor
” or “
Auditors
”
|
|
means the auditor or auditors at any given time of the Company.
|
|
|
|
|
“
Clear Days
”
|
|
in relation to the period of notice to be given under these articles, that period excluding the day when the notice is given or deemed to be given and the day of the event for which
it is given or on which it is to take effect.
|
|
|
|
|
“
Company Shares
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Company Subscriber Shares
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Covered Person
”
|
|
has the meaning set out in article 168.
|
|
|
|
|
“
electronic communication
”
|
|
has the meaning given to those words in the Electronic Commerce Act 2000.
|
|
|
|
|
“
electronic signature
”
|
|
has the meaning given to those words in the Electronic Commerce Act 2000.
|
|
|
|
|
“Euro Deferred Shares” or “deferred ordinary shares”
|
|
means euro deferred shares of nominal value €1.00 per share (or such other nominal value as may result from any reorganisation of capital) in the capital of the Company, having
the rights and being subject to the limitations set out in these articles.
|
|
|
|
|
“
Exchange Act
”
|
|
means the United States Securities Exchange Act of 1934, as amended from time to time.
|
|
|
|
|
“
Exchange Agent
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Member Associated Person
”
|
|
of any member means (A) any person controlling, directly or indirectly, or acting as a “group” (as such term is used in Rule 13d-5(b) under the Exchange Act) with, such
member, (B) any beneficial owner of shares of the Company owned of record or beneficially by such member and (C) any person controlling, controlled by or under common control with such Member Associated Person.
|
9
|
|
|
|
|
“
Merger
”
|
|
means the merger of MergerSub with and into Actavis, Inc., with Actavis, Inc. surviving the merger as a wholly owned subsidiary of the Company.
|
|
|
|
|
“
Merger Consideration
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
Merger Effective Time
”
|
|
has the meaning set out in article 157.
|
|
|
|
|
“
MergerSub
”
|
|
means Actavis W.C. Holding 2 LLC, a company organized in Nevada.
|
|
|
|
|
“
Ordinary Resolution”
|
|
means an ordinary resolution of the Company’s members within the meaning of section 141 of the Act.
|
|
|
|
|
“Ordinary Shares” or “ordinary shares”
|
|
means ordinary shares of nominal value US$0.0001 per share (or such other nominal value as may result from any reorganisation of capital) in the capital of the Company, having the
rights and being subject to the limitations set out in these articles.
|
|
|
|
|
“
Redeemable Shares
”
|
|
means redeemable shares in accordance with section 206 of the 1990 Act.
|
|
|
|
|
“
Register
”
|
|
means the register of members to be kept as required in accordance with section 116 of the Act.
|
|
|
|
|
“
Section 81 Notice
”
|
|
shall mean a notice given to a member in accordance with section 81 of the 1990 Act.
|
|
|
|
|
“Share”
|
|
“Share” and “share” mean, unless specified otherwise or the context otherwise requires, any share in the capital of the Company.
|
|
|
|
|
“
Shareholder
” or “
the Holder
”
|
|
means in relation to any share, the person whose name is entered in the Register as the holder of the share or, where the context permits, the persons whose names are entered in the
Register as the joint holders of shares.
|
|
|
|
|
“
Special Resolution
”
|
|
means a special resolution of the Company’s members within the meaning of section 141 of the Act.
|
|
|
|
|
“
the Company
”
|
|
means the company whose name appears in the heading to these articles.
|
|
|
|
|
“
the Directors
” or “
the Board
”
|
|
means the directors from time to time and for the time being of the Company or the directors present at a meeting of the board of directors and includes any person occupying the
position of director by whatever name called.
|
10
|
|
|
|
|
“
the Office
”
|
|
means the registered office from time to time and for the time being of the Company.
|
|
|
|
|
“
the seal
”
|
|
means the common seal of the Company.
|
|
|
|
|
“
the Secretary
”
|
|
means any person appointed to perform the duties of the secretary of the Company.
|
|
|
|
|
“
these articles
”
|
|
means the articles of association of which this article forms part, as the same may be amended from time to time and for the time being in force.
|
|
|
|
|
“
US Holdco
”
|
|
means Actavis W.C. Holding LLC, a limited liability company organized in Nevada.
|
|
2.2
|
Expressions in these articles referring to writing shall be construed, unless the contrary intention appears, as including references to printing, lithography,
photography and any other modes of representing or reproducing words in a visible form except as provided in these articles and / or where it constitutes writing in electronic form sent to the Company, and the Company has agreed to its receipt in
such form. Expressions in these articles referring to execution of any document shall include any mode of execution whether under seal or under hand or any mode of electronic signature as shall be approved by the Directors. Expressions in these
articles referring to receipt or issuance of any electronic communications shall, be limited to receipt or issuance in such manner as the Company has approved or as set out in these articles. Notwithstanding the foregoing, all written communication
by the Company and the Directors may for the purposes of these articles, to the extent permitted by law, be in electronic form.
|
|
2.3
|
Unless the contrary intention appears, words or expressions contained in these articles shall bear the same meaning as in the Acts or in any statutory modification
thereof in force at the date at which these articles become binding on the Company.
|
|
2.4
|
References herein to any enactment shall mean such enactment as the same may be amended and may be from time to time and for the time being in force.
|
|
2.5
|
The masculine gender shall include the feminine and neuter, and vice versa, and the singular number shall include the plural, and vice versa, and words importing
persons shall include firms or companies.
|
|
2.6
|
Reference to US$, USD, or dollars shall mean the currency of the United States of America and to €, euro, EUR or cent shall mean the currency of Ireland.
|
Share capital and variation of rights
|
3.1
|
The share capital of the Company is €40,000 and US$101,000 divided into 40,000 deferred ordinary shares of €1.00 each, 1,000,000,000 ordinary shares of
US$0.0001 each and 10,000,000 serial preferred shares of US$0.0001 each.
|
11
|
3.2
|
The rights and restrictions attaching to the ordinary shares shall be as follows:
|
|
|
(a)
|
subject to the right of the Company to set record dates for the purposes of determining the identity of members entitled to notice of and / or to vote at a general
meeting, the right to attend and speak at any general meeting of the Company and to exercise one vote per ordinary share held at any general meeting of the Company;
|
|
|
(b)
|
the right to participate pro rata in all dividends declared by the Company; and
|
|
|
(c)
|
the right, in the event of the Company’s winding up, to participate pro rata in the total assets of the Company.
|
The rights attaching to the ordinary shares may be subject to the terms of issue of any series or class of preferred shares allotted by
the Directors from time to time in accordance with article 3.4.
|
3.3
|
The rights and restrictions attaching to the Euro Deferred Shares shall be as follows:
|
|
|
(a)
|
The holders of the Euro Deferred Shares shall not be entitled to receive any dividend or distribution and shall not be entitled to receive notice of, nor to attend,
speak or vote at any meeting of some or all of the Shareholders of the Company. On a return of assets, whether on liquidation or otherwise, the Euro Deferred Shares shall entitle the holder thereof only to the repayment of the amounts paid up on
such shares after repayment of the capital paid up on the ordinary shares plus the payment of $5,000,000 on each of the ordinary shares and the holders of the Euro Deferred Shares (as such) shall not be entitled to any further participation in the
assets or profits of the Company.
|
|
|
(b)
|
The special resolution passed on the date of adoption of these articles (the “
Adoption Date
”) shall be deemed to confer irrevocable authority on the
Company at any time after the Adoption Date:
|
|
|
(i)
|
to acquire all or any of the fully paid Euro Deferred Shares otherwise than for valuable consideration in accordance with section 41(2) of the 1983 Act and without
obtaining the sanction of the holders thereof;
|
|
|
(ii)
|
to appoint any person to execute on behalf of the holders of the Euro Deferred Shares remaining in issue (if any) a transfer thereof and/or an agreement to transfer the
same otherwise than for valuable consideration to the Company or to such other person as the Company may nominate;
|
|
|
(iii)
|
to cancel any acquired Euro Deferred Shares; and
|
|
|
(iv)
|
pending such acquisition and/or transfer and/or cancellation to retain the certificate (if any) for such Euro Deferred Shares.
|
12
|
|
(c)
|
In accordance with section 43(3) of the 1983 Act the Company shall, not later than three years after any acquisition by it of any Euro Deferred Shares as aforesaid,
cancel such shares (except those which, or any interest of the Company in which, it shall have previously disposed of) and reduce the amount of the issued share capital by the nominal value of the shares so cancelled and the Directors may take such
steps as are requisite to enable the Company to carry out its obligations under that subsection without complying with sections 72 and 73 of the 1963 Act including passing resolutions in accordance with section 43(5) of the 1983 Act.
|
|
|
(d)
|
Neither the acquisition by the Company otherwise than for valuable consideration of all or any of the Euro Deferred Shares nor the redemption thereof nor the
cancellation thereof by the Company in accordance with this article shall constitute a variation or abrogation of the rights or privileges attached to the Euro Deferred Shares, and accordingly the Euro Deferred Shares or any of them may be so
acquired, redeemed and cancelled without any such consent or sanction on the part of the holders thereof. The rights conferred upon the holders of the Euro Deferred Shares shall not be deemed to be varied or abrogated by the creation of further
shares ranking in priority thereto or pari passu therewith.
|
|
3.4
|
The Board is authorised to issue all or any of the authorised but unissued preferred shares from time to time in one or more classes or series, and to fix for each such
class or series such voting power, full or limited, or no voting power, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated
and expressed in the resolution or resolutions adopted by the Board providing for the issuance of such class or series, including, without limitation, the authority to provide that any such class or series may be:
|
|
|
(a)
|
redeemable at the option of the Company, or the Holders, or both, with the manner of the redemption to be set by the Board, and redeemable at such time or times,
including upon a fixed date, and at such price or prices;
|
|
|
(b)
|
entitled to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions and at such times, and payable in preference to, or in such
relation to, the dividends payable on any other class or classes of shares or any other series;
|
|
|
(c)
|
entitled to such rights upon the dissolution of, or upon any distribution of the assets of, the Company;
|
|
|
(d)
|
convertible into, or exchangeable for, shares of any other class or classes of shares, or of any other series of the same or any other class or classes of shares, of
the Company at such price or prices or at such rates of exchange and with such adjustments as the Directors determine; or
|
|
|
(e)
|
entitled to the right, voting separately as a class or with other Holders, to elect or appoint directors generally or in certain circumstances,
|
which rights and restrictions may be as stated in such resolution or resolutions of the Directors as determined
by them in accordance with this article. The Board may at any
13
time before the allotment of any preferred share by further resolution in any way amend the designations, preferences, rights, qualifications, limitations or restrictions, or vary or revoke the
designations of such preferred shares.
|
3.5
|
An ordinary share shall be deemed to be a Redeemable Share on, and from the time of, the existence or creation of an agreement, transaction or trade between the Company
and any third party pursuant to which the Company acquires or will acquire ordinary shares, or an interest in ordinary shares, from such third party. In these circumstances, the acquisition of such shares or interest in shares by the Company shall
constitute the redemption of a Redeemable Share in accordance with Part XI of the 1990 Act.
|
|
4
|
Subject to the provisions of Part XI of the 1990 Act and the other provisions of this article, the Company may:
|
|
4.1
|
pursuant to section 207 of the 1990 Act, issue any shares of the Company which are to be redeemed or are liable to be redeemed at the option of the Company or the
member on such terms and in such manner as may be determined by the Company in general meeting (by Special Resolution) on the recommendation of the Directors;
|
|
4.2
|
subject to and in accordance with the provisions of the Acts and without prejudice to any relevant special rights attached to any class of shares pursuant to section
211 of the 1990 Act, purchase any of its own shares (including any Redeemable Shares and without any obligation to purchase on any pro rata basis as between members or members of the same class) and may cancel any shares so purchased or hold them as
treasury shares (as defined in section 209 of the 1990 Act) and may reissue any such shares as shares of any class or classes; or
|
|
4.3
|
pursuant to section 210 of the 1990 Act, convert any of its shares into Redeemable Shares.
|
|
5
|
Without prejudice to any special rights previously conferred on the Holders of any existing shares or class of shares, any share in the Company may be issued with such
preferred or deferred or other special rights or such restrictions, whether in regard to dividend, voting, return of capital or otherwise, as the Company may from time to time by Ordinary Resolution determine.
|
|
6.1
|
Without prejudice to the authority conferred on the Directors pursuant to article 3 to issue preferred shares in the capital of the Company, if at any time the
share capital is divided into different classes of shares the rights attached to any class may, whether or not the Company is being wound up, be varied or abrogated with the consent in writing of the Holders of three-fourths of the issued shares in
that class, or with the sanction of a Special Resolution passed at a separate general meeting of the Holders of the shares of that class, provided that, if the relevant class of Holders has only one Holder, that person present in person or by proxy,
shall constitute the necessary quorum. To every such meeting the provisions of article 52 shall apply.
|
|
6.2
|
The redemption or purchase of preferred shares or any class of preferred shares shall not constitute a variation of rights of the preferred Holders where the redemption
or purchase of the preferred shares has been authorised solely by a resolution of the ordinary Holders.
|
14
|
6.3
|
The issue, redemption or purchase of any of the 10,000,000 serial preferred shares of US$0.0001 each shall not constitute a variation of the rights of the Holders of
ordinary shares.
|
|
6.4
|
The issue of preferred shares or any class of preferred shares which rank junior to any existing preferred shares or class of preferred shares shall not constitute a
variation of the existing preferred shares or class of preferred shares.
|
|
7
|
The rights conferred upon the Holders of the shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of
issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu therewith.
|
|
8.1
|
Subject to the provisions of these articles relating to new shares, the unissued shares of the Company shall be at the disposal of the Directors, and they may (subject
to the provisions of the Acts) allot, grant options over or otherwise dispose of them to such persons, on such terms and conditions and at such times as they may consider to be in the best interests of the Company and its members, but so that no
share shall be issued at a discount save in accordance with sections 26(5) and 28 of the 1983 Act, and so that, in the case of shares offered to the public for subscription, the amount payable on application on each share shall not be less than
one-quarter of the nominal amount of the share and the whole of any premium thereon.
|
|
8.2
|
Subject to any requirement to obtain the approval of members under any laws, regulations or the rules of any stock exchange to which the Company is subject, the Board
is authorised, from time to time, in its discretion, to grant such persons, for such periods and upon such terms as the Board deems advisable, options to purchase or subscribe for such number of shares of any class or classes or of any series of any
class as the Board may deem advisable, and to cause warrants or other appropriate instruments evidencing such options to be issued.
|
|
8.3
|
The Directors are, for the purposes of section 20 of the 1983 Act, generally and unconditionally authorised to exercise all powers of the Company to allot and issue
relevant securities (as defined by the said section 20) up to the amount of Company’s authorised share capital and to allot and issue any shares purchased by the Company pursuant to the provisions of Part XI of the 1990 Act and held as treasury
shares and this authority shall expire five years from the date of adoption of these articles of association.
|
|
8.4
|
The Directors are hereby empowered pursuant to sections 23 and 24(1) of the 1983 Act to allot equity securities within the meaning of the said section 23 for cash
pursuant to the authority conferred by article 8.3 as if section 23(1) of the said 1983 Act did not apply to any such allotment. The Company may before the expiry of such authority make an offer or agreement which would or might require equity
securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of such an offer or agreement as if the power conferred by this paragraph had not expired.
|
|
8.5
|
Nothing in these articles shall preclude the Directors from recognising a renunciation of the allotment of any shares by any allottee in favour of some other person.
|
15
|
9
|
The Company may pay commission to any person in consideration of a person subscribing or agreeing to subscribe, whether absolutely or conditionally, for any shares in
the Company or procuring or agreeing to procure subscriptions, whether absolute or conditional, for any shares in the Company on such terms and subject to such conditions as the Directors may determine, including, without limitation, by paying cash
or allotting and issuing fully or partly paid shares or any combination of the two. The Company may also, on any issue of shares, pay such brokerage as may be lawful.
|
|
10
|
Except as required by law, no person shall be recognised by the Company as holding any share upon any trust, and the Company shall not be bound by or be compelled in
any way to recognise (even when having notice thereof) any equitable, contingent, future or partial interest in any share or any interest in any fractional part of a share or (except only as by these articles or by law otherwise provided) any other
rights in respect of any share except an absolute right to the entirety thereof in the Holder. This shall not preclude the Company from requiring the members or a transferee of shares to furnish the Company with information as to the beneficial
ownership of any share when such information is reasonably required by the Company.
|
|
11
|
The shares of the Company may be either represented by certificates or, if the conditions of issue of the relevant shares so provide, by uncertificated shares. Except
as required by law, the rights and obligations of the Holders of uncertificated shares and the rights and obligations of the Holders of shares represented by certificates of the same class shall be identical.
|
|
12
|
Any person claiming a share certificate to have been lost, destroyed or stolen, shall make an affidavit or affirmation of that fact, and if required by the Board shall
advertise the same in such manner as the Board may require, and shall give the Company, its transfer agents and its registrars a bond of indemnity, in form and with one or more sureties satisfactory to the Board or anyone designated by the Board
with authority to act thereon, whereupon a new certificate may be executed and delivered of the same tenor and for the same number of shares as the one alleged to have been lost, destroyed or stolen.
|
Disclosure of beneficial ownership
|
13
|
If at any time the Directors are satisfied that any member, or any other person appearing to be interested in shares held by such member:
|
|
13.1
|
(x) has been duly served with a Section 81 Notice and is in default for the prescribed period (as defined in article 13.6(b)) in supplying to the Company the
information thereby required; or (y) in purported compliance with such a notice, has made a statement which is false or inadequate in a material particular, then the Directors may, in their absolute discretion at any time thereafter by notice
(a “
direction notice
”) to such member direct that:
|
|
|
(a)
|
in respect of the shares in relation to which the default occurred (the “
default shares
”) the member shall not be entitled to attend or to vote at a
general meeting either personally or by proxy or to exercise any other right conferred by membership in relation to meetings of the Company; and
|
|
|
(b)
|
where the nominal value of the default shares represents at least 0.25 per cent of the nominal value of the issued shares of the class concerned, then the
direction notice may additionally direct that:
|
|
|
(i)
|
except in a liquidation of the Company, no payment shall be made of any sums due from the Company on the default shares, whether in respect of capital or dividend or
otherwise, and the Company shall not have any liability to pay interest on any such payment when it is finally paid to the member;
|
16
|
|
(ii)
|
no other distribution shall be made on the default shares; and / or
|
|
|
(iii)
|
no transfer of any of the default shares held by such member shall be registered unless:
|
|
|
(1)
|
the member is not himself in default as regards supplying the information requested and the transfer when presented for registration is accompanied by a certificate by
the member in such form as the Directors may in their absolute discretion require to the effect that after due and careful enquiry the member is satisfied that no person in default as regards supplying such information is interested in any of the
shares the subject of the transfer; or
|
|
|
(2)
|
the transfer is an approved transfer (as defined in article 13.6(c));
|
the Company shall send to each other person appearing to be interested in the shares the subject of any direction notice a copy of the notice, but the failure or omission by the Company to do so shall not
invalidate such notice.
|
13.2
|
Where any person appearing to be interested in the default shares has been duly served with a direction notice or copy thereof and the default shares which are the
subject of such direction notice are held by an Approved Nominee, the provisions of this article shall be treated as applying only to such default shares held by the Approved Nominee and not (insofar as such person’s apparent interest is
concerned) to any other shares held by the Approved Nominee.
|
|
13.3
|
Where the member upon whom a Section 81 Notice is served is an Approved Nominee acting in its capacity as such, the obligations of the Approved Nominee as a member
of the Company shall be limited to disclosing to the Company such information as has been recorded by it relating to any person appearing to be interested in the shares held by it.
|
|
13.4
|
Any direction notice shall cease to have effect:
|
|
|
(a)
|
in relation to any shares which are transferred by such member by means of an approved transfer; or
|
|
|
(b)
|
when the Directors are satisfied that such member, and any other person appearing to be interested in shares held by such member, has given to the Company the
information required by the relevant Section 81 Notice.
|
17
|
13.5
|
The Directors may at any time give notice cancelling a direction notice.
|
|
13.6
|
For the purposes of this article:
|
|
|
(a)
|
a person shall be treated as appearing to be interested in any shares if the member holding such shares has given to the Company a Section 81 Notice which either
(a) names such person as being so interested or (b) fails to establish the identities of all those interested in the shares and (after taking into account the said notification and any other relevant Section 81 Notice) the Company
knows or has reasonable cause to believe that the person in question is or may be interested in the shares;
|
|
|
(b)
|
the prescribed period is 28 days from the date of service of the said Section 81 Notice unless the nominal value of the default shares represents at least
0.25 per cent of the nominal value of the issued shares of that class, when the prescribed period is 14 days from that date;
|
|
|
(c)
|
a transfer of shares is an approved transfer if but only if:
|
|
|
(i)
|
it is a transfer of shares to an offeror by way or in pursuance of acceptance of an offer made to all the Holders (or all the Holders other than the person making the
offer and his nominees) of the shares in the Company to acquire those shares or a specified proportion of them; or
|
|
|
(ii)
|
the Directors are satisfied that the transfer is made pursuant to a sale of the whole of the beneficial ownership of the shares the subject of the transfer to a party
unconnected with the member and with other persons appearing to be interested in such shares; or
|
|
|
(iii)
|
the transfer results from a sale made through a stock exchange on which the Company’s shares are normally traded;
|
|
|
(d)
|
Nothing contained in this article shall limit the power of the Company under section 85 of the 1990 Act; and
|
|
|
(e)
|
For the purpose of establishing whether or not the terms of any notice served under this article shall have been complied with the decision of the Directors in this
regard shall be final and conclusive and shall bind all persons interested.
|
Lien
|
14
|
The Company shall have a first and paramount lien on every share (not being a fully paid share) for all moneys (whether immediately payable or not) called or payable at
a fixed time or in accordance with the terms of issue of such share in respect of such share. The Directors may at any time declare any share to be wholly or in part exempt from the provisions of this regulation. The Company’s lien on a share
shall extend to all dividends payable thereon.
|
18
|
15
|
The Company may sell, in such manner as the Directors think fit, any shares on which the Company has a lien, but no sale shall be made unless a sum in respect of which
the lien exists is immediately payable, nor until the expiration of 14 days after a notice in writing, stating and demanding payment of such part of the amount in respect of which the lien exists as is immediately payable, has been given to the
Holder for the time being of the share or the person entitled thereto by reason of his death or bankruptcy.
|
|
16
|
To give effect to any such sale, the Directors may authorise some person to transfer the shares sold to the purchaser thereof. The purchaser shall be registered as the
Holder of the shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings in reference to the
sale. Where a share, which is to be sold as provided for in article 26, is held in uncertificated form, the Directors may authorise some person to do all that is necessary under the 1990 Act (Uncertificated Securities) Regulations 1996 to change
such share into certificated form prior to its sale.
|
|
17
|
The proceeds of the sale shall be received by the Company and applied in payment of such part of the amount in respect of which the lien exists as is immediately
payable, and the residue, if any, shall (subject to a like lien for sums not immediately payable as existed upon the shares before the sale) be paid to the person entitled to the shares at the date of the sale.
|
|
18
|
Whenever any law for the time being of any country, state or place imposes or purports to impose any immediate or future or possible liability upon the Company to make
any payment or empowers any government or taxing authority or government official to require the Company to make any payment in respect of any shares registered in the Register as held either jointly or solely by any Holder or in respect of any
dividends, bonuses or other moneys due or payable or accruing due or which may become due or payable to such Holder by the Company on or in respect of any shares registered as aforesaid or for or on account or in respect of any Holder and whether in
consequence of:
|
|
|
(a)
|
the death of such Holder;
|
|
|
(b)
|
the non-payment of any income tax or other tax by such Holder;
|
|
|
(c)
|
the non-payment of any estate, probate, succession, death, stamp, or other duty by the executor or administrator of such Holder or by or out of his estate; or
|
|
|
(d)
|
any other act or thing;
|
in
every such case (except to the extent that the rights conferred upon Holders of any class of shares render the Company liable to make additional payments in respect of sums withheld on account of the foregoing):
|
|
(A)
|
the Company shall be fully indemnified by such Holder or his executor or administrator from all liability;
|
|
|
(B)
|
the Company shall have a lien upon all dividends and other moneys payable in respect of the shares registered in the Register as held either jointly or
solely by such Holder for all moneys paid or payable by the Company in respect of such shares or in respect of any dividends or other moneys as aforesaid thereon or for or on account or in respect of such Holder under or in consequence of any
|
19
|
|
such law together with interest at the rate of fifteen percent per annum thereon from the date of payment to date of repayment and may deduct or set off against such dividends or other moneys
payable as aforesaid any moneys paid or payable by the Company as aforesaid together with interest as aforesaid;
|
|
|
(C)
|
the Company may recover as a debt due from such Holder or his executor or administrator wherever constituted any moneys paid by the Company under or in consequence of
any such law and interest thereon at the rate and for the period aforesaid in excess of any dividends or other moneys as aforesaid then due or payable by the Company;
|
|
|
(D)
|
the Company may, if any such money is paid or payable by it under any such law as aforesaid, refuse to register a transfer of any shares by any such Holder or his
executor or administrator until such money and interest as aforesaid is set off or deducted as aforesaid, or in case the same exceeds the amount of any such dividends or other moneys as aforesaid then due or payable by the Company, until such excess
is paid to the Company; and
|
|
|
(E)
|
subject to the rights conferred upon the Holders of any class of shares, nothing herein contained shall prejudice or affect any right or remedy which any law may confer
or purport to confer on the Company and as between the Company and every such Holder as aforesaid, his estate representative, executor, administrator and estate wheresoever constituted or situate, any right or remedy which such law shall confer or
purport to confer on the Company shall be enforceable by the Company.
|
Calls on shares
|
19
|
The Directors may from time to time make calls upon the members in respect of any moneys unpaid on their shares (whether on account of the nominal value of the shares
or by way of premium) and not by the conditions of allotment thereof made payable at fixed times or in accordance with such terms of allotment, and each member shall (subject to receiving at least 14 days notice specifying the time or times and
place of payment) pay to the Company at the time or times and place so specified the amount called on his shares. A call may be revoked or postponed as the Directors may determine.
|
|
20
|
A call shall be deemed to have been made at the time when the resolution of the Directors authorising the call was passed and may be required to be paid by instalments.
|
|
21
|
The joint Holders of a share shall be jointly and severally liable to pay all calls in respect thereof.
|
|
22
|
If a sum called in respect of a share is not paid before or on the day appointed for payment thereof, the person from whom the sum is due shall pay interest on the sum
from the day appointed for payment thereof to the time of actual payment at such rate as the Directors may determine, but the Directors shall be at liberty to waive payment of such interest wholly or in part.
|
|
23
|
Any sum which by the terms of issue of a share becomes payable on allotment or at any fixed date, whether on account of the nominal value of the share
or by way of premium, shall for the purpose of these regulations be deemed to be a call duly made and payable
|
20
|
|
on the date on which, by the terms of issue, the same becomes payable, and in case of non-payment all the relevant provisions of these regulations as to payment of interest and expenses,
forfeiture or otherwise, shall apply as if such sum had become payable by virtue of a call duly made and notified.
|
|
24
|
The Directors may, on the issue of shares, differentiate between the Holders as to the amount of calls to be paid and the time of payment.
|
|
25
|
The Directors may, if they think fit, receive from any member willing to advance the same all or any part of the moneys uncalled and unpaid upon any shares held by him,
and upon all or any of the moneys so advanced may (until the same would, but for such advance, become payable) pay interest at such rate not exceeding (unless the Company in general meeting otherwise directs) fifteen per cent per annum, as may be
agreed upon between the Directors and the member paying such sum in advance.
|
Transfer of Shares
|
26.1
|
Subject to compliance with the Acts and to any applicable restrictions contained in these articles, applicable law, including U.S. securities laws, and any agreement
binding on such Holder as to which the Company is aware, any Holder may transfer all or any of its shares by an instrument of transfer in the usual common form or in any other form or by any other method permissible under applicable law, as may be
approved by the Directors. The instrument of transfer of any share may be executed for and on behalf of the transferor by the Secretary, Assistant Secretary or any duly authorised delegate or attorney of the Secretary or Assistant Secretary (whether
an individual, a corporation or other body of persons, whether corporate or not, and whether in respect of specific transfers or pursuant to a general standing authorisation) and the Secretary or Assistant Secretary or a relevant authorised delegate
shall be deemed to have been irrevocably appointed agent for the transferor of such share or shares with full power to execute, complete and deliver in the name of and on behalf of the transferor of such share or shares all such transfers of shares
held by the members in the share capital of the Company. Any document which records the name of the transferor, the name of the transferee, the class and number of shares agreed to be transferred and the date of the agreement to transfer shares,
shall, once executed by the transferor or the Secretary or Assistant Secretary or relevant authorised delegate as agent for the transferor, be deemed to be a proper instrument of transfer for the purposes of section 81 of the Act. The transferor
shall be deemed to remain the Holder of the share until the name of the transferee is entered on the Register in respect thereof, and neither the title of the transferee nor the title of the transferor shall be affected by any irregularity or
invalidity in the proceedings in reference to the sale should the Directors so determine.
|
|
26.2
|
The Company, at its absolute discretion, may, or may procure that a subsidiary of the Company shall, pay Irish stamp duty arising on a transfer of
shares on behalf of the transferee of such shares of the Company. If stamp duty resulting from the transfer of shares in the Company which would otherwise be payable by the transferee is paid by the Company or any subsidiary of the Company on behalf
of the transferee, then in those circumstances, the Company shall, on its behalf or on behalf of its subsidiary (as the case may be), be entitled to (i) seek reimbursement of the stamp duty from either the transferee or, at the Company’s
sole discretion, the transferor; (ii) set-off the stamp duty against any
|
21
|
|
dividends payable to the transferee of those shares; and (iii) claim a first and permanent lien on the shares on which stamp duty has been paid by the Company or its subsidiary for the
amount of stamp duty paid. The Company’s lien shall extend to all dividends paid on those shares.
|
|
26.3
|
Notwithstanding the provisions of these articles and subject to any regulations made under section 239 of the 1990 Act, title to any shares in the Company may also be
evidenced and transferred without a written instrument in accordance with section 239 of the 1990 Act or any regulations made thereunder. The Directors shall have power to permit any class of shares to be held in uncertificated form and to implement
any arrangements they think fit for such evidencing and transfer which accord with such regulations and in particular shall, where appropriate, be entitled to disapply or modify all or part of the provisions in these articles with respect to the
requirement for written instruments of transfer and share certificates (if any), in order to give effect to such regulations.
|
|
27
|
Subject to such of the restrictions of these articles and to such of the conditions of issue of any share warrants as may be applicable, any share warrant may be
transferred by instrument in writing in any usual or common form or any other form which the Directors may approve.
|
|
28
|
The Directors in their absolute discretion and without assigning any reason therefor may decline to register any transfer of a share which is not fully paid. The
Directors may also decline to recognise any instrument of transfer unless:
|
|
28.1
|
the instrument of transfer is duly stamped (if required by law) and lodged with the Company, at such place as the Directors shall appoint for the purpose, accompanied
by the certificate for the shares (if any has been issued) to which it relates, and such other evidence as the Directors may reasonably require to show the right of the transferor to make the transfer;
|
|
28.2
|
the instrument of transfer is in respect of only one class of share; and
|
|
28.3
|
they are satisfied that all applicable consents, authorisations, permissions or approvals required to be obtained pursuant to any applicable law or agreement prior to
such transfer have been obtained or that no such consents, authorisations, permissions or approvals are required.
|
|
29
|
If the Directors refuse to register a transfer they shall, within three months after the date on which the transfer was lodged with the Company, send to the transferee
notice of the refusal.
|
|
30
|
In order that the Directors may determine the members entitled to receive payment of any dividend or other distribution or allotment of any rights or the members
entitled to exercise any rights in respect of any change, conversion or exchange of shares, or for the purpose of any other lawful action, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing
the record date is adopted. If no record date is fixed, the record date for determining members for such purpose shall be at the close of business on the day on which the Directors adopt the resolution relating thereto.
|
|
31
|
Registration of transfers may be suspended at such times and for such period, not exceeding in the whole 30 days in each year, as the Directors may from time to time
determine subject to the requirements of section 121 of the Act.
|
|
32
|
All instruments of transfer shall upon their being lodged with the Company remain the property of the Company and the Company shall be entitled to retain them.
|
22
Transmission of Shares
|
33
|
In the case of the death of a member, the survivor or survivors, where the deceased was a joint Holder, and the personal representatives of the deceased where he was a
sole Holder, shall be the only persons recognised by the Company as having any title to his interest in the shares; but nothing herein contained shall release the estate of a deceased joint Holder from any liability in respect of any share which had
been jointly held by him with other persons. For greater certainty, where two or more persons are registered as joint Holders of a share or shares, then in the event of the death of any joint Holder or Holders the remaining joint Holder or Holders
shall be absolutely entitled to the said share or shares and the Company shall recognise no claim in respect of the estate of any joint Holder except in the case of the last survivor of such joint Holders.
|
|
34
|
Any person becoming entitled to a share in consequence of the death or bankruptcy of a member may, upon such evidence being produced as may from time to time properly
be required by the Directors and subject as herein provided, elect either to be registered himself as Holder of the share or to have some person nominated by him registered as the transferee thereof, but the Directors shall, in either case, have the
same right to decline or suspend registration as they would have had in the case of a transfer of the shares by that member before his death or bankruptcy, as the case may be. If the person so becoming entitled elects to be registered himself, he
shall deliver or send to the Company a notice in writing signed by him stating that he so elects. If he elects to have another person registered, he shall testify his election by executing to that person a transfer of the share. All the limitations,
restrictions and provisions of these articles relating to the right to transfer and the registration of transfers of shares shall be applicable to any such notice or transfer as aforesaid as if the death or bankruptcy of the member had not occurred
and the notice of transfer were a transfer signed by that member.
|
|
35
|
A person becoming entitled to a share by reason of the death or bankruptcy of the Holder shall be entitled to the same dividends and other advantages to which he would
be entitled if he were the registered Holder of the share, except that he shall not, before being registered as a member in respect of the share, be entitled in respect of it to exercise any right conferred by membership in relation to the meetings
of the Company, so, however, that the Directors may at any time give notice requiring such person to elect either to be registered himself or to transfer the share, and if the notice is not complied with within 60 days, the Directors may thereupon
withhold payment of all dividends, bonuses or other moneys payable in respect of the share until the requirements of the notice have been complied with.
|
Forfeiture of Shares
|
36
|
If a member fails to pay any call or instalment of a call on the day appointed for payment thereof, the Directors may, at any time thereafter during such time as any
part of the call or instalment remains unpaid, serve a notice on him requiring payment of so much of the call or instalment as is unpaid together with any interest which may have accrued.
|
|
37
|
The notice shall name a further day (not earlier than the expiration of 14 days from the date of service of the notice) on or before which the payment required by the
notice is to be made, and shall state that, in the event of non-payment at or before the time appointed, the shares in respect of which the call was made will be liable to be forfeited.
|
23
|
38
|
If the requirements of any such notice as aforesaid are not complied with any shares in respect of which the notice has been given may at any time thereafter, before
the payment required by the notice has been made, be forfeited by a resolution of the Directors to that effect. Such forfeiture shall include all dividends declared in respect of the forfeited shares and not actually paid before the forfeiture.
|
|
39
|
A forfeited share shall be deemed to be the property of the Company and may be sold, re-offered or otherwise disposed of either to the person who was, before the
forfeiture, the Holder thereof or entitled thereto or to any other person on such terms and in such manner as the Directors think fit, and at any time before a sale or disposition the forfeiture may be cancelled on such terms as the Directors think
fit.
|
|
40
|
When any share has been forfeited, notice of the forfeiture shall be served upon the person who was before forfeiture the Holder of the share, but no forfeiture shall
be in any manner invalidated by any omission or neglect to give such notice.
|
|
41
|
A person whose shares have been forfeited shall cease to be a member in respect of the forfeited shares, but shall, notwithstanding, remain liable to pay to the Company
all moneys which, at the date of forfeiture, were payable by him to the Company in respect of the shares, but his liability shall cease if and when the Company shall have received payment in full of all such moneys in respect of the shares.
|
|
42
|
A statutory declaration that the declarant is a Director or the Secretary, and that a share in the Company has been duly forfeited on the date stated in the
declaration, shall be conclusive evidence of the facts therein stated as against all persons claiming to be entitled to the share. The Company may receive the consideration, if any, given for the share on any sale or disposition thereof and may
execute a transfer of the share in favour of the person to whom the share is sold or disposed of and he shall thereupon be registered as the Holder of the share, and shall not be bound to see to the application of the purchase money, if any, nor
shall his title to the share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the share.
|
|
43
|
The provisions of these articles as to forfeiture shall apply in the case of non-payment of any sum which, by the terms of issue of a share, becomes payable at a fixed
time, whether on account of the nominal value of the share or by way of premium, as if the same had been payable by virtue of a call duly made and notified.
|
|
44
|
The Directors may accept the surrender of any share which the Directors have resolved to have been forfeited upon such terms and conditions as may be agreed and,
subject to any such terms and conditions, a surrendered share shall be treated as if it has been forfeited.
|
Financial assistance
|
45
|
The Company may give any form of financial assistance which is permitted by the Acts for the purpose of or in connection with a purchase or subscription made or to be
made by any person of or for any shares in the Company or in the Company’s holding company.
|
24
Alteration of Capital
|
46
|
The Company may from time to time by Ordinary Resolution increase its authorised share capital by such sum, to be divided into shares of such amount, as the resolution
shall prescribe.
|
|
47
|
The Company may by Ordinary Resolution:
|
|
47.1
|
reduce its authorised share capital;
|
|
47.2
|
consolidate and divide all or any of its share capital into shares of larger amount than its existing shares;
|
|
47.3
|
subdivide its existing shares, or any of them, into shares of smaller amount than is fixed by the memorandum of association subject, nevertheless, to section 68(1)(d)
of the Act;
|
|
47.4
|
make provision for the issue and allotment of shares which do not carry any voting rights;
|
|
47.5
|
cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and reduce the amount of its authorised
share capital by the amount of the shares so cancelled; and
|
|
47.6
|
subject to applicable law, change the currency denomination of its share capital.
|
Where any difficulty arises in regard to any division, consolidation or sub-division under this article 47, the Directors may settle the same as they think expedient and in particular, may arrange
for the sale of the shares representing fractions and the distribution of the net proceeds of sale in due proportion amongst the Holders who would have been entitled to the fractions, and for this purpose the Directors may authorise some person to
transfer the shares representing fractions to the purchaser thereof, who shall not be bound to see to the application of purchase money nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings related to the
sale.
|
48
|
The Company may by Special Resolution reduce its issued share capital, any capital redemption reserve fund or any share premium account in any manner and with and
subject to any incident authorised, and consent required, by law.
|
General meetings
|
49
|
The Company shall in each year hold a general meeting as its annual general meeting in addition to any other meeting in that year, and shall specify the meeting as such
in the notices calling it. Not more than 15 months shall elapse between the date of one annual general meeting of the Company and that of the next. Subject to section 140 of the Act, all general meetings of the Company may be held outside of
Ireland.
|
|
50
|
All general meetings other than annual general meetings shall be called extraordinary general meetings.
|
|
51
|
The Directors may, whenever they think fit, convene an extraordinary general meeting, and extraordinary general meetings shall also be convened on such requisition, or
in default may be convened by such requisitionists, as provided in section 132 of the Act.
|
25
|
52
|
All provisions of these articles relating to general meetings of the Company shall, mutatis mutandis, apply to every separate general meeting of the Holders of any
class of shares in the capital of the Company, except that:
|
|
52.1
|
the necessary quorum shall be two or more persons holding or representing by proxy (whether or not such Holder actually exercises his voting rights in whole, in part or
at all at the relevant general meeting) more than 50% of the total issued-voting rights of the Company’s shares, provided, however, that if the class of shares shall have only one Holder, one Holder present in person or by proxy shall
constitute the necessary quorum;
|
|
52.2
|
any Holder of shares of the class present in person or by proxy may demand a poll; and
|
|
52.3
|
on a poll, each Holder of shares of the class shall have one vote in respect of every share of the class held by him.
|
|
53
|
A Director shall be entitled, notwithstanding that he is not a member, to attend and speak at any general meeting and at any separate meeting of the Holders of any
class of shares in the Company.
|
Notice of General Meetings
|
54.1
|
Subject to the provisions of the Acts allowing a general meeting to be called by shorter notice, an annual general meeting, and an extraordinary general meeting called
for the passing of a Special Resolution, shall be called by not less than 21 Clear Days’ notice and all other extraordinary general meetings shall be called by not less than 14 Clear Days’ notice.
|
|
54.2
|
Notice of every general meeting shall be given in any manner permitted by these articles to all Shareholders (other than those who, under the provisions of these
articles or the terms of issue of the shares which they hold, are not entitled to receive such notice from the Company) and to each Director and to the Auditors.
|
|
54.3
|
Any notice convening a general meeting shall specify the time and place of the meeting and, in the case of special business, the general nature of that business and, in
reasonable prominence, that a member entitled to attend and vote is entitled to appoint a proxy to attend, speak and vote in his place and that a proxy need not be a member of the Company. It shall also give particulars of any Directors who are to
retire at the meeting and of any persons who are recommended by the Directors for election or re-election as Directors at the meeting or in respect of whom notice has been duly given to the Company of the intention to propose them for election or
re-election as Directors at the meeting. Provided that the latter requirement shall only apply where the intention to propose the person has been received by the Company in accordance with the provisions of these articles. Subject to any
restrictions imposed on any shares, the notice of the meeting shall be given to all the Holders of any class of shares of the Company as of the record date set by the Directors other than shares which, under the terms of these articles or the terms
of allotment of such shares, are not entitled to receive such notice from the Company, and to the Directors and the Company’s auditors.
|
|
54.4
|
The Board may fix a future time not exceeding 60 days preceding any meeting of Shareholders as a record date for the determination of the Shareholders
entitled to attend
|
26
|
|
and vote at any such meeting or any adjournments thereof, and, in such case, only Shareholders of record at the time so fixed shall be entitled to notice of and to vote at such meetings or any
adjournment thereof. Subject to section 121 of the Act, the Board may close the Register against transfers of Shares during the whole or part of the period between the record date so fixed and the date of such meeting or the date to which such
meeting is adjourned. If no record date is fixed, the record date for determining the Shareholders who are entitled to vote at a meeting of Shareholders shall be close of business on the date preceding the day on which notice is given.
|
|
54.5
|
The accidental omission to give notice of a meeting to, or, in cases where instruments of proxy are sent out without the notice, the accidental omission to send such
instrument of proxy to, or the non-receipt of notice of a meeting or instrument of proxy by, any person entitled to receive notice shall not invalidate the proceedings at the meeting.
|
|
54.6
|
A Holder of shares present, either in person or by proxy, at any meeting of the Company or of the Holders of any class of shares in the Company shall be deemed to have
received notice of the meeting and, where required, of the purposes for which it was called.
|
|
54.7
|
Upon request in writing of Shareholders holding such number of shares as is prescribed by section 132 of the Act, delivered to the Office, it shall be the duty of the
Directors to convene a general meeting to be held within two months from the date of the deposit of the requisition in accordance with the section 132 of the Act. If such notice is not given within two months after the delivery of such request, the
requisitionists, or any one of them representing more than one half of the total voting rights of all of them, may themselves convene a meeting, but any meeting so convened shall not be held after the expiration of three months from the said date
and any notice of such meeting shall be in compliance with these articles.
|
|
55.1
|
The Directors may postpone a general meeting of the members (other than a meeting requisitioned by a member in accordance with section 132 of the Act or where the
postponement of which would be contrary to the Acts or a court order pursuant to the Acts) after it has been convened, and notice of such postponement shall be served in accordance with article 54 upon all members entitled to notice of the
meeting so postponed setting out, where the meeting is postponed to a specific date, notice of the new meeting in accordance with article 54.
|
|
55.2
|
The Directors may cancel a general meeting of the members (other than a meeting requisitioned by a member in accordance with section 132 of the Act or where the
cancellation of which would be contrary to the Acts or a court order pursuant to the Acts) after it has been convened, and notice of such cancellation shall be served in accordance with article 54 upon all members entitled to notice of the
meeting so cancelled.
|
Proceedings at General Meetings
|
56
|
No business shall be transacted at any general meeting unless a quorum is present at the time when the meeting proceeds to business. Except as
otherwise provided in these articles, a quorum shall be two or more persons holding or representing by proxy (whether or not such Holder actually exercises his voting rights in whole, in part or at all at the relevant general meeting) more than 50%
of the total issued voting rights of the Company’s
|
27
|
|
shares, provided that if the Company has only one member, one member present in person or by proxy shall constitute a quorum. Abstentions and broker non-votes will be counted as present for
purposes of determining whether there is a quorum.
|
|
57
|
If within five minutes from the time appointed for a general meeting (or such longer interval as the chairman of the meeting may think fit to allow) a quorum is not
present, the meeting, if convened upon the requisition of members, shall be dissolved. In any other case it shall stand adjourned to such other day and such other time and place as the chairman of the meeting shall determine. The Company shall give
not less than five days’ notice of any meeting adjourned through want of a quorum.
|
|
58
|
All business shall be deemed special that is transacted at an extraordinary general meeting, and also all that is transacted at an annual general meeting, with the
exception of declaring a dividend, the consideration of the accounts, balance sheets and the reports of the Directors and auditors, the election of Directors, the re-appointment of the retiring auditors and the fixing of the remuneration of the
auditors.
|
|
59
|
A meeting of the members or any class thereof may be held by means of such telephone, electronic or other communication facilities (including, without limitation of the
foregoing, by telephone or video conferencing) as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence at such meeting.
|
|
60
|
No business may be transacted at a meeting of members, other than business that is either proposed by or at the direction of the Directors; proposed at the direction of
the High Court of Ireland; proposed on the requisition in writing of such number of members as is prescribed by, and is made in accordance with, the relevant provisions of the Acts and, in respect of an annual general meeting only, these articles;
or the chairman of the meeting determines in his absolute and sole discretion that the business may properly be regarded as within the scope of the meeting. For business or nominations to be properly brought by a member at any general meeting, the
member proposing such business must be a Holder of record at the time of giving of the notice provided for in articles 54 and 55 and must be entitled to vote at such meeting and any proposed business must be a proper matter for member action.
|
|
61.1
|
Subject to the Acts, a resolution may only be put to a vote at a general meeting of the Company if:
|
|
|
(a)
|
it is specified in the notice of the meeting; or
|
|
|
(b)
|
it is otherwise properly brought before the meeting by the chairman of the meeting or by or at the direction of the Board; or
|
|
|
(c)
|
it is proposed at the direction of a court of competent jurisdiction; or
|
|
|
(d)
|
it is proposed with respect to an extraordinary general meeting in the requisition in writing for such meeting made by such number of Shareholders as is prescribed by
(and such requisition in writing is made in accordance with) section 132 of the Act; or
|
28
|
|
(e)
|
in the case of an annual general meeting, it is proposed in accordance with article 70; or
|
|
|
(f)
|
it is proposed in accordance with article 118; or
|
|
|
(g)
|
the chairman of the meeting in his discretion decides that the resolution may properly be regarded as within the scope of the meeting.
|
|
62
|
No amendment may be made to a resolution at or before the time when it is put to a vote unless the chairman of the meeting in his absolute discretion decides that the
amendment or the amended resolution may properly be put to a vote at that meeting.
|
|
63
|
If the chairman of the meeting rules a resolution or an amendment to a resolution admissible or out of order, as the case may be, the proceedings of the meeting or on
the resolution in question shall not be invalidated by any error in his ruling. Any ruling by the chairman of the meeting in relation to a resolution or an amendment to a resolution shall be final and conclusive, subject to any subsequent order by a
court of competent jurisdiction.
|
|
64
|
The Chairman, if any, of the Board, shall preside as chairman at every meeting of the Company, or if there is no such Chairman, or if he is not present within fifteen
minutes after the time appointed for the holding of the meeting or is unwilling to act, the Directors present shall elect one of their number to be chairman of the meeting.
|
|
65
|
If at any meeting no Director is willing to act as chairman of the meeting or if no Director is present within fifteen minutes after the time appointed for holding the
meeting, the members present shall choose one of their number to be chairman of the meeting.
|
|
66
|
The chairman of the meeting may, with the consent of any meeting at which a quorum is present, and shall if so directed by the meeting, adjourn the meeting from time to
time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. When a meeting is adjourned for three months or more, notice of
the adjourned meeting shall be given as in the case of the original meeting. Save as aforesaid, it shall not be necessary to give any notice of an adjournment or of the business to be transacted at an adjourned meeting.
|
|
67
|
The Board may, and at any general meeting or meeting of a class of members, the chairman of such meeting may, make any arrangement and impose any requirement or
restriction it or he considers appropriate to ensure the security of the meeting including, without limitation, requirements for evidence of identity to be produced by those attending the meeting, the searching of their personal property and the
restriction of items that may be taken into the meeting place. The Board and, at any general meeting or meeting of a class of members, the chairman of such meeting, is entitled to refuse entry to a person who refuses to comply with any such
arrangements, requirements or restrictions.
|
|
68.1
|
The Board may make such arrangements as it considers appropriate to enable the members to participate in any general meeting by means of two-way, audio-visual
electronic facilities, so as to permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting.
|
29
|
68.2
|
The Board may, and at any general meeting or meeting of a class of members, the chairman of such meeting may make any arrangement and impose any requirement as may be
reasonable for the purpose of verifying the identity of members participating by way of electronic facilities, as described in article 68.1.
|
|
69
|
Subject to section 141 of the Act and the requirements of the Acts, anything which may be done by resolution in general meeting may, without a meeting and without any
previous notice being required, be done by resolution in writing, signed by all of the Shareholders entitled generally to vote at general meetings who at the date of the resolution in writing would be entitled to attend a meeting and vote on the
resolution and if described as a Special Resolution shall be deemed to be a Special Resolution or a Special Resolution of the class, as applicable. Such resolution in writing may be signed in as many counterparts as may be necessary. This
article 69 shall not apply to those matters required by the Acts to be carried out in a meeting.
|
|
69.1
|
For the purposes of any written resolution under this article 69, the date of the resolution in writing is the date when the resolution is signed by, or on behalf
of, the last Shareholder to sign and any reference in any enactment to the date of passing of a resolution is, in relation to a resolution in writing made in accordance with this article 69, a reference to such date.
|
|
69.2
|
A resolution in writing made in accordance with this article 69 is as valid as if it had been passed by the Company in general meeting.
|
Advance notice of member business and nominations for Annual General Meetings
|
70
|
In addition to any other applicable requirements, for business or nominations to be properly brought before an annual general meeting by a member, such member must have
given timely notice thereof in proper written form to the Secretary of the Company.
|
|
71
|
To be timely for an annual general meeting, a member’s notice to the Secretary as to the business or nominations to be brought before the meeting must be delivered
to or mailed and received at the Office not less than 120 calendar days nor more than 150 calendar days before the first anniversary of the notice convening the Company’s annual general meeting for the prior year (and in the case of the
Company’s first annual general meeting, references to the preceding year’s annual general meeting shall be to the annual meeting of Actavis, Inc. in that preceding year); provided, however, that in the event that less than 70 days’
notice or prior public disclosure of the date of the meeting is given or made to Shareholders, notice by the Shareholder must be so delivered not later than the close of business on the 15th calendar day following the day on which public
announcement of the date of such meeting is first made. In no event shall the public announcement of an adjournment or postponement of an annual general meeting commence a new time period (or extend any time period) for the giving of a member’s
notice as described in articles 72 and 73.
|
|
72
|
A member’s notice to the Secretary must set forth as to each matter such member proposes to bring before the meeting:
|
|
72.1
|
a brief description of the business desired to be brought before the meeting, the text of the proposal or business (including the text of any resolutions proposed for
consideration and if such business includes a proposal to amend the articles of the Company, the text of the proposed amendment) and the reasons for conducting such business at the meeting;
|
30
|
72.2
|
as to the member giving the notice:
|
|
|
(a)
|
the name and address, as they appear in the Register, of such member and any Member Associated Person covered by clauses (b) and (c) below;
|
|
|
(b)
|
(A) the class and number of shares of the Company which are held of record or are beneficially owned by the member and by any Member Associated Person with respect to
the Company’s securities; (B) a description of any agreement, arrangement or understanding in connection with the proposal of such business between or among such member and any Member Associated Person, any of their respective affiliates
or associates, and any others (including their names) acting as a “group” (as such term is used in Rule 13d-5(b) under the Exchange Act) with any of the foregoing; (C) a description of any agreement, arrangement or understanding
(including, regardless of the form of settlement, any derivative, long or short positions, profit interests, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed or loaned securities)
that has been entered into, the effect or intent of which is to mitigate loss to, manage risk or benefit from share price changes for, or increase or decrease the voting power of, such member or such Member Associated Person, with respect to shares
of the Company; (D) a representation that the member is a Holder of shares of the Company (either of record or beneficially) entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business;
(E) a representation whether the member or the Member Associated Person, if any, intends or is part of a group which intends (x) to deliver a proxy statement and / or form of proxy to Holders of at least the percentage of the
Company’s outstanding shares required to adopt the proposal and / or (y) otherwise to solicit proxies from members in support of such proposal. If requested by the Company, the information required under clauses (A), (B) and
(C) of the preceding sentence shall be supplemented by such member and any Member Associated Person not later than ten days after the later of the record date for the meeting or the date notice of the record date is first publicly disclosed to
disclose such information as of the record date; and
|
|
|
(c)
|
any material interest of the member or any Member Associated Person in such business.
|
The chairman of the meeting shall have the power and duty to determine whether any business proposed to be brought before the meeting was
made or proposed in accordance with the procedures set forth in this article, and if any proposed business is not in compliance with this article, to declare that such defective proposal shall be disregarded. The chairman of such meeting shall, if
the facts reasonably warrant, refuse to acknowledge that a proposal that is not made in compliance with the procedure specified in this article, and any such proposal not properly brought before the meeting, be considered.
31
|
73.1
|
A member’s notice to the Secretary must set forth as to each nomination such member proposes to bring before the meeting:
|
as to each person whom the member proposes to nominate for election as a Director all information relating to such person that is required
to be disclosed in solicitations of proxies for election of Directors in an election contest, or its otherwise required, in each case pursuant to Regulation 14A under the Exchange Act (including such person’s written consent to being named in
the proxy statement as nominee and to serving as director if elected); and
|
|
(a)
|
the name and address, as they appear in the Register, of such member and any Member Associated Person covered by clause (b) below; and
|
|
|
(b)
|
(A) the class and number of shares of the Company which are held of record or are beneficially owned by the member and by any Member Associated Person with respect to
the Company’s securities; (B) a description of any agreement, arrangement or understanding in connection with the nomination between or among such member and any Member Associated Person, any of their respective affiliates or associates,
and any others (including their names) acting as a “group” (as such term is used in Rule I3d-5(b) under the Exchange Act) with any of the foregoing; (C) a description of any agreement, arrangement or understanding (including,
regardless of the form of settlement, any derivative, long or short positions, profit interests, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed or loaned securities) that has been
entered into as of the date of the member’s notice by, or on behalf of, such member and any Member Associated Person, the effect or intent of which is to mitigate loss to, manage risk or benefit from share price changes for, or increase or
decrease the voting power of, such member or such Member Associated Person, with respect to shares of the Company; (D) a representation that the member is a Holder of shares of the Company (either of record or beneficially) entitled to vote at
such meeting and intends to appear in person or by proxy at the meeting to propose such nomination; (E) a representation whether the member or the Member Associated Person, if any, intends or is part of a group which intends (x) to deliver
a proxy statement and / or form of proxy to Holders of at least the percentage of the Company’s outstanding shares required to adopt the proposal and / or (y) otherwise to solicit proxies from members in support of such proposal. If
requested by the Company, the information required under clauses (A), (B) and (C) of the preceding sentence shall be supplemented by such member and any Member Associated Person not later than ten days after the later of the record date
for the meeting or the date notice of the record date is first publicly disclosed to disclose such information as of the record date.
|
|
73.2
|
The Company may require any proposed nominee to furnish such other information as it may reasonably require, including the completion of any questionnaires to determine
the eligibility of such proposed nominee to serve as a Director of the Company and the impact that such service would have on the ability of the Company to satisfy the requirements of laws, rules, regulations and listing standards applicable to the
Company or its Directors.
|
|
73.3
|
The chairman of the meeting shall have the power and duty to determine whether a nomination to be brought before the meeting was made or proposed in accordance with the
procedures set forth in this article, and if any proposed nomination is not in compliance with this article, to declare that such defective nomination shall be disregarded. The chairman of such meeting shall, if the facts reasonably warrant, refuse
to acknowledge a nomination that is not made in compliance with the procedure specified in this article, and any such nomination not properly brought before the meeting shall not be considered.
|
32
|
74
|
Notwithstanding the foregoing provisions of articles 72 and 73, unless otherwise required by law, if the member (or a qualified representative of the member) does
not appear at the annual general meeting to present a nomination or proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been
received by the Company. For purposes of articles 72 and 73, to be considered a qualified representative of the member, a person must be a duly authorized officer, manager or partner of such member or must be authorized by a writing executed by
such member or an electronic transmission delivered by such member to act for such member as proxy at the meeting of member and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic
transmission, at the general meeting of members.
|
|
75
|
In addition, if the member intends to solicit proxies from the members of the Company, such member shall notify the Company of this intent in accordance with Rule 14a-4
and / or Rule 14a-8 under the Exchange Act. Any references in these articles to the Exchange Act or the rules promulgated thereunder are not intended to and shall not limit any requirements applicable to member nominations or proposals as to any
other business to be considered pursuant to these articles and compliance with these articles shall be the exclusive means for a member to make nominations or submit proposals for any other business to be considered at an annual general meeting
(other than matters brought properly under and in compliance with Rule 14a-8 of the Exchange Act, or any successor rule). Nothing in these articles shall be deemed to affect any rights of members to request inclusion of proposals in the
Company’s proxy statement pursuant to applicable rules and regulations under the Exchange Act.
|
Voting,
proxies and corporate representatives
|
76
|
Except where a greater majority is required by the Acts or these articles, any question, business or resolution proposed at any general meeting shall be decided by a
simple majority of the votes cast.
|
|
77
|
Subject to any rights or restrictions attached to any class of shares, at any meeting of the Company each member present in person shall be entitled to one vote on any
question to be decided on a show of hands and each member in person or by proxy shall be entitled on a poll to one vote for each share held by him.
|
|
78
|
At any general meeting a resolution put to the vote of the meeting shall be decided on a show of hands unless a poll is (before or on the declaration of the result of
the show of hands) demanded by:
|
|
78.1
|
the chairman of the meeting; or
|
|
78.2
|
by at least three members present in person or represented by proxy; or
|
|
78.3
|
by any member or members present in person or represented by proxy and representing not less than one-tenth of the total voting rights of all the members having the
right to vote at the meeting; or
|
33
|
78.4
|
by a member or members holding shares in the Company conferring the right to vote at the meeting being shares on which an aggregate sum has been paid up equal to not
less than one-tenth of the total sum paid up on all the shares conferring that right.
|
Unless a poll is so
demanded, a declaration by the chairman of the meeting that a resolution has, on a show of hands, been carried or carried unanimously, or by a particular majority, or lost, and an entry to that effect in the book containing the minutes of the
proceedings of the Company, shall be conclusive evidence of the fact without proof of the number or proportion of the votes recorded in favour of or against such resolution.
The demand for a poll may be withdrawn.
|
79
|
Except as provided in article 80, if a poll is duly demanded it shall be taken in such manner as the Chairman directs, and the result of the poll shall be deemed
to be the resolution of the meeting at which the poll was demanded.
|
|
80
|
A poll demanded on the election of the Chairman or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such
time as the Chairman of the meeting directs, and any business other than that on which a poll has been demanded may be proceeded with pending the taking of the poll.
|
|
81
|
When there are joint Holders, the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other
joint Holders; and for this purpose, seniority shall be determined by the order in which the names stand in the Register.
|
|
82
|
A member of unsound mind, or in respect of whom an order has been made by any court having jurisdiction (whether in Ireland or elsewhere) in matters concerning mental
disorder, may vote, whether on a show of hands or on a poll, by his committee, receiver, guardian or other person appointed by that court and any such committee, receiver, guardian or other person may vote by proxy on a show of hands or on a poll.
Evidence to the satisfaction of the Directors of the authority of the person claiming to exercise the right to vote shall be received at the Office or at such other address as is specified in accordance with these articles for the receipt of
appointments of proxy, not less than 48 hours before the time appointed for holding the meeting or adjourned meeting at which the right to vote is to be exercised and in default the right to vote shall not be exercisable.
|
|
83
|
No member shall be entitled to vote at any general meeting unless any calls or other sums immediately payable by him in respect of shares in the Company have been paid.
|
|
84
|
No objection shall be raised to the qualification of any voter except at the meeting or adjourned meeting at which the vote objected to is given or tendered, and every
vote not disallowed at such meeting shall be valid for all purposes. Any such objection made in due time shall be referred to the Chairman of the meeting, whose decision shall be final and conclusive.
|
|
85
|
A Holder entitled to more than one vote on a poll need not use all his votes or cast all the votes he uses in the same way.
|
|
86.1
|
any objection shall be raised as to the qualification of any voter; or
|
34
|
86.2
|
any votes have been counted which ought not to have been counted or which might have been rejected; or
|
|
86.3
|
any votes are not counted which out to have been counted,
|
the objection or error shall not vitiate the decision of the meeting or adjourned meeting on any resolution unless the same is raised or pointed out at the meeting or, as the case may be, the adjourned
meeting at which the vote objected to is given or tendered or at which the error occurs. Any objection or error shall be referred to the chairman of the meeting and shall only vitiate the decision of the meeting on any resolution if the chairman
decides that the same may have affected the decision of the meeting. The decision of the chairman on such matters shall be final and conclusive.
|
87
|
Votes may be given either personally or by proxy.
|
|
88.1
|
Every member entitled to attend and vote at a general meeting may appoint a proxy to attend, speak and vote on his behalf and may appoint more than one proxy to attend,
speak and vote at the same meeting. The appointment of a proxy shall be in any form which the Directors may approve and, if required by the Company, shall be signed by or on behalf of the appointor. In relation to written proxies, a body corporate
may sign a form of proxy under its common seal or under the hand of a duly authorised officer thereof or in such other manner as the Directors may approve. A proxy need not be a member of the Company. The appointment of a proxy in electronic or
other form shall only be effective in such manner as the Directors may approve.
|
|
88.2
|
Without limiting the foregoing, the Directors may from time to time permit appointments of a proxy to be made by means of an electronic or internet communication or
facility and may in a similar manner permit supplements to, or amendments or revocations of, any such electronic or internet communication or facility to be made. The Directors may in addition prescribe the method of determining the time at which
any such electronic or internet communication or facility is to be treated as received by the Company. The Directors may treat any such electronic or Internet communication or facility which purports to be or is expressed to be sent on behalf of a
Holder of a share as sufficient evidence of the authority of the person sending that instruction to send it on behalf of that Holder.
|
|
89
|
Any body corporate which is a member of the Company may authorise such person as it thinks fit to act as its representative at any meeting of the Company or of any
class of members of the Company and the person so authorised shall be entitled to exercise the same powers on behalf of the body corporate which he represents as that body corporate could exercise if it were an individual member of the Company. The
Company may require evidence from the body corporate of the due authorisation of such person to act as the representative of the relevant body corporate.
|
|
90
|
An appointment of proxy relating to more than one meeting (including any adjournment thereof) having once been received by the Company for the purposes of any meeting
shall not require to be delivered, deposited or received again by the Company for the purposes of any subsequent meeting to which it relates.
|
|
91
|
Receipt by the Company of an appointment of proxy in respect of a meeting shall not preclude a member from attending and voting at the meeting or at
any adjournment
|
35
|
|
thereof. An appointment proxy shall be valid, unless the contrary is stated therein, as well for any adjournment of the meeting as for the meeting to which it relates. A standing proxy shall be
valid for all meetings and adjournments thereof or resolutions in writing, as the case may be, until notice of revocation is received by the Company. Where a standing proxy exists, its operation shall be deemed to have been suspended at any meeting
or adjournment thereof at which the Holder is present or in respect to which the Holder has specially appointed a proxy. The Directors may from time to time require such evidence as it shall deem necessary as to the due execution and continuing
validity of any standing proxy and the operation of any such standing proxy shall be deemed to be suspended until such time as the Directors determine that they have received the requested evidence or other evidence satisfactory to it.
|
|
92
|
A vote given or poll demanded in accordance with the terms of an appointment of proxy or a resolution authorising a representative to act on behalf of a body corporate
shall be valid notwithstanding the death or insanity of the principal, or the revocation of the appointment of proxy or of the authority under which the proxy was appointed or of the resolution authorising the representative to act or transfer of
the share in respect of which the proxy was appointed or the authorisation of the representative to act was given, provided that no intimation in writing (whether in electronic form or otherwise) of such death, insanity, revocation or transfer shall
have been received by the Company at the Office, at least one hour before the commencement of the meeting or adjourned meeting at which the appointment of proxy is used or at which the representative acts PROVIDED HOWEVER, that where such intimation
is given in electronic form it shall have been received by the Company at least 24 hours (or such lesser time as the Directors may specify) before the commencement of the meeting.
|
|
93
|
The Directors may send, at the expense of the Company, by post, electronic mail or otherwise, to the members forms for the appointment of a proxy (with or without
stamped envelopes for their return) for use at any general meeting or at any class meeting, either in blank or nominating any one or more of the Directors or any other persons in the alternative.
|
|
94
|
The instrument appointing a proxy shall be deemed to confer authority to demand or join in demanding a poll.
|
Directors
|
95
|
The number of Directors shall (subject to: (a) automatic increases to accommodate the exercise of the rights of Holders of any class or series of shares then in
issue having special rights to nominate or appoint Directors in accordance with the terms of issue of such class or series of shares; and / or (b) any resolution passed in accordance with article 121) not be less than five nor more than
fourteen. The continuing Directors may act notwithstanding any vacancy in their body, provided that if the number of the Directors is reduced below the prescribed minimum the remaining Director or Directors shall appoint forthwith an additional
Director or additional Directors to make up such minimum or shall convene a general meeting of the Company for the purpose of making such appointment.
|
|
96
|
Each Director shall be entitled to receive such fees for his services as a Director, if any, as the Board may from time to time determine. Each Director shall be paid
all expenses properly and reasonably incurred by him in the conduct of the Company’s business or in the discharge of his duties as a Director, including his reasonable travelling, hotel and incidental expenses in attending and returning from
meetings of the Board or any committee of the Board or general meetings.
|
36
|
97
|
The Board may from time to time determine that, subject to the requirements of the Acts, all or part of any fees or other remuneration payable to any Director of the
Company shall be provided in the form of shares or other securities of the Company or any subsidiary of the Company, or options or rights to acquire such shares or other securities, on such terms as the Board may decide.
|
|
98
|
If any Director shall be called upon to perform extra services which in the opinion of the Directors are outside the scope of the ordinary duties of a Director, the
Company may remunerate such Director either by a fixed sum or by a percentage of profits or otherwise as may be determined by a resolution passed at a meeting of the Directors and such remuneration may be either in addition to or in substitution for
any other remuneration to which he may be entitled as a Director.
|
|
99
|
No shareholding qualification for Directors shall be required. A Director who is not a member of the Company shall nevertheless be entitled to attend and speak at
general meetings.
|
|
100
|
Unless the Company otherwise directs, a Director of the Company may be or become a Director or other officer of, or otherwise interested in, any company promoted by the
Company or in which the Company may be interested as Holder or otherwise, and no such Director shall be accountable to the Company for any remuneration or other benefits received by him as a Director or officer of, or from his interest in, such
other company.
|
Borrowing powers
|
101
|
Subject to Part III of the 1983 Act, the Directors may exercise all the powers of the Company to borrow or raise money, and to mortgage or charge its undertaking,
property, assets and uncalled capital or any part thereof and to issue debentures, debenture stock, guarantees and other securities whether outright or as collateral security for any debt, liability or obligation of the Company or of any third
party, without any limitation as to amount.
|
Powers and duties of the Directors
|
102
|
Subject to the provisions of the Acts and these articles, the Board shall manage the business and affairs of the Company and may exercise all of the powers of the
Company as are not required by the Acts or by these articles to be exercised by the Company in general meeting. No alteration of these articles shall invalidate any prior act of the Board which would have been valid if that alteration had not been
made. The powers given by this article shall not be limited by any special power given to the Board by these articles and, except as otherwise expressly provided in these articles, a meeting of the Board at which a quorum is present shall be
competent to exercise all of the powers, authorities and discretions vested in or exercisable by the Board.
|
|
103
|
The Directors may from time to time and at any time by power of attorney appoint any company, firm or person or body of persons, whether nominated
directly or indirectly by the Directors, to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the
|
37
|
|
Directors under these articles) and for such period and subject to such conditions as they may think fit, and any such power of attorney may contain such provisions for the protection of persons
dealing with any such attorney as the Directors may think fit, and may also authorise any such attorney to delegate all or any of the powers, authorities and discretions vested in him.
|
|
104
|
The Company may exercise the powers conferred by section 41 of the Act with regard to having an official seal for use abroad and such powers shall be vested in the
Directors.
|
|
105
|
A Director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with the Company shall declare the nature of his interest at
a meeting of the Directors in accordance with section 194 of the Act.
|
|
106.1
|
A Director who to his knowledge is in any way, whether directly or indirectly, interested in a contract or proposed contract, transaction or arrangement with the
Company and has complied with the Acts and these articles with regard to disclosure of his interest shall be entitled to vote in respect of any contract, transaction or arrangement in which he is so interested and if he shall do so his vote shall be
counted, and he shall be taken into account in ascertaining whether a quorum is present, but the resolution with respect to the contract, transaction or arrangement will fail unless it is approved by a majority of the disinterested Directors voting
on the resolution.
|
|
106.2
|
Where proposals are under consideration concerning the appointment (including fixing or varying the terms of appointment) of two or more Directors to offices or
employments with the Company or any company in which the Company is interested, such proposals may be divided and considered in relation to each Director separately and in such case each of the Directors concerned shall be entitled to vote (and be
counted in the quorum) in respect of each resolution except that concerning his own appointment.
|
|
106.3
|
For the purposes of this article, an interest of a person who is the spouse or a minor child of a Director shall be treated as an interest of the Director.
|
|
106.4
|
The Company by Ordinary Resolution may suspend or relax the provisions of this article to any extent or ratify any transaction not duly authorised by reason of a
contravention of this article.
|
|
107
|
A Director may hold and be remunerated in respect of any other office or place of profit under the Company or any other company in which the Company may be interested
(other than the office of auditor of the Company or any subsidiary thereof) in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine, and no Director or intending
Director shall be disqualified by his office from contracting or being interested, directly or indirectly, in any contract or arrangement with the Company or any such other company either with regard to his tenure of any such other office or place
of profit or as vendor, purchaser or otherwise nor shall any Director so contracting or being so interested be liable to account to the Company for any profits and advantages accruing to him from any such contract or arrangement by reason of such
Director holding that office or of the fiduciary relationship thereby established.
|
|
108
|
So long as, where it is necessary, a Director declares the nature of his interest at the first opportunity at a meeting of the Board or by writing to
the Directors, a Director shall not by
|
38
|
|
reason of his office be accountable to the Company for any benefit which he derives from any office or employment to which these articles allow him to be appointed or from any transaction or
arrangement in which these articles allow him to be interested, and no such transaction or arrangement shall be liable to be avoided on the ground of any interest or benefit.
|
|
109
|
To the maximum extent permitted from time to time under the laws of Ireland, the Company renounces any interest or expectancy of the Company in, or in being offered an
opportunity to participate in, business opportunities that are from time to time presented to its Directors, officers or members or the affiliates of the foregoing, other than those Directors, officers or members or affiliates who are employees of
the Company. No amendment or repeal of this article shall apply to or have any effect on the liability or alleged liability of any such Director, officer or member or affiliate of the Company for or with respect to any opportunities of which such
Director, officer or member or affiliate becomes aware prior to such amendment or repeal.
|
|
110
|
The Directors may exercise the voting powers conferred by shares of any other company held or owned by the Company in such manner in all respects as they think fit and
in particular they may exercise their voting powers in favour of any resolution appointing the Directors or any of them as Directors or officers of such other company or providing for the payment of remuneration or pensions to the Directors or
officers of such other company.
|
|
111
|
Any Director may act by himself or his firm in a professional capacity for the Company, and he or his firm shall be entitled to remuneration for professional services
as if he were not a Director, but nothing herein contained shall authorise a Director or his firm to act as auditor for the Company.
|
|
112
|
All cheques, promissory notes, drafts, bills of exchange and other negotiable instruments and all receipts for money paid to the Company shall be signed, drawn,
accepted, endorsed or otherwise executed, as the case may be, by such person or persons and in such manner as the Directors shall from time to time by resolution determine.
|
|
113
|
The Directors shall cause minutes to be made in books provided for the purpose:
|
|
113.1
|
of all appointments of officers made by the Directors;
|
|
113.2
|
of the names of the Directors present at each meeting of the Directors and of any committee of the Directors; and
|
|
113.3
|
of all resolutions and proceedings at all meetings of the Company and of the Directors and of committees of Directors.
|
|
114
|
The Directors, on behalf of the Company, may procure the establishment and maintenance of or participate in, or contribute to any non-contributory or
contributory pension or superannuation fund, scheme or arrangement or life assurance scheme or arrangement for the benefit of, and pay, provide for or procure the grant of donations, gratuities, pensions, allowances, benefits or emoluments to any
persons (including Directors or other officers) who are or shall have been at any time in the employment or service of the Company or of any company which is or was a subsidiary of the Company or of the Predecessor in business of the Company or any
such subsidiary or holding Company and the wives, widows, families, relatives or dependants of any such persons. The Directors may also procure the establishment and subsidy of or subscription to and support of any institutions,
|
39
|
|
associations, clubs, funds or trusts calculated to be for the benefit of any such persons as aforesaid or otherwise to advance the interests and well being of the Company or of any such other
Company as aforesaid, or its members, and payments for or towards the insurance of any such persons as aforesaid and subscriptions or guarantees of money for charitable or benevolent objects or for any exhibition or for any public, general or useful
object. Any Director shall be entitled to retain any benefit received by him under this article, subject only, where the Acts require, to disclosure to the members and the approval of the Company in general meeting.
|
Disqualification of Directors
|
115
|
The office of a Director shall be vacated ipso facto if the Director:
|
|
115.1
|
is restricted or disqualified to act as a Director under the provisions of Part VII of the 1990 Act; or
|
|
115.2
|
resigns his office by notice in writing to the Company or in writing offers to resign and the Directors resolve to accept such offer; or
|
|
115.3
|
is removed from office under article 122.
|
Appointment, rotation and removal of Directors
|
116
|
At each annual general meeting of the Company, all the Directors shall retire from office and be re-eligible for re-election.
|
|
117
|
Upon the resignation or termination of office of any Director, if a new Director shall be appointed to the Board he will be designated to fill the vacancy arising.
|
|
118.1
|
No person shall be appointed a Director, unless nominated in accordance with the provisions of this article 118. Nominations of persons for appointment as
Directors may be made:
|
|
|
(a)
|
by the affirmative vote of two-thirds of the Board; or
|
|
|
(b)
|
with respect to election at an annual general meeting, by any Shareholder who holds Ordinary Shares or other shares carrying the general right to vote at general
meetings of the Company, who is a Shareholder at the time of the giving of the notice provided for in article 70 and at the time of the relevant annual general meeting, and who timely complies with the notice procedures set forth in this
articles 71 - 73; or
|
|
|
(c)
|
with respect to election at an extraordinary general meeting requisitioned in accordance with section 132 of the Act, by a Shareholder or Shareholders who hold Ordinary
Shares or other shares carrying the general right to vote at general meetings of the Company and who make such nomination in the written requisition of the extraordinary general meeting and in compliance with the other provisions of these articles
and the Acts relating to nominations of Directors and the proper bringing of special business before an extraordinary general meeting; or
|
|
|
(d)
|
by Holders of any class or series of shares in the Company then in issue having special rights to nominate or appoint Directors in accordance with the terms of issue of
such class or series, but only to the extent provided in such terms of issue,
|
40
(sub-clauses (b), (c) and (d) being the exclusive means for a Shareholder to make
nominations of persons for election to the Board).
|
118.2
|
For nominations of persons for election as Directors at an extraordinary general meeting to be in proper written form, a Shareholder’s notice must comply with the
requirements outlined in articles 72 and 73.
|
|
118.3
|
The determination of whether a nomination of a candidate for election as a Director of the Company has been timely and properly brought before such meeting in
accordance with this article 118 will be made by the presiding officer of such meeting. If the presiding officer determines that any nomination has not been timely and properly brought before such meeting, he or she will so declare to the
meeting and such defective nomination will be disregarded.
|
|
119
|
A retiring Director shall be eligible to be nominated for re-election at an annual general meeting.
|
|
120
|
If a Director stands for re-election, he shall be deemed to have been re-elected, unless at such meeting the Ordinary Resolution for the re-election of such Director
has been defeated.
|
|
121
|
The Company may from time to time by Ordinary Resolution increase or reduce the maximum number of Directors.
|
|
122
|
The Company may, by Ordinary Resolution, of which extended notice has been given in accordance with section 142 of the Act, remove any Director before the expiration of
his period of office notwithstanding anything in these regulations or in any agreement between the Company and such Director. Such removal shall be without prejudice to any claim such Director may have for damages for breach of any contract of
service between him and the Company.
|
|
123
|
The Directors may appoint a person who is willing to act to be a Director, either to fill a vacancy or as an additional Director, provided that the appointment does not
cause the number of Directors to exceed any number fixed by or in accordance with these articles as the maximum number of Directors.
|
|
124
|
The Company may by Ordinary Resolution elect another person in place of a Director removed from office under article 122; and without prejudice to the powers of
the Directors under article 123 the Company in general meeting may elect any person to be a Director either to fill a vacancy or an additional Director, subject to the maximum number of Directors set out in article 95.
|
Officers
|
125
|
The Board may elect a chairman of the Board and determine the period for which he is to hold office and may appoint any person (whether or not a
Director) to fill the position of chief executive officer (who may be the same person as the chairman of the Board). The
|
41
|
|
chairman of the Board shall vacate that office if he vacates his office as a Director (otherwise than by the expiration of his term of office at a general meeting of the Company at which he is
re-appointed).
|
|
126
|
The Board may from time to time appoint one or more of its body to hold any office or position with the Company for such period and on such terms as the Board may
determine and may revoke or terminate any such appointment. Any such revocation or termination shall be without prejudice to any claim for damages that such Director may have against the Company or the Company may have against such Director for any
breach of any contract of service between him and the Company that may be involved in such revocation or termination or otherwise. Any person so appointed shall receive such remuneration, if any (whether by way of salary, commission, participation
in profits or otherwise), as the Board may determine.
|
|
127
|
In addition, the Board may appoint any person, whether or not he is a Director, to hold such executive or official position (except that of Auditor) as the Board may
from time to time determine. The same person may hold more than one office or executive or official position.
|
|
128
|
Any person elected or appointed pursuant to this article 128 shall hold his office or other position for such period and on such terms as the Board may determine
and the Board may revoke or vary any such election or appointment at any time by resolution of the Board. Any such revocation or variation shall be without prejudice to any claim for damages that such person may have against the Company or the
Company may have against such person for any breach of any contract of service between him and the Company which may be involved in such revocation or variation. If any such office or other position becomes vacant for any reason, the vacancy may be
filled by the Board.
|
|
129
|
Except as provided in the Acts or these articles, the powers and duties of any person elected or appointed to any office or executive or official position pursuant to
this article 129 shall be such as are determined from time to time by the Board.
|
|
130
|
The use or inclusion of the word “officer” (or similar words) in the title of any executive or other position shall not be deemed to imply that the person
holding such executive or other position is an “officer” of the Company within the meaning of the Acts.
|
|
131
|
The Secretary (including one or more deputy or assistant secretaries) shall be appointed by the Directors at such remuneration (if any) and upon such terms as it may
think fit and any Secretary so appointed may be removed by the Directors.
|
|
131.1
|
It shall be the duty of the Secretary to make and keep records of the votes, doings and proceedings of all meetings of the members and Board of the Company, and of its
committees, and to authenticate records of the Company.
|
|
131.2
|
A provision of the Acts or these articles requiring or authorising a thing to be done by or to a Director and the Secretary shall not be satisfied by its being done by
or to the same person acting both as Director and as, or in place of, the Secretary.
|
42
Proceedings of Directors
|
132.1
|
The Directors may meet together for the dispatch of business, adjourn and otherwise regulate their meetings as they may think fit. The quorum necessary for the
transaction of the business of the Directors shall be a majority of the Directors in office at the time when the meeting is convened. Questions arising at any meeting shall be decided by a majority of votes. Each director present and voting shall
have one vote.
|
|
132.2
|
Any Director may participate in a meeting of the Directors by means of telephonic or other similar communication whereby all persons participating in the meeting can
hear each other speak, and participation in a meeting in this manner shall be deemed to constitute presence in person at such meeting and any director may be situated in any part of the world for any such meeting.
|
|
132.3
|
A meeting of the Directors or any committee appointed by the Directors may be held by means of such telephone, electronic or other communication facilities (including,
without limiting the foregoing, by telephone or by video conferencing) as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously and participation in such a meeting shall constitute presence
in person at such meeting. Such a meeting shall be deemed to take place where the largest group of those Directors participating in the meeting is physically assembled, or, if there is no such group, where the chairman of the meeting then is.
|
|
133
|
The President or Chairman, as the case may be, or any four Directors, may, and the Secretary on the requisition of the President or Chairman, as the case may be, or any
four Directors shall, at any time summon a meeting of the Directors.
|
|
134
|
The continuing Directors may act notwithstanding any vacancy in their number but, if and so long as their number is reduced below the number fixed by or pursuant to
these articles as the necessary quorum of Directors, the continuing Directors or Director may act for the purpose of increasing the number of Directors to that number or of summoning a general meeting of the Company but for no other purpose.
|
|
135
|
The Board may from time to time designate committees of the Board, with such powers and duties as the Board may decide to confer on such committees, and shall, for
those committees and any others provided for herein, elect a director or directors to serve as the member or members, designating, if it desires, other directors as alternate members who may replace any absent or disqualified member at any meeting
of the committee. Adequate provision shall be made for notice to members of all meetings of committees; a majority of the members shall constitute a quorum unless the committee shall consist of one or two members, in which event one member shall
constitute a quorum; and all matters shall be determined by a majority vote of the members present. Action may be taken by any committee without a meeting if all members thereof consent thereto in writing, and the writing or writings are filed with
the minutes of the proceedings of such committees.
|
|
136
|
A committee may elect a chairman of its meeting. If no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time
appointed for holding the same, the members present may choose one of their number to be chairman of the meeting.
|
43
|
137
|
All acts done by any meeting of the Directors or of a committee of Directors or by any person acting as a Director shall, notwithstanding that it be afterwards
discovered that there was some defect in the appointment of any such Director or person acting as aforesaid, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and was qualified to be a
Director.
|
|
138
|
Notwithstanding anything in these articles or in the Acts which might be construed as providing to the contrary, notice of every meeting of the Directors shall be given
to all Directors either by mail not less than 48 hours before the date of the meeting, by telephone, email, or any other electronic means on not less than 24 hours’ notice, or on such shorter notice as person or persons calling such meeting may
deem necessary or appropriate and which is reasonable in the circumstances. Any director may waive any notice required to be given under these articles, and the attendance of a director at a meeting shall be deemed to be a waiver by such Director.
|
|
139
|
A resolution or other document in writing (in electronic form or otherwise) signed (whether by electronic signature, advanced electronic signature or otherwise as
approved by the Directors) by all the Directors entitled to receive notice of a meeting of Directors or of a committee of Directors shall be as valid as if it had been passed at a meeting of Directors or (as the case may be) a committee of Directors
duly convened and held and may consist of several documents in the like form each signed by one or more Directors, and such resolution or other document or documents when duly signed may be delivered or transmitted (unless the Directors shall
otherwise determine either generally or in any specific case) by facsimile transmission, electronic mail or some other similar means of transmitting the contents of documents.
|
Rights plan
|
140
|
Subject to applicable law, the Board is hereby expressly authorised to adopt any shareholder rights plan or similar plan, agreement or arrangement pursuant to which,
under circumstances provided therein, some or all Shareholders will have rights to acquire Shares or interests in Shares at a discounted price, upon such terms and conditions as the Board deems expedient and in the best interests of the Company.
|
The seal
|
141
|
The Company, in accordance with article 104, may have for use in any territory outside Ireland one or more additional Seals, each of which shall be a duplicate of
the Seal with or without the addition on its face of the name of one or more territories, districts or places where it is to be used and a securities seal as provided for in the Companies (Amendment) Act 1977.
|
|
142
|
Any Authorised Person may affix the Seal of the Company over his signature alone to any document of the Company required to be authenticated or executed under Seal.
Subject to the Acts, any instrument to which a Seal is affixed shall be signed by one or more Authorised Persons. As used in this article 142, “Authorised Person” means (i) any Director, the Secretary or any Assistant Secretary,
and (ii) any other person authorised for such purpose by the Board from time to time (whether, in the case of this clause (ii), identified individually or collectively and whether identified by name, title, function or such other criteria as
the Board may determine).
|
44
Dividends and reserves
|
143
|
The Company in general meeting may declare dividends, but no dividends shall exceed the amount recommended by the Directors.
|
|
144
|
The Directors may from time to time pay to the members such interim dividends as appear to the Directors to be justified by the profits of the Company.
|
|
145
|
No dividend or interim dividend shall be paid otherwise than in accordance with the provisions of Part IV of the 1983 Act.
|
|
146
|
The Directors may, before recommending any dividend, set aside out of the profits of the Company such sums as they think proper as a reserve or reserves which shall, at
the discretion of the Directors, be applicable for any purpose to which the profits of the Company may be properly applied and pending such application may at the like discretion either be employed in the business of the Company or be invested in
such investments as the Directors may lawfully determine. The Directors may also, without placing the same to reserve, carry forward any profits which they may think it prudent not to divide.
|
|
147
|
Subject to the rights of persons, if any, entitled to shares with special rights as to dividends, all dividends shall be declared and paid according to the amounts paid
or credited as paid on the shares in respect whereof the dividend is paid, but no amount paid or credited as paid on a share in advance of calls shall be treated for the purposes of this article as paid on the share. All dividends shall be
apportioned and paid proportionately to the amounts paid or credited as paid on the shares during any portion or portions of the period in respect of which the dividend is paid; but if any share is issued on terms providing that it shall rank for
dividend as from a particular date, such share shall rank for dividend accordingly.
|
|
148
|
The Directors may deduct from any dividend payable to any member all sums of money (if any) immediately payable by him to the Company on account of calls or otherwise
in relation to the shares of the Company.
|
|
149
|
Any general meeting declaring a dividend or bonus and any resolution of the Directors declaring an interim dividend may direct payment of such dividend, bonus or
interim dividend wholly or partly by the distribution of specific assets and in particular of paid up shares, debentures or debenture stocks of any other company or in any one or more of such ways, and the Directors shall give effect to such
resolution, and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think expedient, and in particular may fix the value for distribution of such specific assets or any part thereof and may determine
that cash payments shall be made to any members upon the footing of the value so fixed, in order to adjust the rights of all the parties, and may vest any such specific assets in trustees as may seem expedient to the Directors.
|
|
150
|
Any dividend or other moneys payable in respect of any share may be paid by cheque or warrant sent by post, at the risk of the person or persons
entitled thereto, to the registered address of the Holder or, where there are joint Holders, to the registered address of that one of the joint Holders who is first named on the members Register or to such person and to such address as the Holder or
joint Holders may in writing direct. Every such cheque or warrant shall be made payable to the order of the person to whom it is sent and payment of the cheque or warrant shall be a good discharge to the Company. Any joint Holder or other
|
45
|
|
person jointly entitled to a share as aforesaid may give receipts for any dividend or other moneys payable in respect of the share. Any such dividend or other distribution may also be paid by any
other method (including payment in a currency other than US$, electronic funds transfer, direct debit, bank transfer or by means of a relevant system) which the Directors consider appropriate and any member who elects for such method of payment
shall be deemed to have accepted all of the risks inherent therein. The debiting of the Company’s account in respect of the relevant amount shall be evidence of good discharge of the Company’s obligations in respect of any payment made by
any such methods.
|
|
151
|
No dividend shall bear interest against the Company.
|
|
152
|
If the Directors so resolve, any dividend which has remained unclaimed for six years from the date of its declaration shall be forfeited and cease to remain owing by
the Company. The payment by the Directors of any unclaimed dividend or other moneys payable in respect of a share into a separate account shall not constitute the Company a trustee in respect thereof.
|
Accounts
|
153.1
|
The Directors shall cause to be kept proper books of account, whether in the form of documents, electronic form or otherwise, that:
|
|
|
(a)
|
correctly record and explain the transactions of the Company;
|
|
|
(b)
|
will at any time enable the financial position of the Company to be determined with reasonable accuracy;
|
|
|
(c)
|
will enable the Directors to ensure that any balance sheet, profit and loss account or income and expenditure account of the Company complies with the requirements of
the Acts; and
|
|
|
(d)
|
will enable the accounts of the Company to be readily and properly audited.
|
Books of account shall be kept on a continuous and consistent basis and entries therein shall be made in a timely manner and be consistent from year to year. Proper books of account shall not be deemed to
be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company’s affairs and to explain its transactions.
The Company may send by post, electronic mail or any other means of electronic communication a summary financial statement to its members or persons nominated by any member. The Company may meet, but
shall be under no obligation to meet, any request from any of its members to be sent additional copies of its full report and accounts or summary financial statement or other communications with its members.
|
153.2
|
The books of account shall be kept at the Office or, subject to the provisions of the Acts, at such other place as the Directors think fit and shall be open at all
reasonable times to the inspection of the Directors.
|
46
|
153.3
|
In accordance with the provisions of the Acts, the Directors shall cause to be prepared and to be laid before the annual general meeting of the Company from time to
time such profit and loss accounts, balance sheets, group accounts and reports as are required by the Acts to be prepared and laid before such meeting.
|
|
153.4
|
A copy of every balance sheet (including every document required by law to be annexed thereto) which is to be laid before the annual general meeting of the Company
together with a copy of the Directors’ report and Auditors’ report shall be sent by post, electronic mail or any other means of communication (electronic or otherwise), not less than 21 Clear Days before the date of the annual general
meeting, to every person entitled under the provisions of the Acts to receive them; provided that in the case of those documents sent by electronic mail or any other means of electronic communication, such documents shall be sent with the consent of
the recipient, to the address of the recipient notified to the Company by the recipient for such purposes.
|
Capitalisation of profits
|
154
|
The Directors may resolve to capitalise any part of the amount for the time being standing to the credit of any of the Company’s reserve accounts or to the credit
of the profit and loss account which is not available for distribution by applying such sum in paying up in full unissued shares to be allotted as fully paid bonus shares to those members of the Company who would have been entitled to that sum if it
were distributable and had been distributed by way of dividend (and in the same proportions). In pursuance of any such resolution under this article 154, the Directors shall make all appropriations and applications of the undivided profits
resolved to be capitalised thereby and all allotments and issues of fully paid shares or debentures, if any, and generally shall do all acts and things required to give effect thereto with full power to the Directors to make such provisions as they
shall think fit for the case of shares or debentures becoming distributable in fractions (and, in particular, without prejudice to the generality of the foregoing, either to disregard such fractions or to sell the shares or debentures represented by
such fractions and distribute the net proceeds of such sale to and for the benefit of the Company or to and for the benefit of the members otherwise entitled to such fractions in due proportions) and to authorise any person to enter on behalf of all
the members concerned into an agreement with the Company providing for the allotment to them respectively, credited as fully paid up, of any further shares or debentures to which they may become entitled on such capitalisation or, as the case may
require, for the payment up by the application thereto of their respective proportions of the profits resolved to be capitalised of the amounts remaining unpaid on their existing shares and any agreement made under such authority shall be binding on
all such members.
|
Amendment of articles
|
155
|
Subject to the provisions of the Acts, the Company may by Special Resolution alter or add to its articles.
|
Audit
|
156
|
Auditors shall be appointed and their duties regulated in accordance with sections 160 to 163 of the Act or any statutory amendment thereof.
|
47
Merger mechanism
|
157
|
Pursuant to the terms of the Merger, at the time the Merger becomes effective (the “
Merger Effective Time
”), US Holdco shall deposit with the exchange
agent (the “
Exchange Agent
”) certificates or, at the Company’s option, evidence of shares in book entry form, representing all of the ordinary shares of US$0.0001 each in the capital of the Company (the “
Company
Shares
”) in issue immediately prior to the Merger Effective Time (other than the seven Company Shares in issue at the date of adoption of these articles (the “
Company Subscriber Shares
”)). All certificates or evidence of
shares in book entry form representing the Company Shares deposited with the Exchange Agent pursuant to the preceding sentence shall hereinafter be referred to as the “
Actavis Exchange Fund
”. As soon as reasonably practicable after
the Merger Effective Time and in any event within four business days after the Merger Effective Time, the Company shall cause the Exchange Agent to mail to each Holder of record of a certificate or certificates, which immediately prior to the Merger
Effective Time represented outstanding Actavis Shares (the “
Actavis Certificates
”); and to each Holder of record of non-certificated outstanding Actavis Shares represented by book entry (the “
Actavis Book Entry
Shares
”), which at the Merger Effective Time were converted into the right to receive, for each such Actavis Share, one Company Share (the “
Merger Consideration
”):
|
|
|
(a)
|
a letter of transmittal which shall specify that delivery shall be effected, and that risk of loss and title to the Actavis Certificates shall pass, only upon delivery
of the Actavis Certificates to the Exchange Agent or, in the case of the Actavis Book Entry Shares, upon adherence to the procedures set forth in the letter of transmittal, and
|
|
|
(b)
|
instructions for use in effecting the surrender of the Actavis Certificates and the Actavis Book Entry Shares (as applicable), in exchange for payment of the Merger
Consideration therefor.
|
|
158
|
Upon surrender of Actavis Certificates and / or Actavis Book Entry Shares (as applicable) for cancellation to the Exchange Agent, together with such
letter of transmittal, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may reasonably be required by the Exchange Agent, the Holder of such Actavis Certificates or Actavis Book Entry
Shares (as applicable) shall be entitled to receive in exchange therefore (i) that number of Company Shares into which such Holder’s Actavis shares represented by such Holder’s properly surrendered Actavis Certificates or Actavis Book
Entry Shares (as applicable) were converted pursuant to the Merger, and (ii) a cheque in an amount of US dollars equal to any cash dividends or other distributions that such Holder has a right to receive and the amount of any cash payable in
lieu of any fractions of shares in the Company that such Holder has the right to receive pursuant to the Merger. In the event of transfers of ownership of shares of Actavis common stock which are not registered in the transfer records of Actavis,
the proper number of Company Shares may be transferred to a person other than the person in whose name the Actavis Certificate or the Actavis Book Entry Shares (as applicable) so surrendered is registered, if such Actavis Certificate or the Actavis
Book Entry Shares (as applicable) shall be properly endorsed or otherwise be in proper form for transfer and the person requesting such transfer shall pay any transfer or other taxes required by reason of the transfer of Company Shares to a person
other than the registered Holder of such Actavis Certificate or Actavis Book Entry Shares (as applicable) or establish to the reasonable satisfaction of the Exchange Agent that such tax has been paid or is not applicable. Any portion of the
|
48
|
|
Actavis Exchange Fund which has not been transferred to the Holders of the Actavis Certificates or the Actavis Book Entry Shares (as applicable) as of the one year anniversary of the Merger
Effective Time, shall be delivered to the Company or its designee, upon demand, and the Company Shares included therein shall be sold at the best price reasonably obtainable at that time. Any Holder of Actavis Certificates or Actavis Book Entry
Shares (as applicable) who has not complied with the applicable exchange procedures or duly completed and validly executed the applicable documents necessary to receive the Merger Consideration, prior to the one year anniversary of the Merger
Effective Time shall thereafter look only to the Company for payment of such Holder’s claim for the Merger Consideration (subject to abandoned property, escheat or other similar applicable laws), such claim only being a claim for cash equal to
the amount of monies received by the Company for sale of the Company Shares to which such Holder had been entitled pursuant to the Merger.
|
Notices
|
159
|
Any notice to be given, served, sent or delivered pursuant to these articles shall be in writing (whether in electronic form or otherwise).
|
|
160.1
|
A notice or document to be given, served, sent or delivered in pursuance of these articles may be given to, served on or delivered to any member by the Company:
|
|
|
(a)
|
by handing same to him or his authorised agent;
|
|
|
(b)
|
by leaving the same at his registered address;
|
|
|
(c)
|
by sending the same by the post in a pre-paid cover addressed to him at his registered address;
|
|
|
(d)
|
by sending the same by courier in a pre-paid cover addressed to him at his registered address; or
|
|
|
(e)
|
by sending, with the consent of the member, the same by means of electronic mail or facsimile or other means of electronic communication approved by the Directors, with
the consent of the member, to the address of the member notified to the Company by the member for such purpose (or if not so notified, then to the address of the member last known to the Company).
|
|
160.2
|
For the purposes of these articles and the Act, a document shall be deemed to have been sent to a member if a notice is given, served, sent or delivered to the member
and the notice specifies the website or hotlink or other electronic link at or through which the member may obtain a copy of the relevant document.
|
|
160.3
|
Where a notice or document is given, served or delivered pursuant to article 160.1(b) of this article, the giving, service or delivery thereof shall be deemed to
have been effected at the time the same was handed to the member or his authorised agent, or left at his registered address (as the case may be).
|
49
|
160.4
|
Where a notice or document is given, served or delivered pursuant to article 160.1(c) of this article, the giving, service or delivery thereof shall be deemed to
have been effected at the expiration of 48 hours after the cover containing it was posted.
|
|
160.5
|
Where a notice or document is given, served or delivered pursuant to article 160.1(d) of this article the giving, service or delivery thereof shall be deemed to
have been effected at the expiration of 24 hours after the cover containing it was posted. In proving service or delivery it shall be sufficient to prove that such cover was properly addressed, stamped and posted.
|
|
160.6
|
Where a notice or document is given, served or delivered pursuant to article 160.1(e) of this article, the giving, service or delivery thereof shall be deemed to
have been effected at the expiration of 12 hours after dispatch.
|
|
160.7
|
Every legal personal representative, committee, receiver, curator bonis or other legal curator, assignee in bankruptcy, examiner or liquidator of a member shall be
bound by a notice given as aforesaid if sent to the last registered address of such member, or, in the event of notice given or delivered pursuant to article 160.1(e) of this article, if sent to the address notified by the Company by the member
for such purpose notwithstanding that the Company may have notice of the death, lunacy, bankruptcy, liquidation or disability of such member.
|
|
160.8
|
Notwithstanding anything contained in this article the Company shall not be obliged to take account of or make any investigations as to the existence of any suspension
or curtailment of postal services within or in relation to all or any part of any jurisdiction or other area other than Ireland.
|
|
160.9
|
Any requirement in these articles for the consent of a member in regard to the receipt by such member of electronic mail or other means of electronic communications
approved by the Directors, including the receipt of the Company’s audited accounts and the directors’ and auditor’s reports thereon, shall be deemed to have been satisfied where the Company has written to the member informing him/her
of its intention to use electronic communications for such purposes and the member has not, within four weeks of the issue of such notice, served an objection in writing on the Company to such proposal. Where a member has given, or is deemed to have
given, his/her consent to the receipt by such member of electronic mail or other means of electronic communications approved by the Directors, he/she may revoke such consent at any time by requesting the Company to communicate with him/her in
documented form PROVIDED HOWEVER that such revocation shall not take effect until five days after written notice of the revocation is received by the Company.
|
|
160.10
|
Without prejudice to the provisions of articles 160.1(a) and 160.1(b), if at any time by reason of the suspension or curtailment of postal services in any
territory, the Company is unable effectively to convene a general meeting by notices sent through the post, a general meeting may be convened by a public announcement and such notice shall be deemed to have been duly served on all members entitled
thereto at noon on the day on which the said public announcement is made. In any such case the Company shall put a full copy of the notice of the general meeting on its website.
|
50
|
161
|
A notice may be given by the Company to the joint Holders of a share by giving the notice to the joint Holder whose name stands first in the Register in respect of the
share and notice so given shall be sufficient notice to all the joint Holders.
|
|
162.1
|
Every person who becomes entitled to a share shall before his name is entered in the Register in respect of the share, be bound by any notice in respect of that share
which has been duly given to a person from whom he derives his title.
|
|
162.2
|
A notice may be given by the Company to the persons entitled to a share in consequence of the death or bankruptcy of a member by sending or delivering it, in any manner
authorised by these articles for the giving of notice to a member, addressed to them at the address, if any, supplied by them for that purpose. Until such an address has been supplied, a notice may be given in any manner in which it might have been
given if the death or bankruptcy had not occurred.
|
|
163
|
The signature (whether electronic signature, an advanced electronic signature or otherwise) to any notice to be given by the Company may be written (in electronic form
or otherwise) or printed.
|
Winding up
|
164
|
If the Company shall be wound up and the assets available for distribution among the members as such shall be insufficient to repay the whole of the paid up or credited
as paid up share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the members in proportion to the capital paid up or credited as paid up at the commencement of the winding up on the shares held by
them respectively. And if in a winding up the assets available for distribution among the members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess
shall be distributed among the members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said shares held by them respectively. Provided that this article shall not affect the rights of the
Holders of shares issued upon special terms and conditions.
|
|
165.1
|
In case of a sale by the liquidator under section 260 of the Act, the liquidator may by the contract of sale agree so as to bind all the members for the allotment to
the members directly of the proceeds of sale in proportion to their respective interests in the Company and may further by the contract limit a time at the expiration of which obligations or shares not accepted or required to be sold shall be deemed
to have been irrevocably refused and be at the disposal of the Company, but so that nothing herein contained shall be taken to diminish, prejudice or affect the rights of dissenting members conferred by the said section.
|
|
165.2
|
The power of sale of the liquidator shall include a power to sell wholly or partially for debentures, debenture stock, or other obligations of another company, either
then already constituted or about to be constituted for the purpose of carrying out the sale.
|
|
166
|
If the Company is wound up, the liquidator, with the sanction of a Special Resolution and any other sanction required by the Acts, may divide among the
members in specie or kind the whole or any part of the assets of the Company (whether they shall consist of property
|
51
|
|
of the same kind or not), and, for such purpose, may value any assets and determine how the division shall be carried out as between the members or different classes of members. The liquidator,
with the like sanction, may vest the whole or any part of such assets in trustees upon such trusts for the benefit of the contributories as, with the like sanction, he determines, but so that no member shall be compelled to accept any assets upon
which there is a liability.
|
Limitation on liability
|
167
|
To the maximum extent permitted by law, no Director or officer of the Company shall be personally liable to the Company or its Shareholders for monetary damages for his
or her acts or omissions save where such acts or omissions involve negligence, default, breach of duty or breach of trust.
|
Indemnity
|
168.1
|
Subject to the provisions of and so far as may be admitted by the Acts, every Director and the Secretary of the Company shall be entitled to be indemnified by the
Company against all costs, charges, losses, expenses and liabilities incurred by him in the execution and discharge of his duties or in relation thereto including any liability incurred by him in defending any proceedings, civil or criminal, which
relate to anything done or omitted or alleged to have been done or omitted by him as an officer or employee of the Company and in which judgment is given in his favour (or the proceedings are otherwise disposed of without any finding or admission of
any material breach of duty on his part) or in which he is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or omission in which relief is granted to him by the Court.
|
|
168.2
|
The Directors shall have power to purchase and maintain for any Director, the Secretary or other employees of the Company insurance against any such liability as
referred to in section 200 of the Act.
|
|
168.3
|
As far as is permissible under the Acts, the Company shall indemnify any current or former executive officer of the Company (excluding any present or former Directors
of the Company or Secretary of the Company), or any person who is serving or has served at the request of the Company as a director or executive officer of another company, joint venture, trust or other enterprise, including any Company subsidiary
(each individually, a “
Covered Person
”), against any expenses, including attorney’s fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with any threatened,
pending, or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, to which he or she was, is, or is threatened to be made a party, or is otherwise involved (a “
proceeding
”), by reason of the
fact that he or she is or was a Covered Person; provided, however, that this provision shall not indemnify any Covered Person against any liability arising out of (a) any fraud or dishonesty in the performance of such Covered Person’s duty
to the Company, or (b) such Covered Party’s conscious, intentional or wilful breach of the obligation to act honestly and in good faith with a view to the best interests of the Company. Notwithstanding the preceding sentence, this section
shall not extend to any matter which would render it void pursuant to the Acts or to any person holding the office of auditor in relation to the Company.
|
52
|
168.4
|
In the case of any threatened, pending or completed action, suit or proceeding by or in the name of the Company, the Company shall indemnify each Covered Person against
expenses, including attorneys’ fees, actually and reasonably incurred in connection with the defence or the settlement thereof, except no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have
been adjudged to be liable for fraud or dishonesty in the performance of his or her duty to the Company, or for conscious, intentional or wilful breach of his or her obligation to act honestly and in good faith with a view to the best interests of
the Company, unless and only to the extent that the High Court of Ireland or the court in which such action or suit was brought shall determine upon application that despite the adjudication of liability, but in view of all the circumstances of the
case, such Covered Person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper. Notwithstanding the preceding sentence, this section shall not extend to any matter which would render it void pursuant to the
Acts or to any person holding the office of auditor in relation to the Company.
|
|
168.5
|
Any indemnification under this article (unless ordered by a court) shall be made by the Company only as authorised in the specific case upon a determination that
indemnification of the Covered Person is proper in the circumstances because such person has met the applicable standard of conduct set forth in this article. Such determination shall be made by any person or persons having the authority to act on
the matter on behalf of the Company. To the extent, however, that any Covered Person has been successful on the merits or otherwise in defence of any proceeding, or in defence of any claim, issue or matter therein, such Covered Person shall be
indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith, without necessity of authorisation in the specific case.
|
|
168.6
|
As far as permissible under the Acts, expenses, including attorneys’ fees, incurred in defending any proceeding for which indemnification is permitted pursuant to
this article shall be paid by the Company in advance of the final disposition of such proceeding upon receipt by the Board of an undertaking by the particular indemnitee to repay such amount if it shall ultimately be determined that he or she is not
entitled to be indemnified by the Company pursuant to these articles.
|
|
168.7
|
It being the policy of the Company that indemnification of the persons specified in this article shall be made to the fullest extent permitted by law, the
indemnification provided by this article shall not be deemed exclusive (i) of any other rights to which those seeking indemnification or advancement of expenses may be entitled under these articles, any agreement, any insurance purchased by the
Company, vote of members or disinterested directors, or pursuant to the direction (however embodied) of any court of competent jurisdiction, or otherwise, both as to action in his or her official capacity and as to action in another capacity while
holding such office, or (ii) of the power of the Company to indemnify any person who is or was an employee or agent of the Company or of another company, joint venture, trust or other enterprise which he or she is serving or has served at the
request of the Company, to the same extent and in the same situations and subject to the same determinations as are hereinabove set forth. As used in this article, references to the “Company” include all constituent companies in a
consolidation or merger in which the Company or a predecessor to the Company by consolidation or merger was involved. The indemnification provided by this article shall continue as to a person who has ceased to be a Covered Person and shall inure to
the benefit of their heirs, executors, and administrators.
|
53
Untraced Holders
|
169.1
|
The Company shall be entitled to sell at the best price reasonably obtainable any share of a member or any share to which a person is entitled by transmission if and
provided that:
|
|
|
(a)
|
for a period of six years (not less than three dividends having been declared and paid) no cheque or warrant sent by the Company through the post in a prepaid letter
addressed to the member or to the person entitled by transmission to the share or stock at his address on the Register or other the last known address given by the member or the person entitled by transmission to which cheques and warrants are to be
sent has been cashed and no communication has been received by the Company from the member or the person entitled by transmission;
|
|
|
(b)
|
at the expiration of the said period of six years the Company has given notice by advertisement in a leading Dublin newspaper and a newspaper circulating in the area in
which the address referred to in article 169.1 is located of its intention to sell such share or stock;
|
|
|
(c)
|
the Company has not during the further period of three months after the date of the advertisement and prior to the exercise of the power of sale received any
communication from the member or person entitled by transmission; and
|
|
|
(d)
|
if so required by the rules of any securities exchange upon which the shares in question are listed, notice has been given to that exchange of the Company’s
intention to make such sale.
|
|
169.2
|
To the extent necessary in order to comply with any laws or regulations to which the Company is subject in relation to escheatment, abandonment of property or other
similar or analogous laws or regulations (“
Applicable Escheatment Laws
”), the Company may deal with any share of any member and any unclaimed cash payments relating to such share in any manner which it sees fit, including (but not
limited to) transferring or selling such share and transferring to third parties any unclaimed cash payments relating to such share.
|
|
169.3
|
The Company may only exercise the powers granted to it in this article 169 in circumstances where it has complied with, or procured compliance with, the required
procedures (as set out in Applicable Escheatment Laws) with respect to attempting to identify and locate the relevant member of the Company.
|
|
169.4
|
If during any six year period referred to in article 169.1, further shares have been issued in right of those held at the beginning of such period or of any
previously issued during such period and all the other requirements of this article (other than the requirement that they be in issue for six years) have been satisfied in regard to the further shares, the Company may also sell the further shares.
|
|
169.5
|
To give effect to any such sale the Company may appoint any person to execute as transferor an instrument of transfer of such share and such instrument of transfer
shall be as effective as if it had been executed by the registered Holder of or person entitled by transmission to such share.
|
54
|
169.6
|
The Company shall account to the member or other person entitled to such share for the net proceeds of such sale by carrying all moneys in respect thereof to a separate
account which shall be a permanent debt of the Company and the Company shall be deemed to be a debtor and not a trustee in respect thereof for such member or other person. Monies carried to such separate account may either be employed in the
business of the Company or invested in such investments (other than shares of the Company or its holding company if any) as the Directors may from time to time think fit.
|
Destruction of documents
|
170
|
The Company may destroy:
|
|
170.1
|
any dividend mandate or any variation or cancellation thereof or any notification of change of name or address, at any time after the expiry of two years from the date
such mandate variation, cancellation or notification was recorded by the Company;
|
|
170.2
|
any instrument of transfer of shares which has been registered, at any time after the expiry of six years from the date of registration;
|
|
170.3
|
all share certificates which have been cancelled at any time after the expiration of one year from the date of cancellation thereof;
|
|
170.4
|
all paid dividend warrants and cheques at any time after the expiration of one year from the date of actual payment thereof;
|
|
170.5
|
all instruments of proxy which have been used for the purpose of a poll at any time after the expiration of one year from the date of such use;
|
|
170.6
|
all instruments of proxy which have not been used for the purpose of a poll at any time after one month from the end of the meeting to which the instrument of proxy
relates and at which no poll was demanded; and
|
|
170.7
|
any other document on the basis of which any entry in the Register was made, at any time after the expiry of six years from the date an entry in the Register was first
made in respect of it,
|
and it shall be presumed conclusively in favour of the Company that every share
certificate (if any) so destroyed was a valid certificate duly and properly sealed and that every instrument of transfer so destroyed was a valid and effective instrument duly and properly registered and that every other document destroyed hereunder
was a valid and effective document in accordance with the recorded particulars thereof in the books or records of the Company provided always that:
|
|
(a)
|
the foregoing provisions of this article shall apply only to the destruction of a document in good faith and without express notice to the Company that the preservation
of such document was relevant to a claim;
|
|
|
(b)
|
nothing contained in this article shall be construed as imposing upon the Company any liability in respect of the destruction of any such document earlier than as
aforesaid or in any case where the conditions of proviso (a) are not fulfilled; and
|
|
|
(c)
|
references in this article to the destruction of any document include references to its disposal in any manner.
|
55
Exhibit 4.1
EXECUTION VERSION
ACTAVIS,
INC.
,
as Company,
ACTAVIS PLC
,
as
Guarantor,
and
Wells Fargo Bank, National Association,
as Trustee
FOURTH
SUPPLEMENTAL INDENTURE
Dated as of October 1, 2013
to the Indenture dated as of August 24, 2009
5.000% Senior Notes due 2014
1.875% Senior Notes due 2017
6.125% Senior Notes due 2019
3.250% Senior Notes due 2022
4.625% Senior Notes due 2042
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
ARTICLE 1
|
|
|
|
|
|
|
|
APPLICATION OF SUPPLEMENTAL INDENTURE
|
|
|
|
|
|
|
|
|
|
Section 1.01
|
|
Application of Fourth Supplemental Indenture
|
|
|
2
|
|
|
|
|
|
|
|
|
ARTICLE 2
|
|
|
|
|
|
|
|
DEFINITIONS
|
|
|
|
|
|
|
|
|
|
Section 2.01
|
|
Certain Terms Defined in the Indenture
|
|
|
2
|
|
|
Section 2.02
|
|
Definitions
|
|
|
3
|
|
|
|
|
|
|
|
|
ARTICLE 3
|
|
|
|
|
|
|
|
GUARANTEE
|
|
|
|
|
|
|
|
|
|
Section 3.01
|
|
Unconditional Guarantee
|
|
|
3
|
|
|
Section 3.02
|
|
Limitation on Guarantor Liability
|
|
|
4
|
|
|
Section 3.03
|
|
Execution and Delivery of Guarantee
|
|
|
5
|
|
|
Section 3.04
|
|
Defeasance or Discharge
|
|
|
5
|
|
|
Section 3.05
|
|
Waiver of Subrogation
|
|
|
5
|
|
|
Section 3.06
|
|
Guaranteed Obligations Not Reduced
|
|
|
6
|
|
|
Section 3.07
|
|
Guaranteed Obligations Reinstated
|
|
|
6
|
|
|
Section 3.08
|
|
Waiver
|
|
|
6
|
|
|
Section 3.09
|
|
No Obligation To Take Action Against the Company
|
|
|
6
|
|
|
Section 3.10
|
|
Default and Enforcement
|
|
|
7
|
|
|
Section 3.11
|
|
Amendment Etc.
|
|
|
7
|
|
|
Section 3.12
|
|
Acknowledgment
|
|
|
7
|
|
|
Section 3.13
|
|
Costs and Expenses
|
|
|
7
|
|
|
Section 3.14
|
|
No Merger or Waiver; Cumulative Remedies
|
|
|
7
|
|
|
Section 3.15
|
|
Guarantee in Addition to Other Guaranteed Obligations
|
|
|
7
|
|
|
Section 3.16
|
|
Successors and Assigns
|
|
|
8
|
|
|
|
|
|
|
|
|
ARTICLE 4
|
|
|
|
|
|
|
|
ADDITIONAL EVENT OF DEFAULT WITH RESPECT TO THE NOTES
|
|
|
|
|
|
|
|
|
|
Section 4.01
|
|
Event of Default
|
|
|
8
|
|
|
|
|
|
|
|
|
ARTICLE 5
|
|
|
|
|
|
|
|
APPLICATION OF MONEY COLLECTED
|
|
|
|
|
|
|
|
|
|
Section 5.01
|
|
Application of Money Collected
|
|
|
8
|
|
i
|
|
|
|
|
|
|
|
|
|
|
ARTICLE 6
|
|
|
|
|
|
|
|
|
|
|
|
MISCELLANEOUS
|
|
|
|
|
|
|
|
|
|
Section 6.01
|
|
Conflict with Trust Indenture Act
|
|
|
8
|
|
|
Section 6.02
|
|
New York Law to Govern
|
|
|
8
|
|
|
Section 6.03
|
|
Counterparts
|
|
|
9
|
|
|
Section 6.04
|
|
Separability Clause
|
|
|
9
|
|
|
Section 6.05
|
|
Ratification
|
|
|
9
|
|
|
Section 6.06
|
|
Effectiveness
|
|
|
9
|
|
|
Section 6.07 Trustee’s Disclaimer. The Trustee accepts the amendments of the Indenture effected by this Supplemental Indenture, but on the terms and conditions set forth in the Indenture, including the terms
and provisions defining and limiting the liabilities and responsibilities of the Trustee. Without limiting the generality of the foregoing, the Trustee shall not be responsible in any manner whatsoever for or with respect to any of the recitals or
statements contained herein, all of which recitals or statements are made solely by the Company, or for or with respect to (i) the validity or sufficiency of this Supplemental Indenture or any of the terms or provisions hereof, (ii) the
proper authorization hereof by the Company by action or otherwise, (iii) the due execution hereof by the Company or (iv) the consequences of any amendment herein provided for, and the Trustee makes no representation with respect to any
such matters.
|
|
|
9
|
|
ii
FOURTH SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “
Fourth Supplemental Indenture
”), dated as of October 1, 2013, among ACTAVIS, INC.,
formerly known as WATSON PHARMACEUTICALS, INC., a Nevada corporation (the “
Company
”), ACTAVIS PLC (the “
Guarantor
”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Trustee (the
“
Trustee
”).
RECITALS OF THE COMPANY
WHEREAS
, the Company and the Trustee executed and delivered an Indenture, dated as of August 24, 2009 (the “
Base
Indenture
,” and together with the First Supplemental Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture (each as defined below) and this Fourth Supplemental Indenture, the “
Indenture
”), to
provide for the issuance by the Company from time to time of Securities to be issued in one or more series as provided in the Indenture;
WHEREAS
, the Company executed and delivered a First Supplemental Indenture, dated as of August 24, 2009 (the “
First
Supplemental Indenture
”), pursuant to Section 201 of the Base Indenture to establish the form, and pursuant to Section 301 of the Base Indenture to provide for the issuance, of a series of its senior notes designated as its 5.000%
Senior Notes due August 15, 2014 (the “
2014 Notes
”) and a series of its senior notes designated as its 6.125% Senior Notes due August 15, 2019 (the “
2019 Notes
”) in an initial aggregate principal amount of
$450,000,000 in the case of the 2014 Notes and $400,000,000 in the case of the 2019 Notes;
WHEREAS
, the Company executed and
delivered a Second Supplemental Indenture, dated as of May 7, 2010 (the “
Second Supplemental Indenture
”), pursuant to Section 901(3) of the Base Indenture to amend Section 501 of the Base Indenture to provide for an
additional event of default;
WHEREAS
, the Company executed and delivered a Third Supplemental Indenture, dated as of
October 2, 2012 (the “
Third Supplemental Indenture
”), pursuant to Section 201 of the Base Indenture to establish the form, and pursuant to Section 301 of the Base Indenture to provide for the issuance, of a series of
its senior notes designated as its 1.875% Senior Notes due 2017 (the “
2017 Notes
”), a series of its senior notes designated as its 3.250% Senior Notes due 2022 (the “
2022 Notes
”) and a series of its senior notes
designated as its 4.625% Senior Notes due 2042 (the “
2042 Notes
,” and together with the 2014 Notes, the 2019 Notes, the 2017 Notes and the 2022 Notes, the “
Notes
” and each of the 2042 Notes, 2022 Notes, 2017 Notes,
2019 Notes and 2014 Notes, a series of Securities under the Indenture), in an initial aggregate principal amount of $1,200,000,000 in the case of the 2017 Notes, $1,700,000,000 in the case of the 2022 Notes and $1,000,000,000 in the case of the 2042
Notes;
WHEREAS
,
Section 901(10) of the Base Indenture provides, among other things, that the Company and the Trustee
may enter into one or more indentures supplemental to the Base Indenture, without the consent of any Holders of Securities of any series, to make any modifications or add other provisions;
provided
that such action shall not adversely affect
the interests of Holders of Securities of any series;
WHEREAS
, Section 901(3) of the Base Indenture provides that the Company and the
Trustee may add any additional Events of Default for the benefit of the Holders of all or any series of Securities, without the consent of any Holders of Securities of any series;
WHEREAS
, the Guarantor has become the ultimate parent company of the Company and desires to add a covenant to fully and unconditionally
guarantee all of the obligations of the Company under the Notes and the Indenture on the terms set forth herein;
WHEREAS
, the
Company has delivered to the Trustee an Opinion of Counsel and an Officers’ Certificate pursuant to Sections 102 and 903 of the Base Indenture to the effect that the execution and delivery of the Fourth Supplemental Indenture is authorized or
permitted under the Base Indenture and that all conditions precedent provided for in the Base Indenture to the execution and delivery of this Fourth Supplemental Indenture have been complied with;
WHEREAS
, the Company has requested that the Trustee execute and deliver this Fourth Supplemental Indenture; and
WHEREAS
, all things necessary have been done by the Company and the Guarantor to make this Fourth Supplemental Indenture, when executed
and delivered by the Company and the Guarantor, a valid and legally binding instrument.
NOW, THEREFORE:
In consideration of the premises stated herein, the Company, the Guarantor and the Trustee mutually covenant and agree for the equal and
proportionate benefit of the respective Holders from time to time of each series of Notes as follows:
ARTICLE 1
APPLICATION OF SUPPLEMENTAL INDENTURE
Section 1.01
Application of Fourth Supplemental Indenture
. Notwithstanding any other provision of this Fourth Supplemental
Indenture, all provisions of this Fourth Supplemental Indenture are expressly and solely for the benefit of the Holders of the Notes and any such provisions shall not be deemed to apply to any other series of Securities issued under the Base
Indenture and shall not be deemed to amend, modify or supplement the Base Indenture for any purpose other than with respect to the Notes. Unless otherwise expressly specified, references in this Fourth Supplemental Indenture to specific Article
numbers or Section numbers refer to Articles and Sections contained in this Fourth Supplemental Indenture as they amend or supplement the Base Indenture, and not the Base Indenture or any other document.
ARTICLE 2
DEFINITIONS
Section 2.01
Certain Terms Defined in the Indenture
. For purposes of this Fourth Supplemental Indenture, all capitalized
terms used but not defined herein shall have the meanings ascribed to such terms in the Base Indenture, as amended to date and further amended hereby.
2
Section 2.02
Definitions
.
(1) For the benefit of the Holders of each series of the Notes, Section 101 of the Base Indenture shall be amended by adding the following
new definitions:
“
Bankruptcy Law
” means Title 11, U.S. Code or any similar federal or state law for the relief of
debtors.
“
Guarantee
” means the guarantee of the Company’s obligations under the Notes of the applicable series and
the Indenture by the Guarantor under this Supplemental Indenture. When used as a verb “Guarantee” shall have a corresponding meaning.
“
Guaranteed Obligations
” has the meaning specified in Section 3.01(a) hereof.
“
Guarantor
” means the Person named as the “Guarantor” in the first paragraph of this Fourth Supplemental Indenture
until a successor Person shall have become such pursuant to the applicable provisions of the Indenture, and thereafter “Guarantor” shall mean such successor Person.
(2) Section 101 of the Base Indenture shall be further amended as follows:
“Opinion of Counsel” shall be amended by inserting the words “or the Guarantor” after “the Company”.
ARTICLE 3
GUARANTEE
Section 3.01
Unconditional Guarantee
. With respect to each series of Notes, the Guarantor hereby unconditionally and
irrevocably guarantees, as a primary obligor and not merely as a surety, on a senior unsecured basis to each Holder of that series of Notes and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the
Indenture, that series of Notes or the obligations of the Company to such Holders or the Trustee hereunder or thereunder: (a) (x) the full and punctual payment of the principal of, premium, if any, and interest on the Notes of that series
when and as the same shall become due and payable, whether at maturity, upon redemption or repurchase, by acceleration or otherwise, (y) the due and punctual payment of interest on the overdue principal and (to the extent permitted by law)
interest, if any, on the Notes of that series (including interest accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding relating to the Company or the Guarantor, whether or
not a claim for post-filing or post-petition interest is allowed in such proceeding) and (z) the due and punctual payment and performance of all other obligations of the Company, in each case, to the Holders of that series of Notes or the
Trustee hereunder or thereunder (including amounts due the Trustee under
Section 607
of the Base Indenture), all in accordance with the terms hereof and thereof (collectively, the “
Guaranteed Obligations
”); and
(b) in case of any extension of time of payment or renewal of any Notes of that series or any of such other obligations, the due and punctual payment and performance of Guaranteed Obligations in accordance with the terms of the extension or
renewal, whether at maturity, upon redemption or repurchase, by acceleration or otherwise. Failing payment when due of any amount so guaranteed, or failing performance of
3
any other obligation of the Company to the Holders of a particular series of Notes under the Indenture or under the Notes of that series, for whatever reason, the Guarantor shall be obligated to
pay, or to perform or cause the performance of, the same immediately. An Event of Default under the Indenture or the Notes shall constitute an event of default under the Guarantee with respect to that series of Notes, and shall entitle the Holders
of such series of Notes to accelerate the obligations of the Guarantor thereunder in the same manner and to the same extent as the obligations of the Company. The Guarantor further agrees that the Guaranteed Obligations may be extended or renewed,
in whole or in part, without notice or further assent from the Guarantor, and that the Guarantor shall remain bound under this Section 3.01 notwithstanding any extension or renewal of any Guaranteed Obligation.
The Guarantor hereby agrees that its obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability
of the Notes of that series or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to
enforce the same, whether or not a Guarantee is affixed to any particular Note, or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of the Guarantor. The Guarantor hereby waives the benefit of
diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenants
that its Guarantee of a particular series of Notes shall not be discharged except by complete performance of the obligations contained in the Notes of that series, the Indenture and the Guarantee. The Guarantee of each series of Notes is a guarantee
of payment and not of collection. If any Holder of a particular series of Notes or the Trustee is required by any court or otherwise to return to the Company or to the Guarantor, or any custodian, trustee, liquidator or other similar official acting
in relation to the Company or the Guarantor, any amount paid by the Company or the Guarantor to the Trustee or such Holder, the Guarantee of that series of Notes, to the extent theretofore discharged, shall be reinstated in full force and effect.
The Guarantor further agrees that, as between it, on the one hand, and the Holders of each series of Notes and the Trustee, on the other hand, (a) subject to this
Article Three
the maturity of the obligations of a particular series of
Notes guaranteed hereby may be accelerated as provided in
Article Five
of the Base Indenture for the purposes of the Guarantee of that series of Notes, notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the obligations of that series of Notes guaranteed hereby, and (b) in the event of any acceleration of such obligations as provided in
Article Five
thereof, such obligations of a particular series of notes (whether or not due
and payable) shall forthwith become due and payable by the Guarantor for the purpose of the Guarantee of that series of Notes.
Section 3.02
Limitation on Guarantor Liability
. Each Holder and the Trustee, hereby confirms that it is the intention of all such
parties that the Guarantee of the Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the
extent applicable to any Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantor hereby irrevocably agree that the obligations of the Guarantor shall be limited to the maximum amount as will, after giving effect
to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under such laws and result in the obligations of the Guarantor under its Guarantee not constituting a fraudulent transfer or conveyance.
4
Section 3.03
Execution and Delivery of Guarantee
.
The Guarantor hereby agrees that its Guarantee of a particular series of Notes set forth in
Section 3.01
shall remain in full
force and effect notwithstanding any failure to endorse on each Note of that series a notation of such Guarantee.
If an Officer of the
Guarantor whose signature is on this Fourth Supplemental Indenture no longer holds that office at the time the Trustee authenticates the Note on which such Guarantee is endorsed or at any time thereafter, the Guarantor’s Guarantee of such Note
shall nevertheless be valid.
The delivery of any Note by the Trustee, after the authentication thereof hereunder, shall constitute due
delivery of any Guarantee set forth in this Fourth Supplemental Indenture on behalf of the Guarantor.
Section 3.04
Defeasance or
Discharge
.
The Guarantee of the Guarantor shall be released if the Company (1) exercises its option under
Section 1302
or
1303
of the Base Indenture or (2) discharges its Obligations under the Indenture in accordance with
Section 401
of the Base Indenture.
The Trustee shall execute an appropriate instrument prepared by the Company evidencing the release of the Guarantor from its obligations under
its Guarantee upon receipt of a request by the Company or the Guarantor accompanied by an Officers’ Certificate and an Opinion of Counsel certifying as to the compliance with this
Section 3.04
;
provided
,
however
, that
the legal counsel delivering such Opinion of Counsel may rely as to matters of fact on one or more Officers’ Certificates of the Company.
Section 3.05
Waiver of Subrogation
.
Until the Indenture is discharged and all of the Notes of a particular series are discharged and paid in full, the Guarantor hereby
irrevocably waives and agrees not to exercise any claim or other rights which it may now or hereafter acquire against the Company that arise from the existence, payment, performance or enforcement of the Company’s obligations under that series
of Notes or the Indenture and the Guarantor’s obligations under the Guarantee with respect to that series of Notes and the Indenture, in any such instance including any right of subrogation, reimbursement, exoneration, contribution,
indemnification, and any right to participate in any claim or remedy of the Holders of a particular series of Notes against the Company, whether or not such claim, remedy or right arises in equity, or under contract, statute or common law, including
the right to take or receive from the Company, directly or indirectly, in cash or other assets or by set-off or in any other manner, payment or security on account of such claim or other rights. If any amount shall be paid to the Guarantor in
violation of the preceding sentence and any amounts owing to the Trustee or the Holders under the Notes, the Indenture, or any other document or instrument delivered under or in connection with such agreements or instruments, shall not have been
paid in full, such amount shall have been deemed to have been paid to the
5
Guarantor for the benefit of, and held in trust for the benefit of, the Trustee or the Holders and shall forthwith be paid to the Trustee for the benefit of itself or such Holders to be credited
and applied to the obligations in favor of the Trustee or the Holders, as the case may be, whether matured or unmatured, in accordance with the terms of the Indenture. The Guarantor acknowledges that it will receive direct and indirect benefits from
the financing arrangements contemplated by the Indenture and that the waiver set forth in this
Section 3.05
is knowingly made in contemplation of such benefits.
Section 3.06
Guaranteed Obligations Not Reduced
.
The obligations of the Guarantor with respect to a particular series of Notes shall not be satisfied, reduced or discharged solely by the
payment of such principal, premium, if any, interest, fees and other monies or amounts as may at any time prior to discharge of the Indenture pursuant to
Article Four
of the Base Indenture be or become owing or payable under or by virtue of
or otherwise in connection with the Notes of a particular series or the Indenture.
Section 3.07
Guaranteed Obligations
Reinstated
.
The obligations of the Guarantor with respect to a particular series of Notes shall continue to be effective or shall be
reinstated, as the case may be, if at any time any payment which would otherwise have reduced the obligations of the Guarantor with respect to that series of Notes (whether such payment shall have been made by or on behalf of the Company or by or on
behalf of the Guarantor) is rescinded or reclaimed from any of the Holders of that series of Notes upon the insolvency, bankruptcy, liquidation or reorganization of the Company or the Guarantor or otherwise, all as though such payment had not been
made. If demand for, or acceleration of the time for, payment by the Company or the Guarantor is stayed upon the insolvency, bankruptcy, liquidation or reorganization of the Company or the Guarantor, all such Indebtedness otherwise subject to demand
for payment or acceleration shall nonetheless be payable by the Guarantor as provided herein.
Section 3.08
Waiver
.
Without in any way limiting the provisions of
Section 3.01
, the Guarantor hereby waives notice of acceptance hereof, notice of any
liability of the Guarantor hereunder, notice or proof of reliance by the Holders of a particular series of notes upon the obligations of the Guarantor, and diligence, presentment, demand for payment on the Company, protest, notice of dishonor or
non-payment of any of the Guaranteed Obligations, or other notice or formalities to the Company or the Guarantor of any kind whatsoever.
Section 3.09
No Obligation To Take Action Against the Company
.
Neither the Trustee nor any other Person shall have any obligation to enforce or exhaust any rights or remedies against the Company or any
other Person or any property of the Company or any other Person before the Trustee is entitled to demand payment and performance by the Guarantor of its liabilities and obligations under its Guarantees of a particular series of Notes or under the
Indenture.
6
Section 3.10
Default and Enforcement
.
If the Guarantor fails to pay in accordance with
Section 3.06
hereof, the Trustee may proceed in its name as trustee hereunder in
the enforcement of the Guarantee of a particular series of Notes of the Guarantor and the Guarantor’s obligations with respect to that series of Notes by any remedy provided by law, whether by legal proceedings or otherwise, and to recover from
the Guarantor the obligations.
Section 3.11
Amendment Etc.
No amendment, modification or waiver of any provision of the Indenture relating to the Guarantor or consent to any departure by the Guarantor
or any other Person from any such provision shall in any event be effective unless it is signed by the Issuer, the Guarantor and the Trustee.
Section 3.12
Acknowledgment
.
The Guarantor hereby acknowledges communication of the terms of the Indenture and the Notes and consents to and approves of the same.
Section 3.13
Costs and Expenses
.
The Guarantor shall pay on demand by the Trustee any and all costs, fees and expenses (including legal fees and expenses on a solicitor and
client basis) incurred by the Trustee, its agents, advisors and counsel or any of the Holders in enforcing any of their rights under any Guarantee of a particular series of Notes.
Section 3.14
No Merger or Waiver; Cumulative Remedies
.
No Guarantee shall operate by way of merger of any of the obligations of the Guarantor under any other agreement, including the Indenture. No
failure to exercise and no delay in exercising, on the part of the Trustee or the Holders of a particular series of Notes, any right, remedy, power or privilege hereunder or under the Indenture or the Notes, shall operate as a waiver thereof; nor
shall any single or partial exercise of any right, remedy, power or privilege hereunder or under the Indenture or the Notes preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights,
remedies, powers and privileges in the Guarantee and under the Indenture, the Notes and any other document or instrument between the Guarantor or the Company and the Trustee are cumulative and not exclusive of any rights, remedies, powers and
privilege provided by law.
Section 3.15
Guarantee in Addition to Other Guaranteed Obligations
.
The obligations of the Guarantor under its Guarantee of each series of Notes and the Indenture are in addition to and not in substitution for
any other obligations to the Trustee or to any of the Holders of that series of Notes in relation to the Indenture or the Notes and any guarantees or security at any time held by or for the benefit of any of them.
7
Section 3.16
Successors and Assigns
.
The Guarantee shall be binding upon and inure to the benefit of the Guarantor and the Trustee and the other Holders and their respective
successors and permitted assigns, except that the Guarantor may assign any of its obligations hereunder or thereunder.
ARTICLE 4
ADDITIONAL EVENT OF DEFAULT WITH RESPECT TO THE NOTES
Section 4.01
Event of Default
. Section 501 of the Base Indenture is hereby amended, in connection with this Fourth
Supplemental Indenture and with respect to the Notes, by inserting the following clause (10):
(10) The Guarantee ceases to be in full
force and effect (except as contemplated by the terms hereof) or the Guarantor denies or disaffirms its obligations under the Indenture or the Guarantee, other than by reason of the release of the Guarantee in accordance with the terms of the
Indenture, and such Default continues for 10 days.
ARTICLE 5
APPLICATION OF MONEY COLLECTED
Section 5.01
Application of Money Collected
. Section 506 of the Base Indenture is hereby amended, in connection with this
Fourth Supplemental Indenture and with respect to the Notes, by deleting “THIRD: To the Company or to such party as a court of competent jurisdiction shall direct” in its entirety and replacing it with:
“THIRD: To the Company or, if applicable, the Guarantor, as their respective interests may appear, or to such party as a
court of competent jurisdiction shall direct;”
ARTICLE 6
MISCELLANEOUS
Section 6.01
Conflict with Trust Indenture Act
. If any provision hereof limits, qualifies or conflicts with a provision of the
Trust Indenture Act which is required under such Act or deemed to be a part of and govern this Fourth Supplemental Indenture, such required or deemed provision shall control. If any provision of this Fourth Supplemental Indenture modifies or
excludes any provision of the Trust Indenture Act which may be so modified or excluded, the latter provision shall be deemed to apply to this Fourth Supplemental Indenture as so modified or to be excluded, as the case may be.
Section 6.02
New York Law to Govern
. This Fourth Supplemental Indenture and the Notes shall be governed by and construed in
accordance with the laws of the State of New York (including without limitation Section 5-1401 of the New York General Obligations Law or any successor to such statute). The Trustee, the Company and the Guarantor agree to submit to the
non-exclusive jurisdiction of any United States federal or state court located in the borough of Manhattan, in the city of New York in any action or proceeding arising out of or relating to this Fourth Supplemental Indenture or the Notes. This
Fourth Supplemental Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent applicable, be governed by such provisions.
8
The Trustee, the Company and the Guarantor hereby knowingly, voluntarily and intentionally waive
any rights they may have to a trial by jury in respect of any litigation based hereon, or arising out of, under or in connection with this Fourth Supplemental Indenture or any course of conduct, course of dealing, statements (whether oral or
written) or actions of the Trustee, the Company or the Guarantor relating thereto. The Company and the Guarantor acknowledge and agree that they have received full and sufficient consideration for this provision and that this provision is a material
inducement for the Trustee entering into this Fourth Supplemental Indenture.
Section 6.03
Counterparts
. This Fourth
Supplemental Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. The exchange of copies of this
Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the
parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.
Section 6.04
Separability Clause
. In case any provision in this Fourth Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby.
Section 6.05
Ratification
. The Base Indenture, as supplemented and amended by this Fourth
Supplemental Indenture, is in all respects ratified and confirmed. The Indenture shall be read, taken and construed as one and the same instrument. All provisions included in this Fourth Supplemental Indenture supersede any conflicting provisions
included in the Base Indenture unless not permitted by law. The Trustee accepts the trusts created by the Indenture, and agrees to perform the same upon the terms and conditions of the Indenture.
Section 6.06
Effectiveness
. The provisions of this Fourth Supplemental Indenture shall become effective as of the date hereof.
Section 6.07
Trustee’s Disclaimer
. The Trustee accepts the amendments of the Indenture effected by this Supplemental
Indenture, but on the terms and conditions set forth in the Indenture, including the terms and provisions defining and limiting the liabilities and responsibilities of the Trustee. Without limiting the generality of the foregoing, the Trustee shall
not be responsible in any manner whatsoever for or with respect to any of the recitals or statements contained herein, all of which recitals or statements are made solely by the Company, or for or with respect to (i) the validity or sufficiency
of this Supplemental Indenture or any of the terms or provisions hereof, (ii) the proper authorization hereof by the Company by action or otherwise, (iii) the due execution hereof by the Company or (iv) the consequences of any
amendment herein provided for, and the Trustee makes no representation with respect to any such matters.
[Remainder of page intentionally
left blank.]
9
IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed as of
the date first above written.
|
|
|
|
|
|
|
ACTAVIS, INC., as Issuer
|
|
|
|
|
By:
|
|
/s/ David A. Buchen
|
|
|
|
Name:
|
|
David A. Buchen
|
|
|
|
Title:
|
|
Chief Legal Officer – Global and Secretary
|
|
|
|
|
|
|
|
ACTAVIS PLC, as Guarantor
|
|
|
|
|
By:
|
|
/s/ Paul M. Bisaro
|
|
|
|
Name:
|
|
Paul M. Bisaro
|
|
|
|
Title:
|
|
Director and President and CEO
|
|
|
|
|
|
|
|
WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
|
|
|
|
|
By:
|
|
/s/ Michael Tu
|
|
|
|
Name:
|
|
Michael Tu
|
|
|
|
Title:
|
|
Assistant Vice President
|
Exhibit 4.2
EXECUTION VERSION
THIRD
SUPPLEMENTAL INDENTURE
This Supplemental Indenture, dated as of October 1, 2013 (this “
Supplemental Indenture
”
or “
Guarantee
”), among Actavis plc (the “
New Guarantor
”), Warner Chilcott Company, LLC (the “
Company
”) and Warner Chilcott Finance LLC (together with the Company and their respective successors and
assigns, the “
Issuers
”) and Wells Fargo Bank, National Association, as Trustee under the Indenture referred to below.
W I
T N E S S E T H:
WHEREAS, the Issuers, the Notes Guarantors and the Trustee have heretofore executed and delivered an Indenture, dated as
of August 20, 2010 (as amended, supplemented, waived or otherwise modified, the “
Indenture
”), providing for the issuance of 7 3/4% Senior Notes due 2018 of the Issuers (the “
Notes
”);
WHEREAS, pursuant to
Section 9.01
of the Indenture, the Trustee, the New Guarantor and the Issuers are authorized to execute and
deliver this Supplemental Indenture, without the consent of any Holder, to amend or supplement the Indenture to add a Guarantee of the Notes;
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged,
the New Guarantor, the Issuers and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:
ARTICLE I
SECTION 1.1
Defined Terms
. As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recital hereto are used herein as therein defined, except that the term “Holders” in this Guarantee shall refer to the term
“Holders” as defined in the Indenture and the Trustee acting on behalf or for the benefit of such Holders. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental
Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.
ARTICLE II
SECTION 2.1
Agreement to be Bound
. The New Guarantor hereby becomes a party to the Indenture as a Notes Guarantor and as such shall
have all of the rights and be subject to all of the obligations and agreements of a Notes Guarantor under the Indenture. The New Guarantor agrees to be bound by all of the provisions of the Indenture applicable to a Notes Guarantor and to perform
all of the obligations and agreements of a Notes Guarantor under the Indenture.
SECTION 2.2
Guarantee
. The New Guarantor agrees,
on a joint and several basis with all the existing Notes Guarantors, to fully, unconditionally and irrevocably Guarantee to each Holder of the Notes and the Trustee the Obligations on a senior unsecured basis as provided in Article Eleven of
the Indenture.
ARTICLE III
SECTION 3.1
Notices
. All notices and other communications to the New Guarantor shall be given as provided in the Indenture to the New
Guarantor, at its address set forth below, with a copy to the Issuers as provided in the Indenture for notices to the Issuers.
SECTION
3.2
Parties
. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this
Supplemental Indenture or the Indenture or any provision herein or therein contained.
SECTION 3.3
Governing Law
. This Supplemental
Indenture shall be governed by, and construed in accordance with, the laws of the State of New York.
SECTION 3.4
Severability
Clause
. In case any provision in this Supplemental Indenture shall be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction be ineffective to the extent of such invalidity, illegality or unenforceability without
affecting the validity, legality and enforceability of the remaining provisions; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.
SECTION 3.5
Ratification of Indenture; Supplemental Indentures Part of Indenture
. Except as expressly amended hereby, the Indenture is
in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore
or hereafter authenticated and delivered shall be bound hereby. The Trustee makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture.
SECTION 3.6
Counterparts
. The parties hereto may sign one or more copies of this Supplemental Indenture in counterparts, each of which
shall constitute an original, but all of which when taken together shall constitute one and the same agreement.
SECTION 3.7
Headings
. The headings of the Articles and the sections in this Guarantee are for convenience of reference only, are not part of this Supplemental Indenture and shall not be deemed to alter or affect the meaning or interpretation of any
provisions hereof.
IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written.
|
|
|
|
|
|
|
ACTAVIS PLC, as a Guarantor
|
|
|
|
|
By:
|
|
/s/ Paul M. Bisaro
|
|
|
|
Name:
|
|
Paul M. Bisaro
|
|
|
|
Title:
|
|
Director and President and CEO
|
|
|
|
|
|
|
|
WELLS FARGO BANK,
|
|
NATIONAL ASSOCIATION, as Trustee
|
|
|
|
|
By:
|
|
/s/ Martin Reed
|
|
|
|
Name:
|
|
Martin Reed
|
|
|
|
Title:
|
|
Vice President
|
|
|
|
|
|
|
|
WARNER CHILCOTT COMPANY, LLC,
|
|
as Issuer
|
|
|
|
|
By:
|
|
/s/ David A. Buchen
|
|
|
|
Name:
|
|
David A. Buchen
|
|
|
|
Title:
|
|
Chief Legal Officer – Global and Secretary
|
|
|
|
|
|
|
|
WARNER CHILCOTT FINANCE LLC, as Issuer
|
|
|
|
|
By:
|
|
/s/ David A. Buchen
|
|
|
|
Name:
|
|
David A. Buchen
|
|
|
|
Title:
|
|
Chief Legal Officer – Global and Secretary
|
Exhibit 10.6
DEED OF INDEMNIFICATION
This Deed of Indemnification, dated as of ,
20 , is made by and between Actavis plc, an Irish public limited company (the “Company”), and
(“Indemnitee”).
WHEREAS, the Company desires to ensure that the Company benefits from the services of highly qualified,
experienced and otherwise competent persons such as Indemnitee;
WHEREAS, the Company previously requested that Indemnitee serve the
Company as a director of the Company, and, if requested to do so by the Company, as a director, officer, trustee, employee, representative or agent of another corporation, joint venture, trust or other enterprise, in each case whether organized
under the laws of Ireland, any foreign nation or any political subdivision thereof; and
WHEREAS, Indemnitee desires to be indemnified by
the Company and has agreed to become a director of the Company in reliance upon the Company’s promise to provide indemnification on the basis (i) herein set forth and (ii) set forth in an indemnification agreement between Actavis W.C.
Holding Inc. and Indemnitee.
NOW, THEREFORE, in consideration of the foregoing promises and the mutual covenants herein contained, the
parties hereto agree as follows:
Section 1.
Generally
.
(a) In consideration of Indemnitee agreeing to act and continue to act as director of the Company, in addition to and without prejudice to any
other right of indemnity in favour of Indemnitee from time to time, the Company hereby irrevocably and unconditionally agrees and undertakes with Indemnitee subject to Section 200 of the Companies Act 1963 upon first demand to indemnify and
keep Indemnitee (and any alternate director appointed by such Indemnitee to act on his behalf together with their respective estates) indemnified and held harmless from and against, and to assume all liability for, any and all proceedings
(including, without limitation, claims, demands and actions), liability, damage, loss, charge, detriment, cost, Expenses, judgments or fines suffered, incurred or sustained by Indemnitee (or any such alternate director or their respective estates)
arising directly or indirectly out of or in connection with his acting as a director or alternate director (as the case may be) of the Company otherwise than by reason of the dishonesty, fraud, breach of fiduciary duty, negligence or wilful
misconduct of Indemnitee or such alternate director (as the case may be). For the avoidance of doubt, the foregoing indemnity shall extend to any liability incurred by Indemnitee in defending proceedings, whether civil or criminal, in which
judgement is given in his favour in which he is acquitted, in connection with any application under Section 391 of the Companies Act 1963 or Section 42 of the Companies (Amendment) Act 1983 in which relief is granted to him by the court.
(b) The indemnification provided by this
Section 1
shall be from and against Expenses, judgments and fines actually and
reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such proceeding and any appeal therefrom, but shall only be provided if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not
opposed to the best interests of the Company.
(c) The rights of Indemnitee hereunder shall be in addition to any rights Indemnitee may now or
hereafter have to indemnification by the Company or otherwise.
Section 2.
Successful Defense; Partial Indemnification
.
(a) To the extent that Indemnitee has been successful on the merits or otherwise in defense of any proceeding or in defense of any claim, issue
or matter therein, Indemnitee shall be indemnified against Expenses actually and reasonably incurred in connection therewith.
(b) If
Indemnitee is entitled under any provision of this Deed to indemnification by the Company for some or a portion of the Expenses, judgments and fines actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with any
proceeding or investigation, or in defense of any claim, issue or matter therein, and any appeal therefrom but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such Expenses,
judgments and fines.
Section 3.
Determination That Indemnification Is Proper
. Any indemnification hereunder shall (unless
otherwise ordered by a court) be made by the Company unless a determination is made that indemnification of such person is not proper in the circumstances because he or she has not met the applicable standard of conduct set forth in
Section 1(b)
of this Deed. Any such determination shall be made (i) by a majority vote of the directors who are not parties to the proceeding in question (“disinterested directors”), even if less than a quorum,
(ii) by a majority vote of a committee of disinterested directors designated by majority vote of disinterested directors, even if less than a quorum, (iii) by independent legal counsel, or (iv) by a court of competent jurisdiction.
Section 4.
Notification and Defense of Claim
.
(a) Promptly after receipt by Indemnitee of notice of the commencement of any proceeding, Indemnitee shall notify the Company of the
commencement thereof. The failure to promptly notify the Company of the commencement of the proceeding, or Indemnitee’s request for indemnification, will not relieve the Company from any liability that it may have to Indemnitee hereunder,
except to the extent the Company is prejudiced in its defense of such proceeding as a result of such failure.
(b) If any action,
proceeding, claim or demand shall be brought or asserted against Indemnitee or any alternate director appointed by him to act on his behalf in respect of which indemnity may be sought against the Company, the Company, if appropriate, shall be
entitled to assume the defense of such proceeding, with counsel reasonably acceptable to Indemnitee, upon the delivery to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel by Indemnitee
and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Deed for any fees of counsel subsequently incurred by Indemnitee with respect to the same proceeding, provided that (1) Indemnitee shall
have the right to employ Indemnitee’s own counsel in such proceeding at Indemnitee’s expense and (2) if (i) the employment of counsel by Indemnitee has been previously authorized in writing by the Company, (ii) counsel to
the Company or Indemnitee shall have reasonably concluded that there may be a conflict of interest or position, or reasonably believes that a conflict is likely to arise, on any significant issue between the Company and Indemnitee in the conduct of
any such defense or (iii) the Company shall not, in
2
fact, have employed counsel to assume the defense of such proceeding, then the Expenses of Indemnitee’s counsel shall be at the expense of the Company, except as otherwise expressly provided
by this Deed. Notwithstanding the foregoing, in the case of clause (iii) of the preceding sentence, Indemnitee acknowledges that, in connection with any one such proceeding involving at least one other party to whom the Company owes obligations
identical or similar to those owed to Indemnitee under this Deed, or separate but substantially similar proceedings arising out of the same general allegations and involving at least one other party to whom the Company owes obligations identical or
similar to those owed to Indemnitee under this Deed, the Company will not be liable for the Expenses of more than one separate firm of attorneys (in addition to any local counsel necessary for the representation). The Company shall not be entitled,
without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Company or as to which counsel for the Company or Indemnitee shall have reasonably made the conclusion provided for in clause (ii) above.
Section 5.
Warranty
.
The
Company warrants by its execution hereof that it has power to enter into and has duly authorised the execution and delivery of this Indemnity and that its obligations hereunder constitute legal, valid and binding obligations enforceable against the
Company in accordance with its terms.
Section 6.
Procedure for Indemnification
.
(a) To obtain indemnification, Indemnitee shall promptly submit to the Company a written request, including therein or therewith such
documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification. The Company shall, promptly upon receipt of such a request for
indemnification, advise the Board of Directors of the Company in writing that Indemnitee has requested indemnification.
(b) The
Company’s determination whether to grant Indemnitee’s indemnification request shall be made promptly, and in any event within sixty (60) days following receipt of a request for indemnification pursuant to
Section 6(a)
. The
right to indemnification as granted by
Section 1
of this Deed shall be enforceable by Indemnitee in any court of competent jurisdiction if the Company denies such request, in whole or in part, or fails to respond within such 60-day
period. It shall be a defense to any such action that Indemnitee has not met the standard of conduct set forth in
Section 1
hereof, but the burden of proving such defense by clear and convincing evidence shall be on the Company. Neither
the failure of the Company (including its Board of Directors or one of its committees, its independent legal counsel, and its stockholders) to have made a determination prior to the commencement of such action that indemnification of Indemnitee is
proper in the circumstances because Indemnitee has met the applicable standard of conduct set forth in
Section 1
, nor the fact that there has been an actual determination by the Company (including its Board of Directors or one of its
committees, its independent legal counsel, and its stockholders) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has or has not met the applicable standard of
conduct.
(c) Subject to the limitations set forth in
Section 8
, Indemnitee shall be presumed to be entitled to
indemnification under this Deed upon submission of a request for
3
indemnification pursuant to this
Section 6
, and the Company shall have the burden of proof in overcoming that presumption in reaching a determination contrary to that presumption.
Such presumption shall be used as a basis for a determination of entitlement to indemnification unless the Company overcomes such presumption by clear and convincing evidence.
Section 7.
Insurance and Subrogation
.
(a) The Company may purchase and maintain insurance on behalf of Indemnitee who is or was or has agreed to serve at the request of the Company
as a director or officer of the Company against any liability asserted against, and incurred by, Indemnitee or on Indemnitee’s behalf in any such capacity, or arising out of Indemnitee’s status as such, whether or not the Company would
have the power to indemnify Indemnitee against such liability under the provisions of this Deed. If the Company has such insurance in effect at the time the Company receives from Indemnitee any notice of the commencement of a proceeding, the Company
shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the policy. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf
of Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policy.
(b) In the event of any
payment by the Company under this Deed, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee with respect to any insurance policy, who shall execute all papers required and take all action
necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights in accordance with the terms of such insurance policy. The Company shall pay or reimburse all Expenses
actually and reasonably incurred by Indemnitee in connection with such subrogation.
(c) The Company shall not be liable under this Deed
to make any payment of amounts otherwise indemnifiable hereunder (including, but not limited to, judgments, fines and excise taxes or penalties if and to the extent that Indemnitee has otherwise actually received such payment under this Deed or any
insurance policy, contract, agreement or otherwise.
Section 8.
Limitation on Indemnification
. Notwithstanding any other
provision herein to the contrary, the Company shall not be obligated pursuant to this Deed:
(a)
Claims Initiated by Indemnitee
. To
indemnify to Indemnitee with respect to a proceeding (or part thereof) initiated by Indemnitee.
(b)
Action for Indemnification
. To
indemnify Indemnitee for any Expenses incurred by Indemnitee with respect to any proceeding instituted by Indemnitee to enforce or interpret this Deed.
(c)
Section 16 Violations
. To indemnify Indemnitee on account of any proceeding with respect to which final judgment is rendered
against Indemnitee for payment or an accounting of profits arising from the purchase or sale by Indemnitee of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute.
(d)
Non-compete and Non-disclosure
. To indemnify Indemnitee in connection with proceedings involving the enforcement of non-compete
and/or non-disclosure agreements or the non-compete and/or non-disclosure provisions of employment, consulting or similar agreements Indemnitee may be a party to with the Company.
4
(e)
Additional Limitations
. To indemnify Indemnitee in circumstances where Indemnitee is a
defendant or a respondent in a proceeding and (i) Indemnitee is not acquitted or judgment is not given in Indemnitee’s favour and (ii) the court does not grant relief to Indemnitee in connection with any application under
Section 391 or Section 42 of the Companies Act.
Section 9.
Savings Clause
. If any provision or provisions of this
Deed shall be invalidated on any ground by any court of competent jurisdiction, then the Company shall nevertheless indemnify Indemnitee as to Expenses, judgments and fines with respect to any proceeding, including an action by or in the right of
the Company, to the full extent permitted by any applicable portion of this Deed that shall not have been invalidated and to the full extent permitted by applicable law.
Section 10.
Certain Definitions
. For purposes of this Deed, the following definitions shall apply:
(a) The term “Expenses” shall include all reasonable attorneys’ fees (applying the Company’s billing guidelines, if any,
and otherwise consistent with the Company’s past practice for payment of legal fees for outside counsel), retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs,
telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Deed, excise taxes and penalties, and all other disbursements
or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a proceeding. Expenses also shall include
(i) Expenses incurred in connection with any appeal resulting from any proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and
(ii) Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Deed, by litigation or otherwise, in accordance with
Section 16
. Expenses, however, shall not
include the amount of judgments or fines against Indemnitee.
(b) The term “Company” shall include, without limitation and in
addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its
directors and officers, so that any person who is or was a director or officer of such constituent corporation, or is or was serving at the request of such constituent corporation as a director or officer shall stand in the same position under the
provisions of this Deed with respect to the resulting or surviving corporation as he or she would have with respect to such constituent corporation if its separate existence had continued.
(a) A person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and
beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Deed.
5
Section 11.
Form and Delivery of Communications
. Any notice, request or other
communication required or permitted to be given to the parties under this Deed shall be in writing and either delivered in person or sent by telecopy, telex, telegram, overnight mail or courier service, or certified or registered mail, return
receipt requested, postage prepaid, to the parties at the following addresses (or at such other addresses for a party as shall be specified by like notice):
If to the Company:
Actavis plc
Morris Corporate Center III, 400 Interpace Parkway
Parsippany, NJ 07054
Attn: Chief
Legal Officer – Global and Secretary
Facsimile:
If to Indemnitee:
[
—
]
Section 12.
Subsequent Legislation
. If the Companies Act 1963 is
amended after adoption of this Deed to expand further the indemnification permitted to directors or officers, then the Company shall indemnify Indemnitee to the fullest extent permitted by the Companies Act 1963, as so amended.
Section 13.
Effective Date and Release
.
This Indemnity shall be effective and shall remain in full force and effect until Indemnitee confirms in writing to the Company that it is
released from its obligations hereunder. The resignation of Indemnitee shall not terminate or otherwise prejudice his continuing rights hereunder.
Section 14.
Nonexclusivity
; No Duplication of Payments
.
(a) The provisions for indemnification set forth in this Deed shall not be deemed exclusive of any other rights which Indemnitee may have under
any provision of law, the Company’s Memorandum and Articles of Association (as may be amended from time to time), in any court in which a proceeding is brought, the vote of the Company’s stockholders or disinterested directors, other
agreements or otherwise, and Indemnitee’s rights hereunder shall continue after Indemnitee has ceased acting as director or officer of the Company and shall inure to the benefit of the heirs, executors and administrators of Indemnitee. However,
no amendment or alteration of the Company’s Memorandum or Articles of Association or any other agreement shall adversely affect the rights provided to Indemnitee under this Deed.
(b) The Company shall not be liable under this Deed to make any payment to Indemnitee in respect of any expenses, judgments and fines or any
other amounts paid to or incurred by Indemnitee to the extent Indemnitee has otherwise received payment, including, without limitation, under any insurance policy, the Company’s Memorandum or Articles of Association, the organizational
documents of any of the Company’s subsidiaries or any agreement between Indemnitee and any of the Company’s subsidiaries (each, an “
Alternative Source
”), for such expenses, judgments and fines or amounts that are otherwise
indemnifiable by the Company hereunder. In the event that Indemnitee receives from the Company and an
6
Alternative Source a duplicate payment in respect of the same expenses, judgments and fines or any other amounts incurred by Indemnitee, Indemnitee shall promptly reimburse the Company in the
amount of such duplicate payment.
Section 15.
Enforcement
. The Company shall be precluded from asserting in any judicial
proceeding that the procedures and presumptions of this Deed are not valid, binding and enforceable. The Company agrees that its execution of this Deed shall constitute a stipulation by which it shall be irrevocably bound in any court of competent
jurisdiction in which a proceeding by Indemnitee for enforcement of his rights hereunder shall have been commenced, continued or appealed, that its obligations set forth in this Deed are unique and special, and that failure of the Company to comply
with the provisions of this Deed will cause irreparable and irremediable injury to Indemnitee, for which a remedy at law will be inadequate. As a result, in addition to any other right or remedy Indemnitee may have at law or in equity with respect
to breach of this Deed, Indemnitee shall be entitled to injunctive or mandatory relief directing specific performance by the Company of its obligations under this Deed.
Section 16.
Interpretation
.
(a) It is understood that the parties hereto intend this Deed to be interpreted and enforced so as to provide indemnification to Indemnitee to
the fullest extent now or hereafter permitted by law.
(b) In this Deed any reference to any statute shall be construed as a reference to
that statute as extended, modified, replaced or re-enacted from time to time (whether before or after the date hereof) and all statutory instruments, regulations and orders from time to time made thereunder or deriving validity therefrom (whether
before or after the date hereof).
Section 18.
Entire Agreement
. This Deed and the documents expressly referred to herein
constitute the entire agreement between the parties hereto with respect to the matters covered hereby, and any other prior or contemporaneous oral or written understandings or agreements with respect to the matters covered hereby are expressly
superseded by this Deed.
Section 19.
Modification and Waiver
. No supplement, modification or amendment of this Deed shall be
binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Deed shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar) nor shall such waiver constitute a
continuing waiver.
Section 20.
Successor and Assigns
. All of the terms and provisions of this Deed shall be binding upon,
shall inure to the benefit of and shall be enforceable by the parties hereto and their respective successors, assigns, heirs, executors, administrators and legal representatives. The Company shall require and cause any direct or indirect successor
(whether by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company, by written agreement in form and substance reasonably satisfactory to Indemnitee, expressly to assume and agree to
perform this Deed in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.
Section 21.
Service of Process and Venue
. For purposes of any claims or proceedings to enforce this Deed, the Company consents to
the jurisdiction and venue of any court of competent jurisdiction in Ireland, and waives and agrees not to raise any defense that any such court is an inconvenient forum or any similar claim.
7
Section 22.
Supersedes Prior Agreement
. This Deed supersedes any prior deed of
indemnification or indemnification agreement between Indemnitee and the Company or its predecessors; provided, however, for the avoidance of doubt, that this Deed does not supersede or otherwise affect Indemnitee’s rights under any
indemnification agreement between Indemnitee and Actavis W.C. Holding Inc., a Delaware corporation and wholly-owned subsidiary of the Company.
Section 23.
Governing Law
. This Deed shall be governed exclusively by and construed according to the laws of Ireland, as applied
to contracts between Irish residents entered into and to be performed entirely within Ireland. If a court of competent jurisdiction shall make a final determination that the provisions of the law of any jurisdiction other than Ireland govern
indemnification by the Company of its officers and directors, then the indemnification provided under this Deed shall in all instances be enforceable to the fullest extent permitted under such law, notwithstanding any provision of this Deed to the
contrary.
Section 25.
Employment Rights
. Nothing in this Deed is intended to create in Indemnitee any right to employment or
continued employment.
Section 26.
Counterparts
. This Deed may be executed in two or more counterparts, each of which shall be
deemed to be an original and all of which together shall be deemed to be one and the same instrument, notwithstanding that both parties are not signatories to the original or same counterpart.
Section 27.
Headings
. The section and subsection headings contained in this Deed are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Deed.
IN WITNESS WHEREOF, this Deed has been duly executed and delivered to be
effective as of the date first above written.
|
|
|
|
|
GIVEN UNDER THE COMMON SEAL OF ACTAVIS PLC
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
|
Title:
|
|
Director
|
|
|
|
INDEMNITEE:
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
|
Title:
|
|
|
8
Exhibit 10.7
INDEMNIFICATION AGREEMENT
This Indemnification Agreement, dated as of ,
20 , is made by and between Actavis W.C. Holding Inc., a Delaware corporation (the “Company”), and
( “Indemnitee”).
WHEREAS, Actavis plc (“Holdco”), a public limited company incorporated under the laws of Ireland, is the Company’s ultimate
parent company;
WHEREAS, the Company desires to ensure that Holdco benefits from the services of highly qualified, experienced and
otherwise competent persons such as Indemnitee;
WHEREAS, the Company and Indemnitee are aware of provisions under Irish law that limit
the level of indemnification available to a director of Holdco;
WHEREAS, the Company previously requested that Indemnitee serve Holdco as
a director of Holdco, and, if requested to do so by the Company, as a director, officer, trustee, employee, representative or agent of another corporation, joint venture, trust or other enterprise, in each case whether organized under the laws of
the United States, any state thereof, any foreign nation or any political subdivision thereof; and
WHEREAS, Indemnitee desires to be
indemnified by the Company and has agreed to become a director of Holdco in reliance upon the Company’s promise to provide indemnification on the basis (i) herein set forth and (ii) set forth in an indemnification agreement between
Holdco and Indemnitee.
NOW, THEREFORE, in consideration of the foregoing promises and the mutual covenants herein contained, the parties
hereto agree as follows:
Section 1.
Generally
.
To the fullest extent permitted by the laws of the State of Delaware:
(a) The Company shall indemnify Indemnitee if Indemnitee was or is a party or is threatened to be made a party to any Proceeding by reason of
the fact that Indemnitee is or was or has agreed to serve at the request of Holdco as a director, officer, employee or agent of Holdco, or while serving as a director or officer of Holdco, is or was serving or has agreed to serve at the request of
Holdco as a director, officer, employee or agent (which, for purposes hereof, shall include a trustee, partner or manager or similar capacity) of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, or
by reason of any action alleged to have been taken or omitted in such capacity. For the avoidance of doubt, the foregoing indemnification obligation includes, without limitation, claims for monetary damages against Indemnitee in respect of an
alleged breach of fiduciary duties, to the fullest extent permitted under Section 102(b)(7) of the General Corporation Law of Delaware (the “DGCL”).
(b) The indemnification provided by this
Section 1
shall be from and against Expenses, judgments, fines and amounts paid in
settlement actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding and any appeal therefrom, but shall only be provided if Indemnitee acted in good faith and in a manner Indemnitee reasonably
believed to be in or not opposed to the best interests of Holdco, and, with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful.
(c) Notwithstanding the foregoing provisions of this
Section 1
, in the case of any
Proceeding brought by or in the right of Holdco to procure a judgment in its favor by reason of the fact that Indemnitee is or was a director, officer, employee or agent of Holdco, or while serving as a director or officer of Holdco, is or was
serving or has agreed to serve at the request of Holdco as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, no indemnification shall be made in respect of
any claim, issue or matter as to which Indemnitee shall have been adjudged to be liable to Holdco unless, and only to the extent that, the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon
application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such Expenses which the Delaware Court of Chancery or such other court shall deem
proper.
(d) The termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its
equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of Holdco, and, with respect to any criminal
Proceeding, had reasonable cause to believe that Indemnitee’s conduct was unlawful.
(e) The rights of Indemnitee hereunder shall be
in addition to any rights Indemnitee may now or hereafter have to indemnification by the Company, Holdco or otherwise.
Section 2.
Successful Defense; Partial Indemnification
. To the extent that Indemnitee has been successful on the merits or otherwise in defense of any Proceeding referred to in
Section 1
of this Agreement or in defense of any claim, issue or
matter therein, Indemnitee shall be indemnified against Expenses actually and reasonably incurred in connection therewith. For purposes of this Agreement and without limiting the foregoing, if any Proceeding is disposed of, on the merits or
otherwise (including a disposition without prejudice), without (i) the disposition being adverse to Indemnitee, (ii) an adjudication that Indemnitee was liable to Holdco or a plea of guilty or nolo contendere by Indemnitee, (iii) an
adjudication that Indemnitee did not act in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of Holdco, and (iv) with respect to any criminal Proceeding, an adjudication that Indemnitee had
reasonable cause to believe Indemnitee’s conduct was unlawful, Indemnitee shall be considered for the purposes hereof to have been wholly successful with respect thereto.
If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of the Expenses,
judgments, fines or amounts paid in settlement actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding or investigation, or in defense of any claim, issue or matter therein, and any appeal
therefrom but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such Expenses, judgments, fines or amounts paid in settlement to which Indemnitee is entitled.
Section 3.
Determination That Indemnification Is Proper
. Any indemnification hereunder shall (unless otherwise ordered by a court)
be made by the Company unless a
2
determination is made that indemnification of such person is not proper in the circumstances because he or she has not met the applicable standard of conduct set forth in
Section 1(b)
of this Agreement. Any such determination shall be made (i) by a majority vote of the directors who are not parties to the Proceeding in question (“disinterested directors”), even if less than a quorum, (ii) by a majority vote of
a committee of disinterested directors designated by majority vote of disinterested directors, even if less than a quorum, (iii) by independent legal counsel, or (iv) by a court of competent jurisdiction.
Section 4.
Advance Payment of Expenses; Notification and Defense of Claim
.
(a) Expenses incurred by Indemnitee in defending a Proceeding, or in connection with an enforcement action pursuant to
Section 5(b)
, shall be paid by the Company in advance of the final disposition of such Proceeding within thirty (30) days after receipt by the Company of (i) a statement or statements from Indemnitee requesting such advance or
advances from time to time, and (ii) an undertaking by or on behalf of Indemnitee to repay such amount or amounts, only if, and to the extent that, it shall ultimately be determined that Indemnitee is not entitled to be indemnified by the
Company as authorized by this Agreement or otherwise. Such undertaking shall be accepted without reference to the financial ability of Indemnitee to make such repayment. Advances shall be unsecured and interest-free.
(b) Promptly after receipt by Indemnitee of notice of the commencement of any Proceeding, Indemnitee shall, if a claim thereof is to be made
against the Company hereunder, notify the Company of the commencement thereof. The failure to promptly notify the Company of the commencement of the Proceeding, or Indemnitee’s request for indemnification, will not relieve the Company from any
liability that it may have to Indemnitee hereunder, except to the extent the Company is prejudiced in its defense of such Proceeding as a result of such failure.
(c) In the event the Company shall be obligated to pay the Expenses of Indemnitee with respect to a Proceeding, as provided in this Agreement,
the Company, if appropriate, shall be entitled to assume the defense of such Proceeding, with counsel reasonably acceptable to Indemnitee, upon the delivery to Indemnitee of written notice of its election to do so. After delivery of such notice,
approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to the same
Proceeding, provided that (1) Indemnitee shall have the right to employ Indemnitee’s own counsel in such Proceeding at Indemnitee’s expense and (2) if (i) the employment of counsel by Indemnitee has been previously
authorized in writing by the Company, (ii) counsel to the Company or Indemnitee shall have reasonably concluded that there may be a conflict of interest or position, or reasonably believes that a conflict is likely to arise, on any significant
issue between the Company and Indemnitee in the conduct of any such defense or (iii) the Company shall not, in fact, have employed counsel to assume the defense of such Proceeding, then the Expenses of Indemnitee’s counsel shall be at the
expense of the Company, except as otherwise expressly provided by this Agreement. Notwithstanding the foregoing, in the case of clause (iii) of the preceding sentence, Indemnitee acknowledges that, in connection with any one such Proceeding
involving at least one other party to whom the Company owes obligations identical or similar to those owed to Indemnitee under this Agreement, or separate but substantially similar Proceedings arising out of the same general allegations and
involving at least one other party to whom the Company owes obligations identical or similar to those owed to Indemnitee
3
under this Agreement, the Company will not be liable for the Expenses of more than one separate firm of attorneys (in addition to any local counsel necessary for the representation). The Company
shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Company or as to which counsel for the Company or Indemnitee shall have reasonably made the conclusion provided for in
clause (ii) above.
(d) Notwithstanding any other provision of this Agreement to the contrary, to the extent that Indemnitee is, by
reason of Indemnitee’s corporate status with respect to Holdco, the Company or any corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which Indemnitee is or was serving or has agreed to serve at the
request of Holdco or the Company, a witness or otherwise participates in any Proceeding at a time when Indemnitee is not a party in the Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by
Indemnitee or on Indemnitee’s behalf in connection therewith.
Section 5.
Procedure for Indemnification
.
(a) To obtain indemnification, Indemnitee shall promptly submit to the Company a written request, including therein or therewith such
documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification. The Company shall, promptly upon receipt of such a request for
indemnification, advise the Board of Directors of the Company in writing that Indemnitee has requested indemnification.
(b) The
Company’s determination whether to grant Indemnitee’s indemnification request shall be made promptly, and in any event within sixty (60) days following receipt of a request for indemnification pursuant to
Section 5(a)
. The
right to indemnification as granted by
Section 1
of this Agreement shall be enforceable by Indemnitee in any court of competent jurisdiction if the Company denies such request, in whole or in part, or fails to respond within such 60-day
period. It shall be a defense to any such action (other than an action brought to enforce a claim for the advance of costs, charges and Expenses under
Section 4
of this Agreement where the required undertaking, if any, has been received
by the Company) that Indemnitee has not met the standard of conduct set forth in
Section 1
hereof, but the burden of proving such defense by clear and convincing evidence shall be on the Company. Neither the failure of the Company
(including its Board of Directors or one of its committees, its independent legal counsel, and its stockholders) to have made a determination prior to the commencement of such action that indemnification of Indemnitee is proper in the circumstances
because Indemnitee has met the applicable standard of conduct set forth in
Section 1
, nor the fact that there has been an actual determination by the Company (including its Board of Directors or one of its committees, its independent
legal counsel, and its stockholders) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has or has not met the applicable standard of conduct. The
Indemnitee’s Expenses incurred in connection with successfully establishing Indemnitee’s right to indemnification, in whole or in part, in any such proceeding or otherwise shall also be indemnified by the Company.
(c) Subject to the limitations set forth in
Section 7
, the Indemnitee shall be presumed to be entitled to indemnification under
this Agreement upon submission of a request for indemnification pursuant to this
Section 5
, and the Company shall have the burden of proof
4
in overcoming that presumption in reaching a determination contrary to that presumption. Such presumption shall be used as a basis for a determination of entitlement to indemnification unless the
Company overcomes such presumption by clear and convincing evidence.
Section 6.
Insurance and Subrogation
.
(a) The Company may purchase and maintain insurance on behalf of Indemnitee who is or was or has agreed to serve at the request of the Company
or Holdco as a director or officer of the Company or Holdco, or is or was serving at the request of Holdco as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise
against any liability asserted against, and incurred by, Indemnitee or on Indemnitee’s behalf in any such capacity, or arising out of Indemnitee’s status as such, whether or not the Company would have the power to indemnify Indemnitee
against such liability under the provisions of this Agreement. If the Company has such insurance in effect at the time the Company receives from Indemnitee any notice of the commencement of a proceeding, the Company shall give prompt notice of the
commencement of such proceeding to the insurers in accordance with the procedures set forth in the policy. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts
payable as a result of such proceeding in accordance with the terms of such policy.
(b) In the event of any payment by the Company under
this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee with respect to any insurance policy, who shall execute all papers required and take all action necessary to secure such
rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights in accordance with the terms of such insurance policy. The Company shall pay or reimburse all Expenses actually and reasonably
incurred by Indemnitee in connection with such subrogation.
(c) The Company shall not be liable under this Agreement to make any payment
of amounts otherwise indemnifiable hereunder (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) if and to the extent that Indemnitee has otherwise actually received such payment under
this Agreement or any insurance policy, contract, agreement or otherwise.
Section 7.
Limitation on Indemnification
.
Notwithstanding any other provision herein to the contrary, the Company shall not be obligated pursuant to this Agreement:
(a)
Claims
Initiated by Indemnitee
. To indemnify or advance Expenses to Indemnitee with respect to a Proceeding (or part thereof) initiated by Indemnitee without the consent or authorization of the Board of Directors of the Company or Holdco, except with
respect to a Proceeding brought to establish or enforce a right to indemnification (which shall be governed by the provisions of
Section 7(b)
of this Agreement).
(b)
Action for Indemnification
. To indemnify Indemnitee for any Expenses incurred by Indemnitee with respect to any Proceeding
instituted by Indemnitee to enforce or interpret this Agreement, unless Indemnitee is successful in establishing Indemnitee’s right to indemnification in such Proceeding, in whole or in part, or unless and to the extent that the court in such
Proceeding shall determine that, despite Indemnitee’s failure to establish their right to indemnification, Indemnitee is entitled to indemnity for such Expenses; provided, however, that
5
nothing in this
Section 7(b)
is intended to limit the Company’s obligation with respect to the advancement of Expenses to Indemnitee in connection with any such Proceeding
instituted by Indemnitee to enforce or interpret this Agreement, as provided in
Section 4
of this Agreement.
(c)
Section 16 Violations
. To indemnify Indemnitee on account of any Proceeding with respect to which final judgment is rendered against Indemnitee for payment or an accounting of profits arising from the purchase or sale by Indemnitee of
securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute.
(d)
Non-compete and Non-disclosure
. To indemnify Indemnitee in connection with Proceedings involving the enforcement of non-compete and/or non-disclosure agreements or the non-compete and/or non-disclosure provisions of employment, consulting or
similar agreements the Indemnitee may be a party to with the Company, Holdco or any subsidiary of the Company or Holdco or any other applicable foreign or domestic corporation, partnership, joint venture, trust or other enterprise, if any.
(e)
Additional Limitations
. To indemnify Indemnitee with respect to (i) any claim or any part thereof as to which Indemnitee shall
have been adjudged by a court of competent jurisdiction from which no appeal is or can be taken, by clear and convincing evidence, to have acted or failed to act with deliberate intent to cause injury to Holdco or with reckless disregard for the
best interests of Holdco or (ii) any obligation of Indemnitee based upon or attributable to Indemnitee gaining in fact any personal gain, profit or advantage to which Indemnitee was not entitled.
Section 8.
Certain Settlement Provisions
. The Company shall have no obligation to indemnify Indemnitee under this Agreement for
amounts paid in settlement of any Proceeding without the Company’s prior written consent, which shall not be unreasonably withheld. The Company shall not settle any Proceeding in any manner that would impose any fine or other obligation on
Indemnitee without Indemnitee’s prior written consent, which shall not be unreasonably withheld.
Section 9.
Savings
Clause
. If any provision or provisions of this Agreement shall be invalidated on any ground by any court of competent jurisdiction, then the Company shall nevertheless indemnify Indemnitee as to Expenses, judgments, fines and amounts paid in
settlement with respect to any Proceeding, including an action by or in the right of Holdco, to the full extent permitted by any applicable portion of this Agreement that shall not have been invalidated and to the full extent permitted by applicable
law.
Section 10.
Contribution
. In order to provide for just and equitable contribution in circumstances in which the
indemnification provided for herein is held by a court of competent jurisdiction to be unavailable to Indemnitee in whole or in part, it is agreed that, in such event, the Company shall, to the fullest extent permitted by law, contribute to the
payment of Indemnitee’s Expenses, judgments, fines and amounts paid in settlement with respect to any Proceeding, in an amount that is just and equitable in the circumstances, taking into account, among other things, contributions by other
directors and officers of the Company or Holdco or others pursuant to indemnification agreements or otherwise; provided, that, without limiting the generality of the foregoing, such contribution shall not be required where such holding by the court
is due to (i) the failure of Indemnitee to meet the standard of conduct set forth in
Section 1
of this Agreement, or (ii) any limitation on indemnification set forth in Section 6(c), 7 or 8 of this Agreement.
6
Section 11.
Certain Definitions
. For purposes of this Agreement, the following
definitions shall apply:
(a) The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration,
alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or Holdco or otherwise and whether of a civil, criminal,
administrative legislative, or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of the fact that
Indemnitee is or was a director or officer of the Company or Holdco, by reason of any action taken by him or of any action on his part while acting as director or officer of the Company or Holdco, or by reason of the fact that he is or was serving
at the request of Holdco as a director, officer, employee or agent of any other enterprises, in each case whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or
advancement of Expenses can be provided under this Agreement. If the Company believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, this situation shall be considered a Proceeding under this
paragraph.
(b) The term “Expenses” shall include all reasonable attorneys’ fees (applying the Company’s billing
guidelines, if any, and otherwise consistent with the Company’s past practice for payment of legal fees for outside counsel), retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing
and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and
penalties, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a
Proceeding. Expenses also shall include (i) Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or
other appeal bond or its equivalent, and (ii) Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or otherwise, in accordance with
Section 15
. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.
(c) The term “judgments, fines and amounts paid in settlement” shall be broadly construed and shall include, without limitation, all
direct and indirect payments of any type or nature whatsoever, including, without limitation, all penalties and amounts required to be forfeited or reimbursed to the Company or Holdco, as well as any penalties or excise taxes assessed on a person
with respect to an employee benefit plan.
(d) The term “Company” shall include, without limitation and in addition to the
resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors,
officers, and employees or agents, so that any
7
person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as he or
she would have with respect to such constituent corporation if its separate existence had continued.
(e) The term “other
enterprises” shall include, without limitation, employee benefit plans.
(f) The term “serving at the request of Holdco”
shall include, without limitation, any service as a director, officer, employee or agent of Holdco which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants
or beneficiaries.
(g) A person who acted in good faith and in a manner such person reasonably believed to be in the interest of the
participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of Holdco” as referred to in this Agreement.
Section 12.
Form and Delivery of Communications
. Any notice, request or other communication required or permitted to be given to
the parties under this Agreement shall be in writing and either delivered in person or sent by telecopy, telex, telegram, overnight mail or courier service, or certified or registered mail, return receipt requested, postage prepaid, to the parties
at the following addresses (or at such other addresses for a party as shall be specified by like notice):
If to the Company:
Actavis W.C. Holding Inc.
Morris Corporate Center III, 400 Interpace Parkway
Parsippany, NJ 07054
Attn: Chief
Legal Officer – Global and Secretary
Facsimile:
If to Indemnitee:
[
—
]
Section 13.
Subsequent Legislation
. If the DGCL is amended after
adoption of this Agreement to expand further the indemnification permitted to directors or officers, then the Company shall indemnify Indemnitee to the fullest extent permitted by the DGCL, as so amended.
Section 14.
Nonexclusivity; No Duplication of Payments
.
(a) The provisions for indemnification and advancement of Expenses set forth in this Agreement shall not be deemed exclusive of any other
rights which Indemnitee may have under any provision of law, the Company’s Certificate of Incorporation or Bylaws, in any court in which a proceeding is brought, the vote of the Company’s stockholders or disinterested directors, other
agreements or otherwise, and Indemnitee’s rights hereunder shall continue after
8
Indemnitee has ceased acting as an agent of the Company and shall inure to the benefit of the heirs, executors and administrators of Indemnitee. However, no amendment or alteration of the
Company’s Certificate of Incorporation or Bylaws or any other agreement shall adversely affect the rights provided to Indemnitee under this Agreement.
(b) The Company shall not be liable under this Agreement to make any payment to Indemnitee in respect of any Expenses, judgments, fines and
amounts paid in settlement or any other amounts paid to or incurred by Indemnitee to the extent Indemnitee has otherwise received payment, including, without limitation, under any insurance policy, the Company’s Certificate of Incorporation or
Bylaws, Holdco’s Memorandum and Articles of Association (as each may be amended from time to time) or any agreement between Indemnitee and Holdco (each, an “
Alternative Source
”), for such Expenses, judgments, fines and amounts
paid in settlement or amounts that are otherwise indemnifiable by the Company hereunder. In the event that Indemnitee receives from the Company and an Alternative Source a duplicate payment in respect of the same Expenses, judgments, fines, amounts
paid in settlement or any other amounts incurred by Indemnitee, Indemnitee shall promptly reimburse the Company in the amount of such duplicate payment.
Section 15.
Enforcement
. The Company shall be precluded from asserting in any judicial proceeding that the procedures and
presumptions of this Agreement are not valid, binding and enforceable. The Company agrees that its execution of this Agreement shall constitute a stipulation by which it shall be irrevocably bound in any court of competent jurisdiction in which a
proceeding by Indemnitee for enforcement of his rights hereunder shall have been commenced, continued or appealed, that its obligations set forth in this Agreement are unique and special, and that failure of the Company to comply with the provisions
of this Agreement will cause irreparable and irremediable injury to Indemnitee, for which a remedy at law will be inadequate. As a result, in addition to any other right or remedy Indemnitee may have at law or in equity with respect to breach of
this Agreement, Indemnitee shall be entitled to injunctive or mandatory relief directing specific performance by the Company of its obligations under this Agreement.
Section 16.
Interpretation of Agreement
. It is understood that the parties hereto intend this Agreement to be interpreted and
enforced so as to provide indemnification to Indemnitee to the fullest extent now or hereafter permitted by law.
Section 17.
Entire Agreement
. This Agreement and the documents expressly referred to herein constitute the entire agreement between the parties hereto with respect to the matters covered hereby, and any other prior or contemporaneous oral or written
understandings or agreements with respect to the matters covered hereby are expressly superseded by this Agreement.
Section 18.
Modification and Waiver
. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall
constitute a waiver of any other provision hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.
Section 19.
Successor and Assigns
. All of the terms and provisions of this Agreement shall be binding upon, shall inure to the
benefit of and shall be enforceable by the parties hereto
9
and their respective successors, assigns, heirs, executors, administrators and legal representatives. The Company shall require and cause any direct or indirect successor (whether by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company, by written agreement in form and substance reasonably satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.
Section 20.
Service of Process and Venue
. For purposes of any claims or proceedings to enforce this agreement, the Company
consents to the jurisdiction and venue of any federal or state court of competent jurisdiction in the states of Delaware and [New Jersey], and waives and agrees not to raise any defense that any such court is an inconvenient forum or any similar
claim.
Section 21.
Supersedes Prior Agreement
. This Agreement supersedes any prior indemnification agreement between
Indemnitee and the Company or its predecessors.
Section 22.
Governing Law
. This Agreement shall be governed exclusively by
and construed according to the laws of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely within Delaware. If a court of competent jurisdiction shall make a final determination that
the provisions of the law of any state other than Delaware govern indemnification by the Company of its officers and directors or the officers and directors of Holdco, then the indemnification provided under this Agreement shall in all instances be
enforceable to the fullest extent permitted under such law, notwithstanding any provision of this Agreement to the contrary.
Section 23.
Employment Rights
. Nothing in this Agreement is intended to create in Indemnitee any right to employment or continued
employment.
Section 24.
Counterparts
. This Agreement may be executed in two or more counterparts, each of which shall be
deemed to be an original and all of which together shall be deemed to be one and the same instrument, notwithstanding that both parties are not signatories to the original or same counterpart.
Section 25.
Headings
. The section and subsection headings contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Agreement.
[Signature page follows.]
10
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered to be effective as of the
date first above written.
|
|
|
|
|
ACTAVIS W.C. HOLDING INC.
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
|
Title:
|
|
|
|
|
|
INDEMNITEE:
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
|
Title:
|
|
|
11
Exhibit 99.1
NEWS RELEASE
|
|
|
|
|
CONTACTS:
|
|
Investors:
|
|
|
|
Lisa DeFrancesco
|
|
|
|
(862) 261-7152
|
|
|
|
|
|
|
Media:
|
|
|
|
Charlie Mayr
|
|
|
|
(862) 261-8030
|
|
|
|
|
|
|
David Belian
|
|
|
|
(862) 261-8141
|
Actavis Completes Warner Chilcott Acquisition
– Creates Leading Global Specialty Pharmaceutical Company –
– $11.0 Billion Anticipated Pro Forma Combined 2013 Revenue –
– Top 3 U.S. ~$3.0 Billion Revenue Specialty Brand Business –
– Current Leverage Ratio 3.1x Debt to Adjusted EBITDA –
DUBLIN – October 1, 2013
– Actavis plc (NYSE: ACT) (“Actavis”) today announced that it has completed the acquisition of Warner
Chilcott plc (NASDAQ: WCRX) (“Warner Chilcott”) in a stock-for-stock transaction valued at approximately $8.5 billion. The combination creates a leading global specialty pharmaceutical company with approximately $11 billion in anticipated
pro forma combined annual 2013 revenue, and the third-largest specialty pharmaceutical business in the U.S. with approximately $3 billion in annual revenue focused on the core therapeutic categories of Women’s Health, Urology, Gastroenterology
and Dermatology.
In connection with the acquisition, Actavis and Warner Chilcott have been combined under a new company incorporated in Ireland, and have
adopted the global name Actavis plc. Shares of Actavis plc will trade on the New York Stock Exchange under the ticker symbol ACT. The scheme of arrangement to effect Actavis’ acquisition of Warner Chilcott plc has taken effect today, and Warner
Chilcott shareholders will receive the consideration to which they are entitled under the scheme of arrangement within 14 days.
“The combination of Actavis and Warner Chilcott creates a premier specialty pharmaceutical leader under the
Actavis Specialty Brands umbrella. This enhanced business segment is uniquely positioned to meet the healthcare needs of patients around the world – particularly as a leader in Women’s Health,” said Paul Bisaro, President and CEO of
Actavis. “The acquisition more than doubles Actavis’ Specialty Brands portfolio and delivers an industry leading pipeline with more than 25 products in various stages of development.
“Within our Women’s Health segment, we are now a strong leader with over 90 percent share of voice in oral contraceptives based on IMS Audits and
have an expanded pipeline including seven new development programs encompassing three near-term launches and more than 10 products in late-stage development. Additionally, the combination bolsters our Urology business, establishes a platform for
continued expansion into the Gastroenterology and Dermatology therapeutic categories and provides the opportunity to introduce a broader portfolio of new products in Actavis’ expanded global footprint.
“We are pleased with the performance of this business to date, including a record number of launches and the successful introductions of Minastrin™
24, Delzicol™ and Doryx
®
200 mg. When combined with the global commercial presence of Actavis Pharma and supported by our industry-leading Actavis Global Operations team, we now operate a
formidable specialty pharmaceutical company. We have immediately implemented a comprehensive integration process, and will focus our efforts on maximizing our broader portfolio of marketed products, our enhanced research and development capabilities
and pipeline and our expanded manufacturing footprint to capture synergies and drive continued growth and value for our shareholders, customers and employees. With the acquisition now closed, we renew our goal of long-term, double-digit organic
earnings growth from this newly expanded base.”
Financially Compelling Transaction
Actavis continues to expect the transaction to be more than 30 percent accretive to Actavis non-GAAP earnings per share in 2014, including anticipated
after-tax operational synergies, related cost reductions and tax savings in excess of $400 million. Concurrent with the closing, Actavis will refinance the legacy Warner Chilcott term loan with the new term loan previously announced on
August 2, 2013, resulting in interest rate savings of approximately $12 million per quarter assuming contractual amortization. With a combined debt to EBITDA ratio of 3.1x, the Company has the ability to continue to invest in the growth of
its businesses, while strong anticipated cash flows will allow for further ongoing deleveraging.
Additional details on the strengths of the combined companies, including revenue and earnings forecasts and
updated synergy targets, will be discussed in more detail during Actavis‘ third quarter earnings conference call scheduled for Oct. 29, 2013.
Review of the Benefits of the Acquisition
The
combination represents a significant achievement against Actavis’ long-term strategic objective of building a leading global specialty pharmaceutical company. The combined Company begins operations with a defined global management structure,
led by Actavis senior executives, and aggressive integration strategies are being executed to drive continued organic growth and rapid realization of synergies.
Transforms Actavis Specialty Brands into a Global Competitor
The close of the transaction accelerates Actavis Specialty Brands’ evolution into a global competitor and a key growth driver for the new
company. The combination provides a 125 percent increase in the number of marketed Specialty Brands products, a 600 percent increase in Specialty Brands pro forma net revenue and more than doubles Women’s Health Specialty Brands products with
the addition of Actonel
®
, Lo Loestrin
®
, Minastrin™ 24, Estrace
®
and
Atelvia
®
and the recent approval of Lo Minastrin™. It also bolsters Actavis Specialty Brands’ Urology business with the addition of the Enablex franchise and establishes a platform
for continued expansion into the fast-growing areas of Gastroenterology and Dermatology.
Expands Specialty Brands Industry Leading
Pipeline
Actavis Specialty Brands now possess an industry-leading pipeline with more than 25 products in various stages of
development, including the combination of strong life cycle management strategies and new exclusive product opportunities for long-term sustainable growth in each therapeutic category. The combination significantly expands Actavis’ Specialty
Brands Women’s Health pipeline with the addition of seven new pipeline programs, three near-term launches (Levosert
®
, Minastrin™ 24 Fe, WC 3042) and 12 products in Phase III or the
marketing application phase of development. The combination also adds three mid-to-late phase Urology products in development and additional Dermatology and Gastroenterology products in various stages development.
Completes Actavis’ Evolution into a Global Specialty Pharmaceutical Leader
The dramatically strengthened Actavis Specialty Brands, combined with Actavis Pharma and Actavis Global Operations, forms the foundation of
Actavis plc. The
combined organization has a diversified geographic footprint, with commercial operations in more than 60 countries around the world, and is an industry leader in research and development, focused
on building the strongest pipeline in the industry in order to bring the right products to the right markets across the globe – generic, brand, branded generic, OTC products and biosimilars.
Actavis’ global operations network continues to deliver timely product launches and exceptional levels of customer service, and is
structured to fully support the Company’s evolving product portfolio. It encompasses a leading global supply chain, providing the capability to develop and manufacture products in multiple dosage forms and presentations that provide a
competitive advantage in Actavis’ commercial markets. The transaction is expected to further strengthen the global operations network with the addition of extended release and hormone manufacturing capabilities at a state-of-the-art facility in
Puerto Rico, as well as additional manufacturing, packaging and R&D operations in Germany and Northern Ireland.
October 29
th
Conference Call and Webcast Information
Actavis plans to discuss the close of the acquisition on
its third quarter earnings conference call scheduled for October 29, 2013 at 8:30 a.m. Eastern Time. The dial-in number to access the call is U.S./Canada (877) 251-7980, or from international locations, (706) 643-1573. The Conference
ID is 70901052.
A taped replay of the conference call will also be available beginning approximately two hours after the call’s conclusion and will
remain available through 12:00 midnight Eastern Time on November 12, 2013. The replay may be accessed by dialing (855) 859-2056 and entering Conference ID# 70901052. From international locations, the replay may be accessed by dialing
(404) 537-3406 and entering the same pass code. To access the webcast, go to Actavis’ Investor Relations Web site at
http://ir.actavis.com
. A replay of the webcast will also be available.
About Actavis
Actavis plc (NYSE: ACT) is a global,
integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany, New
Jersey, USA.
Operating as Actavis Pharma, Actavis markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60
countries. Actavis Specialty Brands is Actavis’ global branded specialty pharmaceutical business focused in the Women’s Health, Urology, Gastroenterology and Dermatology therapeutic categories. Actavis Specialty Brands
also has a portfolio of five biosimilar products in development in Women’s Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities
around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.
For press release and other company information, visit
Actavis’ Web site at
http://www.actavis.com
.
Statement Required by the Irish Takeover Rules
The directors of Actavis accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the directors of
Actavis (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.
Forward-Looking Statement
Statements contained in this
press release that refer to Actavis’ estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Actavis’ current perspective of existing trends and information as of the date of this
release. For instance, any statements in this press release concerning prospects related to Actavis’ strategic initiatives, product introductions and anticipated financial performance are forward-looking statements. It is important to note that
Actavis’ goals and expectations are not predictions of actual performance. Actavis’ performance, at times, will differ from its goals and expectations. Actual results may differ materially from Actavis’ current expectations depending
upon a number of factors affecting Actavis’ business. These factors include, among others, the inherent uncertainty associated with financial projections; successful integration of the Warner Chilcott acquisition and the ability to recognize
the anticipated synergies and benefits of the Warner Chilcott acquisition; the difficulty of predicting the timing and outcome of pending or future litigation and government investigations and risks that an adverse outcome in such litigation or
investigations could render Actavis liable for substantial damages or penalties; risks that resolution of patent infringement litigation through settlement could result in investigations or actions by private parties or government authorities or
agencies; the impact of competitive products and pricing; risks related to fluctuations in foreign currency exchange rates; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying
patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty of predicting the
timing or outcome of product development efforts and regulatory agency approvals or actions, if any; risks and uncertainties normally incident to the pharmaceutical industry, including product liability claims and the availability of product
liability insurance on reasonable terms; market acceptance of and continued demand for Actavis’ products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance
with governmental regulations applicable to Actavis’ facilities, products and/or businesses; changes in the laws and regulations, including Medicare, Medicaid, and similar laws in foreign countries affecting, among other things, pricing and
reimbursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Actavis, Inc.’s periodic public filings with the Securities and Exchange Commission, including but not limited
to Actavis, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2012 (as revised pursuant to Actavis, Inc.’s Current Report on Form 8-K dated as of June 17, 2013, which was filed with the SEC on June 18, 2013)
and Quarterly Reports on Form 10-Q for the periods ended March 31, 2013 and June 30, 2013, and Warner Chilcott’s periodic public filings with the Securities and Exchange Commission, including but
not limited to Warner Chilcott’s Annual Report on Form 10-K for the year ended December 31, 2012 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2013 and
June 30, 2013. Except as expressly required by law, Actavis disclaims any intent or obligation to update these forward-looking statements.